FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hertz, A
   Azulay-Abulafia, L
   do Nascimento, AP
   Ohara, CY
   Kuschnir, FC
   Porto, LC
AF Hertz, Amanda
   Azulay-Abulafia, Luna
   do Nascimento, Adriana Paulino
   Ohara, Cintya Yumi
   Kuschnir, Fabio Chigres
   Porto, Luis Cristovao
TI Analysis of filaggrin 2 gene polymorphisms in patients with atopic
   dermatitis
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Allergy; Dermatitis, atopic; Immunology; Polymorphism, genetic
ID SKIN BARRIER; MUTATIONS; ECZEMA; ASTHMA; RISK; QUESTIONNAIRE;
   VALIDATION; MECHANISMS; CHILDHOOD; ALLERGIES
AB Background: Polymorphisms of the filaggrin 2 gene (rs 12568784 and rs 16899374) are associated with persistent atopic dermatitis in African American patients. Filaggrin 2 is a protein with a function similar to filaggrin and also encoded in the epidermal differentiation complex on chromosome 1q21.
   Objective: To evaluate the polymorphisms in the filaggrin 2 gene (rs 12568784 and rs 16899374) in children and adults with atopic dermatitis and to verify the association of these with the severity of the clinical picture, presence of other allergic diseases, and socio-demographic factors.
   Method: The study was carried out with patients and control group. Questionnaires were used to evaluate ethnicity, sex, age, family history, scoring, atopic dermatitis (SCORAD), among other parameters. Genotyping of the filaggrin 2 gene was performed by real-time polymerase chain reaction.
   Results: Forty-eight patients and 83 controls were evaluated. No correlation was found between the variables studied in patients with atopic dermatitis and polymorphisms, no significant difference between the prevalence of polymorphisms in the patients and in the control group p> 0.05.
   Study limits: The exclusive use of self-reported ethnicity information and the sample size. Results: The results of this work can be an incentive for the study of the polymorphisms in atopic dermaititis, considering the characteristic of the Brazilian multi ethnic population.
   Conclusion: This is an unpublished work in Brazil and the first study in the world to have a control group to evaluate alterations in the gene of filaggrin 2. (C) 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana, S.L.U.
C1 [Hertz, Amanda] Inst Dermatol Prof Rubem David Azulay, Pediat Dermatol Clin, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, Inst Dermatol Prof Rubem David Azulay, bDept Dermatol, Rio De Janeiro, RJ, Brazil.
   [do Nascimento, Adriana Paulino; Porto, Luis Cristovao] Univ Estado Rio de Janeiro, Histocompatibil & Cryopreservat Lab, Rio De Janeiro, RJ, Brazil.
   [Ohara, Cintya Yumi] Univ Estado Rio de Janeiro, Dept Allergy & Immunopathol, Rio De Janeiro, RJ, Brazil.
   [Kuschnir, Fabio Chigres] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Pediat, Rio De Janeiro, RJ, Brazil.
   [Kuschnir, Fabio Chigres] Univ Estado Rio de Janeiro, Dept Allergy, Rio De Janeiro, RJ, Brazil.
   [Hertz, Amanda; Azulay-Abulafia, Luna; do Nascimento, Adriana Paulino; Ohara, Cintya Yumi; Kuschnir, Fabio Chigres; Porto, Luis Cristovao] Univ Estado Rio de Janeiro, Oliclin Piquet Carneiro, Atop Dermatitis Clin, Rio De Janeiro, RJ, Brazil.
RP Hertz, A (corresponding author), Inst Dermatol Prof Rubem David Azulay, Pediat Dermatol Clin, Rio De Janeiro, RJ, Brazil.
EM hertzamanda@gmail.com
RI ; Porto, Luis Cristovao/I-2984-2013
OI Azulay- Abulafia, Luna/0000-0002-4698-2009; OHARA,
   CINTYA/0000-0002-6282-4246; Paulino do Nascimento,
   Adriana/0000-0002-3240-3651; KUSCHNIR, FABIO/0000-0003-1432-2396; Porto,
   Luis Cristovao/0000-0003-1499-1821
FU Fundode Apoio a Dermatologia (FUNADERM) of the Brazilian Society of
   Dermatology
FX This work was carried out with the financial support of Fundode Apoio a
   Dermatologia (FUNADERM) of the Brazilian Society of Dermatology.
CR Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067
   Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081
   Cardena MMSG, 2013, ETICA JUSTICA, V18, P62
   Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x
   Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034
   Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040
   Makino T, 2014, BIOCHEM BIOPH RES CO, V449, P100, DOI 10.1016/j.bbrc.2014.04.165
   Margolis DJ, 2014, J ALLERGY CLIN IMMUN, V133, P784, DOI 10.1016/j.jaci.2013.09.015
   Margolis DJ, 2012, J ALLERGY CLIN IMMUN, V130, P912, DOI 10.1016/j.jaci.2012.07.008
   Mocsai G, 2014, BRIT J DERMATOL, V170, P617, DOI 10.1111/bjd.12743
   Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x
   Polcari I, 2014, PEDIATR DERMATOL, V31, P489, DOI 10.1111/pde.12355
   RUIZ RGG, 1992, CLIN EXP ALLERGY, V22, P762, DOI 10.1111/j.1365-2222.1992.tb02816.x
   Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969
   Sole D, 1998, J INVEST ALLERG CLIN, V8, P376
   Vanna AT, 2001, PEDIATR ALLERGY IMMU, V12, P95, DOI 10.1034/j.1399-3038.2001.012002095.x
   Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008
   Wadonda Kabondo N, 2004, ARCH DIS CHILD, V89, P917
   WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x
   Winge MCG, 2014, FILAGGRIN, V1, P119
NR 20
TC 0
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAR-APR
PY 2020
VL 95
IS 2
BP 173
EP 179
DI 10.1016/j.abd.2019.07.002
PG 7
WC Dermatology
SC Dermatology
GA LF7IK
UT WOS:000527590600006
PM 32151410
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Araujo, KM
   Bressan, AL
   Azulay-Abulafia, L
AF Araujo, Karin M.
   Bressan, Aline L.
   Azulay-Abulafia, Luna
TI Zika, chikungunya, and dengue infections as exacerbating factors of
   psoriasis in patients receiving biological therapy
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Letter
C1 [Araujo, Karin M.; Bressan, Aline L.; Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, Dept Dermatol, Rio De Janeiro, Brazil.
RP Azulay-Abulafia, L (corresponding author), Univ Estado Rio De Janeiro, Dept Dermatol, Rio De Janeiro, Brazil.
EM lunaazulay@gmail.com
OI ARAUJO, KARIN MILLENI/0000-0003-2421-3978
CR Andersen LK, 2017, INT J DERMATOL, V56, pe84, DOI 10.1111/ijd.13509
   Mondolfi AEP, 2018, CLIN EXP DERMATOL, V43, P171, DOI 10.1111/ced.13294
   Plachouri KM, 2019, INT J DERMATOL, V58, P1008, DOI 10.1111/ijd.14436
   Seetharam KA, 2011, J DERMATOL, V38, P1033, DOI 10.1111/j.1346-8138.2011.01200.x
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
NR 5
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD JUN
PY 2020
VL 59
IS 6
BP E209
EP E211
DI 10.1111/ijd.14785
EA FEB 2020
PG 3
WC Dermatology
SC Dermatology
GA LM9RA
UT WOS:000512111300001
PM 32039473
DA 2020-12-01
ER

PT J
AU Lopes, N
   Dias, LLS
   Azulay-Abulafia, L
   Oyafuso, LKM
   Suarez, MV
   Fabricio, L
   Kobata, CM
   Cestari, T
   Gontijo, B
   Sabbag, CY
   Antonio, JR
   Romiti, R
   Pertel, PC
AF Lopes, Nilceia
   Dias, Leticia L. S.
   Azulay-Abulafia, Luna
   Oyafuso, Luiza K. M.
   Suarez, Maria Victoria
   Fabricio, Lincoln
   Kobata, Clarice Marie
   Cestari, Tania
   Gontijo, Bernardo
   Sabbag, Cid Y.
   Antonio, Joao R.
   Romiti, Ricardo
   Pertel, Patricia C.
TI Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in
   Brazil
SO ADVANCES IN THERAPY
LA English
DT Article
DE Cost of illness; Dermatology; Productivity; Psoriasis; Quality of Life
ID QUALITY-OF-LIFE; CARE RESOURCE USE; WORK PRODUCTIVITY; HOSPITAL ANXIETY;
   DEPRESSION SCALE; INDEX DLQI; ARTHRITIS; EUROQOL; BURDEN; COST
AB Introduction Psoriasis is an immune-mediated, chronic, inflammatory disease, which has a substantial humanistic and economic burden. This study aimed to assess the impact of this disease on health-related quality of life (HRQoL), work productivity, and direct and indirect costs from a societal perspective among Brazilian patients. Methods This is a cross-sectional, observational, multicenter study, enrolling patients with moderate to severe plaque psoriasis according to physician evaluation. Data collection was performed from December 2015 to November 2016 through face-to-face interviews using a structured questionnaire and five standardized patient-reported outcomes instruments. Direct costs were estimated by multiplying the amount of resources used (12-month recall period) by the corresponding unit cost. Indirect costs were grouped in two time horizons: annual costs (income reduction and absenteeism) and lifetime costs (demission and early retirement). Results A total of 188 patients with moderate to severe plaque psoriasis were included, with mean age of 48.0 (SD 13.1). "Anxiety and depression" and "pain and discomfort" were the most impaired dimensions, according to the EuroQol Five-Dimension-Three-Level (EQ-5D-3L). The highest effect was found for "symptoms and feelings" [mean (SD) 2.4 (1.7)] Dermatology Life Quality Index (DLQI) subscale. Psoriatic arthritis (PsA) presence and biologic-naive status were associated with worse HRQoL. Presenteeism was more frequent than absenteeism, according to the Work Productivity and Activity Impairment questionnaire-General Health (WPAI-GH) [17.4% vs. 6.3%], while physical demands and time management were the most affected Work Limitations Questionnaire (WLQ) subscales [means (SD) 23.5 (28.5) and 17.7 (24.9), respectively]. The estimated annual cost per patient was USD 4034. Direct medical costs accounted for 87.7% of this estimate, direct non-medical costs for 2.4%, and indirect costs for 9.9%. Conclusions Results evidenced that moderate to severe plaque psoriasis imposes substantial costs to society. Our data showed that this disease negatively affects both work productivity and HRQoL of Brazilian patients. Subgroups with PsA and biologic-naive patients presented lower HRQoL, showing the impact of this comorbidity and the relevance of biologics in psoriasis treatment. Funding Novartis Biociencias S.A.
C1 [Lopes, Nilceia; Pertel, Patricia C.] Novartis Biociencias SA, Sao Paulo, Brazil.
   [Dias, Leticia L. S.] ANOVA Consultoria Saude, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, Luna] Inst Dermatol & Estet Brasil Ltda, Rio De Janeiro, Brazil.
   [Oyafuso, Luiza K. M.] Fac Med ABC, Santo Andre, Brazil.
   [Suarez, Maria Victoria] Hosp Servidor Publ Municipal, Sao Paulo, Brazil.
   [Fabricio, Lincoln] Hosp Univ Evangel Curitiba, Curitiba, Parana, Brazil.
   [Kobata, Clarice Marie] Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil.
   [Cestari, Tania] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Gontijo, Bernardo] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Sabbag, Cid Y.] Ctr Paulista Invest Clin & Serv Med Ltda, CEPIC, Sao Paulo, Brazil.
   [Antonio, Joao R.] Fundacao Fac Reg Med Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Romiti, Ricardo] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil.
RP Lopes, N (corresponding author), Novartis Biociencias SA, Sao Paulo, Brazil.
EM nilceia.lopes@novartis.com
FU Novartis Biociencias S.A.
FX Novartis Biociencias S.A.
CR Balogh O, 2014, EUR J HEALTH ECON, V15, pS101, DOI 10.1007/s10198-014-0599-z
   Boccuzzi SJ, 2003, CONTEMP CARDIOL, P63
   Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Burgos-Pol R, 2016, ACTAS DERMO-SIFILOGR, V107, P577, DOI 10.1016/j.ad.2016.04.018
   Carrascosa JM, 2006, J EUR ACAD DERMATOL, V20, P840, DOI 10.1111/j.1468-3083.2006.01659.x
   Chan B, 2009, J CUTAN MED SURG, V13, P192, DOI 10.2310/7750.2009.08068
   Ciconelli Rozana Mesquita, 2006, Sao Paulo Med. J., V124, P325, DOI 10.1590/S1516-31802006000600005
   de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x
   DiBonaventura M, 2018, AN BRAS DERMATOL, V93, P197, DOI 10.1590/abd1806-4841.20186069
   Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002
   Driessen RJB, 2010, BRIT J DERMATOL, V162, P1324, DOI 10.1111/j.1365-2133.2010.09693.x
   FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x
   Goncalves DA, 2014, CAD SAUDE PUBLICA, V30, P623, DOI 10.1590/0102-311X00158412
   Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4
   Horn EJ, 2007, J AM ACAD DERMATOL, V57, P963, DOI 10.1016/j.jaad.2007.07.023
   Kossakowska MM, 2010, J EUR ACAD DERMATOL, V24, P429, DOI 10.1111/j.1468-3083.2009.03432.x
   Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009
   Levy AR, 2012, INT J DERMATOL, V51, P1432, DOI 10.1111/j.1365-4632.2011.05359.x
   Liang Y, 2017, CURR OPIN IMMUNOL, V49, P1, DOI 10.1016/j.coi.2017.07.007
   Martins BDL, 2008, AN BRAS DERMATOL, V83, P39, DOI 10.1590/S0365-05962008000100005
   Martins Gladys Aires, 2004, An. Bras. Dermatol., V79, P521, DOI 10.1590/S0365-05962004000500002
   Meyer N, 2010, J EUR ACAD DERMATOL, V24, P1075, DOI 10.1111/j.1468-3083.2010.03600.x
   Michalek IM, 2017, J EUR ACAD DERMATOL, V31, P205, DOI 10.1111/jdv.13854
   Moller AH, 2015, PATIENT-RELAT OUTCOM, V6, P167, DOI 10.2147/PROM.S81428
   Moradi M, 2015, ARCH IRAN MED, V18, P153, DOI 0151803/AIM.004
   Norris D, 2017, J DERMATOL TREAT, V28, P731, DOI 10.1080/09546634.2017.1329501
   Ogdie A, 2015, RHEUM DIS CLIN N AM, V41, P545, DOI 10.1016/j.rdc.2015.07.001
   Puig L, 2015, J DERMATOL TREAT, V26, P7, DOI 10.3109/09546634.2013.860209
   Reilly Associates, 2016, WPAI SCOR
   REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006
   Romiti R, 2018, J DERMATOLOG, V17, P1
   Romiti R, 2017, INT J DERMATOL, V56, pE167, DOI 10.1111/ijd.13604
   Rosen CF, 2012, RHEUMATOLOGY, V51, P571, DOI 10.1093/rheumatology/ker365
   Santos M, 2016, MED DECIS MAKING, V36, P253, DOI 10.1177/0272989X15613521
   Schaefer CP, 2015, J AM ACAD DERMATOL, V73, P585, DOI 10.1016/j.jaad.2015.06.049
   Snaith R, 1993, QUAL LIFE NEWSLETTER, V6, P5
   Sojevic Timotijevic Z, 2013, J DERMATOL, V40, P797, DOI 10.1111/1346-8138.12201
   Tang K, 2011, ARTHRIT CARE RES, V63, pS337, DOI 10.1002/acr.20633
   Tejada CD, 2011, AN BRAS DERMATOL, V86, P1113, DOI 10.1590/S0365-05962011000600008
   Vanderpuye-Orgle J, 2015, J AM ACAD DERMATOL, V72, P961, DOI 10.1016/j.jaad.2015.02.1099
   White D, 1999, BRIT J PSYCHIAT, V175, P452, DOI 10.1192/bjp.175.5.452
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Wu Y, 2009, AM J CLIN DERMATOL, V10, P407, DOI 10.2165/11310440-000000000-00000
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 45
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0741-238X
EI 1865-8652
J9 ADV THER
JI Adv. Ther.
PD OCT
PY 2019
VL 36
IS 10
BP 2849
EP 2865
DI 10.1007/s12325-019-01049-7
PG 17
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA JC0DT
UT WOS:000488950000021
PM 31432463
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Martins, CPD
   Hertz, A
   Luzio, P
   Paludo, P
   Azulay-Abulafia, L
AF Martins, Clarissa Pereira dos Santos
   Hertz, Amanda
   Luzio, Paulo
   Paludo, Patricia
   Azulay-Abulafia, Luna
TI Clinical and epidemiological characteristics of childhood vitiligo: a
   study of 701 patients from Brazil
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
ID CHILDREN; PROFILE; DISEASES; ASSOCIATION; THYROIDITIS; PREVALENCE; CHINA
AB Background Vitiligo is an acquired pigmentary disorder that affects approximately 0.5-2% of the world's population, and 25% of cases begin before 10 years of age. Although prevalent, there are few studies on the characterization of childhood vitiligo. Objective To evaluate the clinical and epidemiological characteristics of childhood vitiligo. Methods Transverse study conducted by reviewing data records of patients under the age of 18 in which disease onset occurred before 13 years of age. Results Predominance of females (62%). The most common subtype was generalized vitiligo (53.8%). The average age of disease onset was 5.9 years. The most affected initial site was head/neck (44.22%). The Koebner phenomenon was present in 38.2%, emotional triggering factors in 67.0% of the patients, halo nevus in 17.4%, and associated autoimmune disease in 6.5% of the patients. Family history of vitiligo was observed in 16.9% of the patients, and stability was reported by 20.1% of patients. The presence of positive family history did not significantly influence the age of onset. We found a significant difference between segmental vitiligo (SV) and nonsegmental vitiligo (NSV) regarding the age of onset, Koebner phenomenon, hypothyroidism, anti-TPO antibodies, family history of psoriasis, and halo nevus. Conclusion Childhood vitiligo has its own characteristics. Vitiligo different subtypes have distinct characteristics. Our study presents a great number of patients, helping to elucidate the peculiarities of childhood vitiligo in the Brazilian population.
C1 [Martins, Clarissa Pereira dos Santos; Hertz, Amanda; Luzio, Paulo; Paludo, Patricia; Azulay-Abulafia, Luna] Prof Rubem David Azulay Inst Dermatol, Vitiligo Clin, Rio De Janeiro, Brazil.
RP Martins, CPD (corresponding author), Barao Torre St 445,Apartment 903, BR-22411003 Ipanema, RJ, Brazil.
EM clapdsm@hotmail.com
CR Agarwal S, 2013, PEDIATR DERMATOL, V30, P348, DOI 10.1111/pde.12032
   Al-Mutairi Nawaf, 2005, Australas J Dermatol, V46, P150, DOI 10.1111/j.1440-0960.2005.00167.x
   Barisic-Drusko V, 2004, COLLEGIUM ANTROPOL, V28, P277
   BECHELLI LM, 1981, DERMATOLOGICA, V163, P78, DOI 10.1159/000250144
   Brazzelli V, 2005, PEDIATR DERMATOL, V22, P257, DOI 10.1111/j.1525-1470.2005.22319.x
   Carvalho VO, 1998, AN BRAS DERMATOL, V73, P419
   Cho S, 2000, PEDIATR DERMATOL, V17, P189, DOI 10.1046/j.1525-1470.2000.01749.x
   de Barros JC, 2014, INT J DERMATOL, V53, P842, DOI 10.1111/ijd.12055
   Ezzedine K, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4126
   Fernandes NC, 2001, AN BRAS DERMATOL, V76, P575
   HALDER RM, 1987, J AM ACAD DERMATOL, V16, P948, DOI 10.1016/S0190-9622(87)70119-4
   Handa S, 2003, PEDIATR DERMATOL, V20, P207, DOI 10.1046/j.1525-1470.2003.20304.x
   Hu Z, 2006, PEDIATR DERMATOL, V23, P114, DOI 10.1111/j.1525-1470.2006.00192.x
   Huggins RH, 2007, CUTIS, V79, P277
   Iacovelli P, 2005, DERMATOLOGY, V210, P26, DOI 10.1159/000081479
   JAISANKAR TJ, 1992, INT J DERMATOL, V31, P621, DOI 10.1111/j.1365-4362.1992.tb03978.x
   Kakourou T, 2005, J AM ACAD DERMATOL, V53, P220, DOI 10.1016/j.jaad.2005.03.032
   Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x
   Lin X, 2011, AM J CLIN DERMATOL, V12, P277, DOI 10.2165/11318020-000000000-00000
   Marinho FD, 2013, AN BRAS DERMATOL, V88, P1026, DOI 10.1590/abd1806-4841.20132219
   Mazereeuw-Hautier J, 2010, J AM ACAD DERMATOL, V62, P945, DOI 10.1016/j.jaad.2009.06.081
   Nicolaidou E, 2012, J AM ACAD DERMATOL, V66, P954, DOI 10.1016/j.jaad.2011.07.010
   Nunes DH, 2011, AN BRAS DERMATOL, V86, P241, DOI 10.1590/S0365-05962011000200006
   Pagovich OE, 2008, CUTIS, V81, P463
   Pajvani U, 2006, J AM ACAD DERMATOL, V55, P238, DOI 10.1016/j.jaad.2006.02.027
   SCHALLREUTER KU, 1994, DERMATOLOGY, V188, P269, DOI 10.1159/000247164
   Silva Cláudia Márcia de Resende, 2007, An. Bras. Dermatol., V82, P47, DOI 10.1590/S0365-05962007000100006
   Silverberg NB, 2014, CLIN DERMATOL, V32, P524, DOI 10.1016/j.clindermatol.2014.02.006
   Silverberg NB, 2014, PEDIATR CLIN N AM, V61, P347, DOI 10.1016/j.pcl.2013.11.008
NR 29
TC 2
Z9 2
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD FEB
PY 2020
VL 59
IS 2
BP 236
EP 244
DI 10.1111/ijd.14645
EA SEP 2019
PG 9
WC Dermatology
SC Dermatology
GA KF1IV
UT WOS:000487477900001
PM 31544238
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Felix, PAO
   Souza, C
   Carvalho, A
   Levy, R
   Valenzuela, F
   Chouela, E
   Amaya-Guerra, M
   Hirayama, AL
   Coberio, A
   Castro, CS
   Campanholo, C
   Nunes, D
   Vieira, E
   Bressan, A
   Palitot, E
   Almeida, TL
   Pinto, J
   D' Elia, M
   Oliveira, MT
   Salas, L
   Magalhaes, R
   Martins, G
AF Azulay-Abulafia, L.
   Felix, P. A. O.
   Souza, C.
   Carvalho, A.
   Levy, R.
   Valenzuela, F.
   Chouela, E.
   Amaya-Guerra, M.
   Hirayama, A. L.
   Coberio, A.
   Castro, C. S.
   Campanholo, C.
   Nunes, D.
   Vieira, E.
   Bressan, A.
   Palitot, E.
   Almeida, T. L.
   Pinto, J.
   D' Elia, M.
   Oliveira, M. T.
   Salas, L.
   Magalhaes, R.
   Martins, G.
TI Immunobiologics in pregnancy: case reports from Latin America
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Meeting Abstract
DE Biologic therapy; Pregnancy; Psoriasis
C1 [Azulay-Abulafia, L.; Vieira, E.; Bressan, A.; D' Elia, M.] Univ Estado Rio de Janeiro, Dermatol, Rio De Janeiro, Brazil.
   [Felix, P. A. O.] Hosp Fed Servidores Estado, Dermatol, Rio De Janeiro, Brazil.
   [Souza, C.] Univ Sao Paulo, Dermatol, Ribeirao Preto, Brazil.
   [Carvalho, A.] Hosp Moinhos de Vento, Dermatol, Porto Alegre, RS, Brazil.
   [Levy, R.] Univ Estado Rio de Janeiro, Rheumatol, Rio De Janeiro, Brazil.
   [Valenzuela, F.] Hosp Clin Univ Chile, Dermatol, Santiago, Chile.
   [Chouela, E.] Univ Buenos Aires, Dermatol, Buenos Aires, DF, Argentina.
   [Amaya-Guerra, M.] Univ Monterrey, Dermatol, Monterrey, Mexico.
   [Hirayama, A. L.] Univ Sao Paulo, Dermatol, Sao Paulo, Brazil.
   [Coberio, A.] Univ Fed Minas Gerais, Dermatol, Belo Horizonte, MG, Brazil.
   [Castro, C. S.] Pontificia Univ Catolica Parnana, Dermatol, Curitiba, Parana, Brazil.
   [Campanholo, C.] Fac Ciencias Med Santa Casa Sao Paulo, Rheumatol, Sao Paulo, Brazil.
   [Nunes, D.] Univ Fed Santa Catarian, Dermatol, Florianpolis, Brazil.
   [Palitot, E.] Univ Fed Paraiba, Dermatol, Joao Pessoa, Paraiba, Brazil.
   [Almeida, T. L.; Oliveira, M. T.] Univ Fed Ceara, Dermatol, Fortaleza, Ceara, Brazil.
   [Pinto, J.] Univ Fed Fluminese, Dermatol, Niteroi, RJ, Brazil.
   [Salas, L.] Univ Santiago Chile, Dermatol, Santiago, Chile.
   [Magalhaes, R.] Univ Estadual Campinas, Dermatol, Campinas, SP, Brazil.
   [Martins, G.] Hosp Univ Brasilia, Dermatol, Brasilia, DF, Brazil.
RI Valenzuela, Fernando/AAX-5037-2020
CR [Anonymous], ACTA DERMATOVENEROLO, V23, P7
   [Anonymous], EXEPERT REV CLIN IMM, V11, P709
   [Anonymous], REPROD TOXICOL, V43, P78
   [Anonymous], J RHEUMATOL, V36, P635
   [Anonymous], DERMATOLOGY, V214, P32
   [Anonymous], J DRUGS DERMATOL, V11, P1240
   [Anonymous], DERMATOLOGY, V220, P71
   [Anonymous], J EUR ACAD DERMATOL, V25, P738
   [Anonymous], AUSTRALAS J DERMATOL, V55, P235
   [Anonymous], J AM ACAD DERMATOL, V64, P71
   [Anonymous], ANN RHEUM DIS, V76, P1890
   [Anonymous], J INVEST DERMATOL, V132, P85
   [Anonymous], BR J CLIN PHARM, V80, P727
   [Anonymous], J REPROD MED, V53, P183
   [Anonymous], J AM ACAD DERMATOL, V71, pe22
   [Anonymous], ACTA REUMATOL PORT, V36, P219
   [Anonymous], J EUR ACAD DERMATOLO, V30, P488
   [Anonymous], ANN RHEUM DIS, V70, P823
   [Anonymous], J EUR ACAD DERMATOLO, V25, P1041
   [Anonymous], AM J CLIN DERMATOL, V16, P389
   [Anonymous], ACTAS DERMOSIFILIOGR, V101, P97
   [Anonymous], J DERMATOL CASE REP, V6, P105
   [Anonymous], DERMATOL THER, P1
   [Anonymous], ACTAS DERMOSIFILIOGR, V105, P734
NR 24
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD APR
PY 2019
VL 33
SU 3
SI SI
MA P026
BP 18
EP 19
PG 2
WC Dermatology
SC Dermatology
GA HU9GU
UT WOS:000465603500026
DA 2020-12-01
ER

PT J
AU de Oliveira, FL
   Bressan, A
   Azulay-Abulafia, L
AF Ladeira de Oliveira, F.
   Bressan, A.
   Azulay-Abulafia, L.
TI Evaluation of microalbuminuria as an indicator of renal impairment in
   patients with moderate to severe psoriasis
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Meeting Abstract
DE comorbidities; Cyclosporine; Microalbuminuria; Nephropathy; Psoriasis
C1 [Ladeira de Oliveira, F.; Bressan, A.; Azulay-Abulafia, L.] Univ Estado Rio de Janeiro, Dermatol, Rio De Janeiro, Brazil.
CR [Anonymous], 2016, CLIN RHEUMATOL, V35, P297
   [Anonymous], 2017, INT UROL NEPHROL, V49, P1999
   [Anonymous], 2016, BR J DERMATOL, V174, P267
   [Anonymous], 2015, DERMATOL SCI, V78, P232
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD APR
PY 2019
VL 33
SU 3
SI SI
MA P179
BP 79
EP 80
PG 2
WC Dermatology
SC Dermatology
GA HU9GU
UT WOS:000465603500156
DA 2020-12-01
ER

PT J
AU Arnone, M
   Takahashi, MDF
   de Carvalho, AVE
   Bernardo, WM
   Bressan, AL
   Ramos, AMC
   Terena, AC
   Souza, CD
   Nunes, DH
   Bortoletto, MCD
   de Oliveira, MDSP
   Neffa, JM
   Fieri, LC
   Azulay-Abulafia, L
   Felix, PAO
   Magalhaes, RF
   Romitil, R
   Jaime, TJ
AF Arnone, Marcelo
   Fonseca Takahashi, Maria Denise
   Esteves de Carvalho, Andre Vicente
   Bernardo, Wanderley Marques
   Bressan, Aline Lopes
   Coelho Ramos, Andrea Machado
   Terena, Aripuana Coberio
   Souza, Cacilda da Silva
   Nunes, Daniel Holthausen
   de Carvalho Bortoletto, Maria Cecilia
   Santos Paim de Oliveira, Maria de Fatima
   Neffa, Jane Marcy
   Fieri, Luciana Cristina
   Azulay-Abulafia, Luna
   Oldani Felix, Paulo Antonio
   Magalhaes, Renata Ferreira
   Romitil, Ricardo
   Jaime, Tatiana Jerez
TI Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian
   Society of Dermatology
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Biological therapy; Comorbidity; Dermatology; Practice guidelines as
   topic; Psoriasis
ID QUALITY-OF-LIFE; BAND-ULTRAVIOLET-B; TO-SEVERE PSORIASIS; RANDOMIZED
   CONTROLLED-TRIAL; INFLAMMATORY-BOWEL-DISEASE; PSORALEN PLUS ULTRAVIOLET;
   CARDIOVASCULAR RISK-FACTORS; PHYSICIAN GLOBAL ASSESSMENT;
   PATIENT-REPORTED OUTCOMES; PLACEBO-CONTROLLED TRIAL
AB Psoriasis is a chronic inflammatory disease that affects 1.3% of the Brazilian population. The most common clinical manifestations are erythematous, scaling lesions that affect both genders and can occur on any anatomical site, preferentially involving the knees, elbows, scalp and genitals. Besides the impact on the quality of life, the systemic nature of the disease makes psoriasis an independent risk factor for cardiovascular disease, especially in young patients with severe disease. By an initiative of the Brazilian Society of Dermatology, dermatologists with renowned clinical experience in the management of psoriasis were invited to form a work group that, in a partnership with the Brazilian Medical Association, dedicated themselves to create the Plaque Psoriasis Diagnostic and Treatment Guidelines. The relevant issues for the diagnosis (evaluation of severity and comorbidities) and treatment of plaque psoriasis were defined. The issues generated a search strategy in the Medline-PubMed database up to July 2018. Subsequently, the answers to the questions of the recommendations were devised, and each reference selected presented the respective level of recommendation and strength of scientific evidence. The final recommendations for making up the final text were worded by the coordinators.
C1 [Arnone, Marcelo; Fonseca Takahashi, Maria Denise; Romitil, Ricardo] Univ Sao Paulo, Dept Dermatol, Hosp Clin, Sch Med, Sao Paulo, SP, Brazil.
   [Esteves de Carvalho, Andre Vicente] Hosp Moinhos Vento, Ctr Psoriasis & Psoriat Arthrit, Serv Rheumatol, Porto Alegre, RS, Brazil.
   [Bernardo, Wanderley Marques] Univ Sao Paulo, Ctr Dev Med Educ, Sch Med, Sao Paulo, SP, Brazil.
   [Bressan, Aline Lopes] Univ Estado Rio de Janeiro, Serv Dermatol, Hosp Univ Pedro Ernesto, Rio De Janeiro, RJ, Brazil.
   [Coelho Ramos, Andrea Machado] Univ Fed Minas Gerais, Serv Dermatol, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Terena, Aripuana Coberio] Ctr Reference Phototherapy & Cutaneous Photobiol, Belo Horizonte, MG, Brazil.
   [Souza, Cacilda da Silva] Univ Sao Paulo, Div Dermatol, Dept Internal Med, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Nunes, Daniel Holthausen] Univ Fed Santa Catarina, Serv Dermatol, Hosp Univ, Florianopolis, SC, Brazil.
   [de Carvalho Bortoletto, Maria Cecilia] Fac Med ABC, Outpatient Dept Dermatol, Santo Andre, SP, Brazil.
   [Santos Paim de Oliveira, Maria de Fatima] Dermatol Clin, DERMAPP, Salvador, BA, Brazil.
   [Neffa, Jane Marcy] Univ Fed Fluminense, Dept Med, Dermatol Clin, Niteroi, RJ, Brazil.
   [Fieri, Luciana Cristina] Univ Mogi das Cruzes, Serv Dermatol, Mogi Das Cruzes, SP, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, Fac Med Sci, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Santa Casa Misericordia Rio de Janeiro, Inst Dermatol Prof RD Azulay, Rio De Janeiro, RJ, Brazil.
   [Oldani Felix, Paulo Antonio] Hosp Fed Servidores Estado, Serv Dermatol, Rio De Janeiro, RJ, Brazil.
   [Magalhaes, Renata Ferreira] Univ Estadual Campinas, Dept Internal Med, Fac Ciencias Med, Campinas, SP, Brazil.
   [Jaime, Tatiana Jerez] Clin Jerez Dermatol, Barueri, SP, Brazil.
RP Arnone, M (corresponding author), Univ Sao Paulo, Dept Dermatol, Hosp Clin, Sch Med, Sao Paulo, SP, Brazil.
EM arnones@uol.com.br
RI bortoletto, maria/AAE-4347-2020; Holthausen Nunes, Daniel/N-9864-2013;
   Silva Souza, Cacilda/F-9926-2012
OI Holthausen Nunes, Daniel/0000-0002-1303-5419; Silva Souza,
   Cacilda/0000-0002-8157-7658; Bressan, Aline/0000-0002-3296-5232;
   Bortoletto, Maria/0000-0002-6156-6097
CR Abrouk Michael, 2016, Int J Womens Dermatol, V2, P62, DOI 10.1016/j.ijwd.2016.02.001
   Afshar M, 2013, J EUR ACAD DERMATOL, V27, P771, DOI 10.1111/j.1468-3083.2012.04582.x
   Aktan S, 2007, CLIN EXP DERMATOL, V32, P141, DOI 10.1111/j.1365-2230.2006.02305.x
   Al-Hamamy HR, 2014, INT J DERMATOL, V53, P1531, DOI 10.1111/ijd.12444
   An JG, 2017, PHARMACOL RES, V121, P158, DOI 10.1016/j.phrs.2017.04.014
   Arnone M, PROJETO DIRETRIZES A
   ARNTZEN N, 1984, ACTA DERM-VENEREOL, V64, P346
   Asahina A, 2010, J DERMATOL, V37, P299, DOI 10.1111/j.1346-8138.2009.00748.x
   Asawanonda P, 2006, J AM ACAD DERMATOL, V54, P1013, DOI 10.1016/j.jaad.2006.01.004
   Awosika Olabola, 2018, J Clin Aesthet Dermatol, V11, P33
   Aydin F, 2006, CLIN EXP DERMATOL, V31, P520, DOI 10.1111/j.1365-2230.2006.02153.x
   Bae YSC, 2012, J AM ACAD DERMATOL, V67, P459, DOI 10.1016/j.jaad.2011.07.039
   Bagel J, 2012, J AM ACAD DERMATOL, V67, P86, DOI 10.1016/j.jaad.2011.07.034
   Bangsgaard N, 2015, AM J CLIN DERMATOL, V16, P389, DOI 10.1007/s40257-015-0137-5
   Bar-Oz B, 2001, TRANSPLANTATION, V71, P1051, DOI 10.1097/00007890-200104270-00006
   Barker J, 2011, BRIT J DERMATOL, V165, P1109, DOI 10.1111/j.1365-2133.2011.10615.x
   Berthelsen BG, 2010, RHEUMATOLOGY, V49, P2225, DOI 10.1093/rheumatology/keq185
   Beutner Karl, 2006, J Drugs Dermatol, V5, P357
   Birkenfeld S, 2009, BRIT J DERMATOL, V161, P1331, DOI 10.1111/j.1365-2133.2009.09398.x
   Bissonnette R, 2017, BRIT J DERMATOL, V177, P1033, DOI 10.1111/bjd.15706
   Blauvelt A, 2017, J AM ACAD DERMATOL, V77, P855, DOI 10.1016/j.jaad.2017.06.153
   Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041
   Brauchli YB, 2008, BRIT J DERMATOL, V158, P1299, DOI 10.1111/j.1365-2133.2008.08563.x
   Brauchli YB, 2009, J CLIN PSYCHOPHARM, V29, P134, DOI 10.1097/JCP.0b013e31819a4b7c
   Bronsard V, 2010, J EUR ACAD DERMATOL, V24, P17, DOI 10.1111/j.1468-3083.2009.03563.x
   Brown SM, 2018, J DERMATOL TREAT, V13, P1
   Cai L, 2017, J EUR ACAD DERMATOL, V31, P89, DOI 10.1111/jdv.13746
   Calzavara-Pinton PG, 2013, BRIT J DERMATOL, V169, P130, DOI 10.1111/bjd.12277
   Capo A, 2018, J EUR ACAD DERMATOL, V32, P57, DOI 10.1111/jdv.14472
   Carman WJ, 2017, PHARMACOEPIDEM DR S, V26, P1109, DOI 10.1002/pds.4261
   Carroll CL, 2005, ARCH DERMATOL, V141, P43, DOI 10.1001/archderm.141.1.43
   Carroll CL, 2004, BRIT J DERMATOL, V151, P895, DOI 10.1111/j.1365-2133.2004.06174.x
   Chan HHL, 2000, J AFFECT DISORDERS, V57, P107, DOI 10.1016/S0165-0327(99)00064-6
   Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0
   Chauhan PS, 2011, CLIN EXP DERMATOL, V36, P169, DOI 10.1111/j.1365-2230.2010.03874.x
   Chi CC, 2011, J INVEST DERMATOL, V131, P884, DOI 10.1038/jid.2010.392
   Choi YM, 2017, PERM J, V21
   CHRISTOPHERS E, 1992, J AM ACAD DERMATOL, V26, P86, DOI 10.1016/0190-9622(92)70012-5
   Chularojanamontri L, 2013, J INVEST DERMATOL, V133, P1956, DOI 10.1038/jid.2013.138
   Clark DWJ, 2003, ARCH DERMATOL, V139, P1223, DOI 10.1001/archderm.139.9.1223
   Clowse MEB, 2016, DRUG SAFETY, V39, P755, DOI 10.1007/s40264-016-0431-z
   Cohen AD, 2008, J EUR ACAD DERMATOL, V22, P585, DOI 10.1111/j.1468-3083.2008.02636.x
   Cohen AD, 2010, ACTA DERM-VENEREOL, V90, P23, DOI 10.2340/00015555-0741
   Cohen BE, 2016, JAMA DERMATOL, V152, P73, DOI 10.1001/jamadermatol.2015.3605
   Colombo D, 2010, INT J IMMUNOPATH PH, V23, P1143, DOI 10.1177/039463201002300418
   Costa-Silva M, 2018, ACTA DERMATOVEN ALP, V27, P5, DOI 10.15570/actaapa.2018.2
   COULTER DM, 1993, NEW ZEAL MED J, V106, P392
   Curco N, 2018, AUSTRALAS J DERMATOL, V59, pE93, DOI 10.1111/ajd.12577
   Dalgard FJ, 2015, J INVEST DERMATOL, V135, P984, DOI 10.1038/jid.2014.530
   Damevska K, 2013, J DTSCH DERMATOL GES, V11, P1169, DOI 10.1111/ddg.12193
   Darrigade AS, 2017, ACTA DERM-VENEREOL, V97, P731, DOI 10.2340/00015555-2636
   Dawe RS, 2003, BRIT J DERMATOL, V148, P1194, DOI 10.1046/j.1365-2133.2003.05482.x
   Dayal S, 2010, INDIAN J DERMATOL VE, V76, P533, DOI 10.4103/0378-6323.69081
   Decroix J, 2004, CUTIS, V74, P201
   DESTEFANO P, 1983, HELV PAEDIATR ACTA, V38, P185
   Dogra S, 2013, J EUR ACAD DERMATOL, V27, pe305, DOI 10.1111/j.1468-3083.2012.04644.x
   Dommasch ED, 2015, BRIT J DERMATOL, V173, P975, DOI 10.1111/bjd.14032
   Douglas WS, 2002, ACTA DERM-VENEREOL, V82, P131, DOI 10.1080/00015550252948194
   Dreiher J, 2008, BRIT J DERMATOL, V159, P956, DOI 10.1111/j.1365-2133.2008.08749.x
   Driessen RJB, 2009, J DERMATOL TREAT, V20, P42, DOI 10.1080/09546630802225702
   DUBERTRET L, 1992, J AM ACAD DERMATOL, V27, P983, DOI 10.1016/0190-9622(92)70299-U
   Egeberg A, 2015, BRIT J DERMATOL, V173, P471, DOI 10.1111/bjd.13778
   Egeberg A, 2015, J AM ACAD DERMATOL, V73, P829, DOI 10.1016/j.jaad.2015.08.039
   El-Saie LT, 2011, LASER MED SCI, V26, P481, DOI 10.1007/s10103-011-0895-0
   Engin B, 2008, ACTA DERM-VENEREOL, V88, P247, DOI 10.2340/00015555-0434
   Eppinga H, 2017, INFLAMM BOWEL DIS, V23, P1783, DOI 10.1097/MIB.0000000000001169
   FELDKAMP M, 1993, TERATOLOGY, V47, P533, DOI 10.1002/tera.1420470605
   Feldman SR, 2008, BRIT J DERMATOL, V159, P704, DOI 10.1111/j.1365-2133.2008.08727.x
   Feldman SR, 2005, J AM ACAD DERMATOL, V53, P887, DOI 10.1016/j.jaad.2005.06.053
   Feldman SR, 2005, BRIT J DERMATOL, V152, P954, DOI 10.1111/j.1365-2133.2005.06510.x
   Feldman SR, 2015, J MANAG CARE SPEC PH, V21, P874, DOI 10.18553/jmcp.2015.21.10.874
   Feldman SR, 2012, AM J CLIN DERMATOL, V13, P261, DOI 10.2165/11630710-000000000-00000
   Franssen MEJ, 1999, ACTA DERM-VENEREOL, V79, P390
   Franz TJ, 2000, INT J DERMATOL, V39, P535, DOI 10.1046/j.1365-4362.2000.00986-4.x
   Fritzsche J, 2012, J CLIN GASTROENTEROL, V46, P718, DOI 10.1097/MCG.0b013e31825f2807
   Gambichler T, 2011, BRIT J DERMATOL, V164, P1383, DOI 10.1111/j.1365-2133.2011.10358.x
   Ghanem ME, 2005, EUR J OBSTET GYN R B, V121, P178, DOI 10.1016/j.ejogrb.2004.11.035
   GILLEAUDEAU P, 1993, J AM ACAD DERMATOL, V28, P490, DOI 10.1016/S0190-9622(08)81761-6
   Gisondi P, 2008, BRIT J DERMATOL, V158, P1345, DOI 10.1111/j.1365-2133.2008.08564.x
   Gisondi P, 2009, J HEPATOL, V51, P758, DOI 10.1016/j.jhep.2009.04.020
   GOLDBERG LD, 1972, LANCET, V2, P1258
   Goldet Gabrielle, 2013, J Evid Based Med, V6, P50, DOI 10.1111/jebm.12018
   Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027
   Gordon PM, 1999, J AM ACAD DERMATOL, V41, P728, DOI 10.1016/S0190-9622(99)70008-3
   Gottlieb AB, 2017, J EUR ACAD DERMATOL, V31, P679, DOI 10.1111/jdv.13990
   Gottlieb AB, 2012, BRIT J DERMATOL, V167, P649, DOI 10.1111/j.1365-2133.2012.11015.x
   Gottlieb AB, 2011, BRIT J DERMATOL, V165, P652, DOI 10.1111/j.1365-2133.2011.10418.x
   Gottlieb AB, 2004, J AM ACAD DERMATOL, V51, P534, DOI 10.1016/j.jaad.2004.02.021
   Gottlieb AB, 2003, ARCH DERMATOL, V139, P1627, DOI 10.1001/archderm.139.12.1627
   Gottlieb AB, 2003, J AM ACAD DERMATOL, V48, P829, DOI 10.1067/mjd.2003.307
   Gottlieb AB, 2003, J CUTAN MED SURG, V7, P185, DOI 10.1007/s10227-002-0114-5
   Gottlieb AB, 2017, J AM ACAD DERMATOL, V77, P1178, DOI 10.1016/j.jaad.2017.06.162
   GREEN C, 1992, BRIT J DERMATOL, V127, P5, DOI 10.1111/j.1365-2133.1992.tb14815.x
   Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8
   Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652
   Guenther L, 2011, J EUR ACAD DERMATOL, V25, P851, DOI 10.1111/j.1468-3083.2011.04082.x
   Guenther L, 2002, BRIT J DERMATOL, V147, P316, DOI 10.1046/j.1365-2133.2002.04967.x
   Guerra I, 2016, INFLAMM BOWEL DIS, V22, P894, DOI 10.1097/MIB.0000000000000757
   Guerra I, 2012, J CROHNS COLITIS, V6, P518, DOI 10.1016/j.crohns.2011.10.007
   Guillonneau M, 1997, ARCH PEDIATRIE, V4, P867, DOI 10.1016/S0929-693X(97)88158-4
   GUNNARSKOG JG, 1993, ARCH DERMATOL, V129, P320, DOI 10.1001/archderm.129.3.320
   GUPTA AK, 1989, J AM ACAD DERMATOL, V20, P1088, DOI 10.1016/S0190-9622(89)70138-9
   Hale EK, 2002, INT J DERMATOL, V41, P197, DOI 10.1046/j.1365-4362.2002.01464.x
   Han CL, 2011, J DRUGS DERMATOL, V10, P843
   Helfrich YR, 2007, BRIT J DERMATOL, V157, P369, DOI 10.1111/j.1365-2133.2007.08037.x
   Helmick CG, 2014, AM J PREV MED, V47, P37, DOI 10.1016/j.amepre.2014.02.012
   HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X
   HIGHTON A, 1995, J AM ACAD DERMATOL, V32, P67, DOI 10.1016/0190-9622(95)90186-8
   Hoffman MB, 2015, EXPERT REV CLIN IMMU, V11, P709, DOI 10.1586/1744666X.2015.1037742
   IEST J, 1989, BRIT J DERMATOL, V120, P665, DOI 10.1111/j.1365-2133.1989.tb01354.x
   Igarashi A, 2012, J DERMATOL, V39, P242, DOI 10.1111/j.1346-8138.2011.01347.x
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Jarratt MT, 2006, CUTIS, V78, P348
   JEKLER J, 1992, ACTA DERM-VENEREOL, V72, P449
   Jeyarajah SK, 2017, QJM-INT J MED, V110, P379, DOI 10.1093/qjmed/hcx003
   Johansen CB, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051349
   JOHNS DG, 1972, AM J OBSTET GYNECOL, V112, P978, DOI 10.1016/0002-9378(72)90824-1
   Kane S, 2009, J CLIN GASTROENTEROL, V43, P613, DOI 10.1097/MCG.0b013e31817f9367
   Karia Sagar B, 2015, Ind Psychiatry J, V24, P125, DOI 10.4103/0972-6748.181724
   Katoulis AC, 2009, CLIN EXP DERMATOL, V34, pe360, DOI 10.1111/j.1365-2230.2009.03315.x
   Kaufmann R, 2002, DERMATOLOGY, V205, P389, DOI 10.1159/000066440
   Khalid U, 2015, EUR HEART J, V36, P2177, DOI 10.1093/eurheartj/ehv185
   Khalid U, 2013, DIABETES CARE, V36, P2402, DOI 10.2337/dc12-2330
   Khanna N, 2018, INDIAN J MED RES, V147, P66, DOI 10.4103/ijmr.IJMR_249_16
   Kim CR, 2013, ANN DERMATOL, V25, P440, DOI 10.5021/ad.2013.25.4.440
   Kimball AB, 2013, J EUR ACAD DERMATOL, V27, P1535, DOI 10.1111/jdv.12046
   Kimball AB, 2012, BRIT J DERMATOL, V166, DOI [10.1111/j.1365-2133.2011.10901.x, 10.1111/j.1365-2133.2012.10901.x]
   Kimball AB, 2012, J AM ACAD DERMATOL, V67, P651, DOI 10.1016/j.jaad.2011.11.948
   KOZLOWSKI RD, 1990, AM J MED, V88, P589, DOI 10.1016/0002-9343(90)90522-F
   Kragballe K, 2004, BRIT J DERMATOL, V150, P1167, DOI 10.1111/j.1365-2133.2004.05986.x
   KRAGBALLE K, 1989, ARCH DERMATOL, V125, P1647, DOI 10.1001/archderm.125.12.1647
   Krueger GG, 2005, BRIT J DERMATOL, V153, P1192, DOI 10.1111/j.1365-2133.2005.06948.x
   Kumar V, 2013, ASIAN J PSYCHIATR, V6, P151, DOI 10.1016/j.ajp.2012.10.005
   Kurd SK, 2010, ARCH DERMATOL, V146, P891, DOI 10.1001/archdermatol.2010.186
   Kurizky PS, 2015, AN BRAS DERMATOL, V90, P367, DOI 10.1590/abd1806-4841.20153113
   LABURTE C, 1994, BRIT J DERMATOL, V130, P366, DOI 10.1111/j.1365-2133.1994.tb02935.x
   Lakshmy Sreelatha, 2015, Indian J Psychol Med, V37, P434, DOI 10.4103/0253-7176.168587
   Lamarque V, 1997, TRANSPLANT P, V29, P2480, DOI 10.1016/S0041-1345(97)00458-2
   Lamba G, 2011, AM J THER, V18, pE78, DOI 10.1097/MJT.0b013e3181c6c0c2
   LANE AT, 1983, J AM ACAD DERMATOL, V8, P523, DOI 10.1016/S0190-9622(83)70059-9
   Langley RG, 2015, BRIT J DERMATOL, V172, P1371, DOI 10.1111/bjd.13469
   Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012
   Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258
   Langley RG, 2010, J AM ACAD DERMATOL, V63, P457, DOI 10.1016/j.jaad.2009.09.014
   LANGNER A, 1993, BRIT J DERMATOL, V128, P566, DOI 10.1111/j.1365-2133.1993.tb00237.x
   Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824
   Lebwohl M, 2010, BRIT J DERMATOL, V162, P137, DOI 10.1111/j.1365-2133.2009.09491.x
   Lebwohl M, 2002, INT J DERMATOL, V41, P269, DOI 10.1046/j.1365-4362.2002.01431.x
   Lebwohl Mark, 2007, J Drugs Dermatol, V6, P428
   Lee JH, 2016, BMC DERMATOL, V16, DOI 10.1186/s12895-016-0048-z
   Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409
   Leonardi C, 2018, J AM ACAD DERMATOL, V79, P824, DOI 10.1016/j.jaad.2018.05.032
   Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4
   Ljosaa TM, 2012, J EUR ACAD DERMATOL, V26, P29, DOI 10.1111/j.1468-3083.2011.04000.x
   LOWE NJ, 1991, J AM ACAD DERMATOL, V24, P591, DOI 10.1016/0190-9622(91)70089-K
   Lozinski A, 2016, J DERMATOL TREAT, V27, P221, DOI 10.3109/09546634.2015.1093588
   Lubrano E, 2012, ARTHRIT CARE RES, V64, P455, DOI 10.1002/acr.20691
   Sanchez-Carazo JL, 2014, J DERMATOL, V41, P673, DOI 10.1111/1346-8138.12465
   Lundberg L, 2000, ACTA DERM-VENEREOL, V80, P430, DOI 10.1080/000155500300012873
   Lynde CW, 2012, J DERMATOL TREAT, V23, P261, DOI 10.3109/09546634.2011.607795
   Madanagobalane Shraddha, 2012, Indian J Dermatol, V57, P353, DOI 10.4103/0019-5154.100474
   Mahajan R, 2010, J EUR ACAD DERMATOL, V24, P595, DOI 10.1111/j.1468-3083.2009.03486.x
   MALLETT R, 1989, BRIT MED J, V299, P1400, DOI 10.1136/bmj.299.6712.1400-a
   Markham T, 2003, ARCH DERMATOL, V139, P325, DOI 10.1001/archderm.139.3.325
   Mattei PL, 2014, J EUR ACAD DERMATOL, V28, P333, DOI 10.1111/jdv.12106
   Mazzotta A, 2009, AM J CLIN DERMATOL, V10, P319, DOI 10.2165/11310770-000000000-00000
   Mebazaa A, 2011, J EUR ACAD DERMATOL, V25, P705, DOI 10.1111/j.1468-3083.2010.03856.x
   Menegon DB, 2014, INT J DERMATOL, V53, pE518, DOI 10.1111/ijd.12186
   Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010
   Menter A, 2010, J AM ACAD DERMATOL, V63, P448, DOI 10.1016/j.jaad.2009.09.040
   Milčić Danijela, 2017, An. Bras. Dermatol., V92, P46, DOI 10.1590/abd1806-4841.20175178
   Mohanan S, 2014, J DERMATOL TREAT, V25, P50, DOI 10.3109/09546634.2013.782094
   Molina-Leyva A, 2016, ARCH SEX BEHAV, V45, P2047, DOI 10.1007/s10508-016-0757-8
   Murase JE, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.09.010
   Murashima A, 2009, ANN RHEUM DIS, V68, P1793, DOI 10.1136/ard.2008.105924
   Nakagawa H, 2012, J DERMATOL, V39, P761, DOI 10.1111/j.1346-8138.2012.01521.x
   Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040
   Nguyen C, 2002, OBSTET GYNECOL, V99, P599, DOI 10.1016/S0029-7844(01)01607-6
   Nyberg G, 1998, TRANSPLANTATION, V65, P253
   Oh EH, 2017, J DERMATOL, V44, P621, DOI 10.1111/1346-8138.13761
   Ohtsuki M, 2018, J DERMATOL, V45, P1053, DOI 10.1111/1346-8138.14504
   Olsen EA, 1996, CUTIS, V57, P57
   Ortonne JP, 2011, J EUR ACAD DERMATOL, V25, P1012, DOI 10.1111/j.1468-3083.2010.03944.x
   Papp KA, 2018, BRIT J DERMATOL, V179, P320, DOI 10.1111/bjd.16464
   Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x
   Papp KA, 2003, J AM ACAD DERMATOL, V48, P48, DOI 10.1067/mjd.2003.130
   Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6
   Parisi R, 2015, J INVEST DERMATOL, V135, P2189, DOI 10.1038/jid.2015.87
   Park KK, 2013, J EUR ACAD DERMATOL, V27, P899, DOI 10.1111/j.1468-3083.2012.04611.x
   Paschoal RS, 2018, AN BRAS DERMATOL, V93, P222, DOI 10.1590/abd1806-4841.20186397
   Paziana K, 2013, DRUG SAFETY, V36, P279, DOI 10.1007/s40264-013-0034-x
   Pearce DJ, 2005, J DERMATOL TREAT, V16, P319, DOI 10.1080/09546630500335977
   Perez A, 1996, BRIT J DERMATOL, V134, P238
   Phillips B, 2001, LEVELS EVIDENCE GRAD
   Picardi A, 2006, J AM ACAD DERMATOL, V54, P420, DOI 10.1016/j.jaad.2005.11.1103
   Pietrzak D, 2017, J AFFECT DISORDERS, V209, P229, DOI 10.1016/j.jad.2016.11.045
   Pompili M, 2017, INT J PSYCHIAT CLIN, V21, P209, DOI 10.1080/13651501.2017.1301482
   Poot F, 2011, ACTA DERM-VENEREOL, V91, P415, DOI 10.2340/00015555-1074
   Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94
   Puzenat E, 2010, J EUR ACAD DERMATOL, V24, P10, DOI 10.1111/j.1468-3083.2009.03562.x
   Queille-Roussel C, 2012, CLIN DRUG INVEST, V32, P613, DOI 10.2165/11634710-000000000-00000
   Rademaker M, 2018, AUSTRALAS J DERMATOL, V59, P86, DOI 10.1111/ajd.12641
   Radtke MA, 2017, J EUR ACAD DERMATOL, V31, P151, DOI 10.1111/jdv.13813
   Reich K, 2006, BRIT J DERMATOL, V154, P1161, DOI 10.1111/j.1365-2133.2006.07237.x
   Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6
   Reich K, 2010, J AM ACAD DERMATOL, V63, P1011, DOI 10.1016/j.jaad.2009.12.029
   Reich K, 2011, J DERMATOL TREAT, V22, P337, DOI 10.3109/09546634.2010.499931
   Revicki D, 2008, BRIT J DERMATOL, V158, P549, DOI 10.1111/j.1365-2133.2007.08236.x
   Revicki DA, 2007, J DERMATOL TREAT, V18, P341, DOI 10.1080/09546630701646172
   Revicki DA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-75
   Baeta IGR, 2014, AN BRAS DERMATOL, V89, P735, DOI 10.1590/abd1806-4841.20142874
   Rich P, 2003, J AM ACAD DERMATOL, V49, P206, DOI 10.1067/S0190-9622(03)00910-1
   Roberts KK, 2015, ALIMENT PHARM THER, V41, P293, DOI 10.1111/apt.13042
   Robinson A, 2012, J AM ACAD DERMATOL, V66, P369, DOI 10.1016/j.jaad.2011.01.022
   ROLLMAN O, 1990, ACTA DERM-VENEREOL, V70, P487
   Ruiz V, 2014, ACTAS DERMO-SIFILOGR, V105, P813, DOI 10.1016/j.ad.2013.06.005
   Salem SAM, 2010, PHOTODERMATOL PHOTO, V26, P235, DOI 10.1111/j.1600-0781.2010.00525.x
   Salunke AS, 2017, J CLIN DIAGN RES, V11, pWC6, DOI 10.7860/JCDR/2017/24390.10348
   Sampogna F, 2017, BRIT J DERMATOL, V176, P1195, DOI 10.1111/bjd.15243
   Saraceno R, 2007, J DERMATOL TREAT, V18, P361, DOI 10.1080/09546630701646156
   Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x
   Schaefer C., 2014, DRUGS PREGNANCY LACT
   Scheepers PTJ, 2009, PEDIATR DERMATOL, V26, P184, DOI 10.1111/j.1525-1470.2009.00880.x
   Schmitt J, 2010, J EUR ACAD DERMATOL, V24, P885, DOI 10.1111/j.1468-3083.2009.03537.x
   Schwandt A, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/792968
   Sezer E, 2007, J DERMATOL, V34, P435, DOI 10.1111/j.1346-8138.2007.00306.x
   Shah K, 2017, J AM ACAD DERMATOL, V77, P287, DOI 10.1016/j.jaad.2017.03.037
   Shapiro J, 2007, J AM ACAD DERMATOL, V56, P629, DOI 10.1016/j.jaad.2006.09.017
   Snellman E, 2004, ACTA DERM-VENEREOL, V84, P132, DOI 10.1080/00015550310022916
   Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z
   Stein LF, 2001, J CUTAN MED SURG, V5, P303, DOI 10.1007/S10227-001-0006-0
   Stengel JZ, 2008, WORLD J GASTROENTERO, V14, P3085, DOI 10.3748/wjg.14.3085
   STERN RS, 1991, ARCH DERMATOL, V127, P347, DOI 10.1001/archderm.127.3.347
   Strober BE, 2011, BRIT J DERMATOL, V165, P661, DOI 10.1111/j.1365-2133.2011.10419.x
   Takahashi H, 2013, J DERMATOL, V40, P424, DOI 10.1111/1346-8138.12102
   TANEW A, 1991, J AM ACAD DERMATOL, V25, P682, DOI 10.1016/0190-9622(91)70253-X
   Tillack C, 2014, GUT, V63, P567, DOI 10.1136/gutjnl-2012-302853
   Tsai TF, 2011, J DERMATOL SCI, V63, P154, DOI 10.1016/j.jdermsci.2011.05.005
   Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002
   Tseng HW, 2013, J EUR ACAD DERMATOL, V27, P1417, DOI 10.1111/jdv.12028
   Tsintsadze N, 2015, Georgian Med News, P70
   Tzaneva S, 2018, BRIT J DERMATOL, V178, P682, DOI 10.1111/bjd.16106
   van de Kerkhof PCM, 2008, BRIT J DERMATOL, V159, P1177, DOI 10.1111/j.1365-2133.2008.08771.x
   van der Velden HMJ, 2010, J DERMATOL TREAT, V21, P13, DOI 10.3109/09546630903214175
   van der Voort EAM, 2014, J AM ACAD DERMATOL, V70, P517, DOI 10.1016/j.jaad.2013.10.044
   van Lumig PPM, 2013, J EUR ACAD DERMATOL, V27, P593, DOI 10.1111/j.1468-3083.2012.04496.x
   van Lumig PPM, 2010, BRIT J DERMATOL, V163, P838, DOI 10.1111/j.1365-2133.2010.09950.x
   Vanaclocha F, 2015, ACTAS DERMO-SIFILOGR, V106, P35, DOI 10.1016/j.ad.2014.06.003
   Vena GA, 2015, PSORIASIS-TARGETS TH, V5, P83, DOI 10.2147/PTT.S82975
   VESTEY JP, 1992, J INFECTION, V24, P211, DOI 10.1016/0163-4453(92)93058-X
   Vun YY, 2006, J AM ACAD DERMATOL, V54, pS28, DOI 10.1016/j.jaad.2005.04.041
   Walsh JA, 2013, J AM ACAD DERMATOL, V69, P931, DOI 10.1016/j.jaad.2013.07.040
   WALTER R, 1976, BIOCHIM BIOPHYS ACTA, V422, P138, DOI 10.1016/0005-2744(76)90015-2
   Warren RB, 2018, BRIT J DERMATOL, V179, P1205, DOI 10.1111/bjd.16901
   Warren RB, 2017, LANCET, V389, P528, DOI 10.1016/S0140-6736(16)32127-4
   Wells G, NEWCASTLE OTTAWA SCA
   Westermann L, 2012, J DERMATOL, V39, P168, DOI 10.1111/j.1346-8138.2011.01376.x
   Wolf P, 2012, BRIT J DERMATOL, V166, P147, DOI 10.1111/j.1365-2133.2011.10616.x
   Wolf P, 2009, BRIT J DERMATOL, V160, P186, DOI 10.1111/j.1365-2133.2008.08926.x
   Wolf P, 2011, PHOTODERMATOL PHOTO, V27, P186, DOI 10.1111/j.1600-0781.2011.00594.x
   Wu S, 2015, ACTA DERM-VENEREOL, V95, P217, DOI 10.2340/00015555-1855
   Xu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169952
   Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x
   Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015
   Yiu KH, 2013, J INTERN MED, V273, P273, DOI 10.1111/joim.12002
   Yiu ZZN, 2015, J DERMATOL TREAT, V26, P329, DOI 10.3109/09546634.2014.991673
   Zachariae C, 2008, ACTA DERM-VENEREOL, V88, P495, DOI 10.2340/00015555-0511
   Zander N, 2017, ARCH DERMATOL RES, V309, P349, DOI 10.1007/s00403-017-1741-4
   Zonneveld IM, 1998, ARCH DERMATOL, V134, P1101, DOI 10.1001/archderm.134.9.1101
NR 269
TC 3
Z9 3
U1 1
U2 4
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAR-APR
PY 2019
VL 94
IS 2
SU 1
BP S76
EP S107
DI 10.1590/abd1806-4841.2019940211
PG 32
WC Dermatology
SC Dermatology
GA IB2CE
UT WOS:000470075200008
PM 31166402
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, CS
   de Castro, CCS
   Carneiro, FRO
   Pinto, JMN
   Fabricio, LHZ
   Azulay-Abulafia, L
   Romiti, R
   Cestari, TF
   Suzuki, CE
   Biegun, PM
   Guedes, LS
   Oyafuso, LKM
AF Souza, Cacilda S.
   de Castro, Caio C. S.
   Carneiro, Francisca R. O.
   Pinto, Jane M. N.
   Fabricio, Lincoln H. Z.
   Azulay-Abulafia, Luna
   Romiti, Ricardo
   Cestari, Tania F.
   Suzuki, Claudia E.
   Biegun, Priscila M.
   Guedes, Luciana S.
   Oyafuso, Luiza K. M.
TI Metabolic syndrome and psoriatic arthritis among patients with psoriasis
   vulgaris: Quality of life and prevalence
SO JOURNAL OF DERMATOLOGY
LA English
DT Article
DE metabolic syndrome; psoriasis; psoriatic arthritis; quality of life;
   systemic disease
ID CARDIOVASCULAR RISK-FACTORS; COMORBIDITIES; POPULATION; VALIDATION
AB Interest has increased in comorbidities associated with psoriasis and their effects on health-related quality of life (HRQoL). This study aimed to evaluate the prevalence of metabolic syndrome (MetS) and psoriatic arthritis (PsA) and to investigate HRQoL and the prevalence of hypertension, type 2 diabetes mellitus (T2DM), obesity and dyslipidemia. In a cross-sectional design, patients diagnosed with plaque psoriasis answered an interview and standardized questionnaires (Dermatology Life Quality Index questionnaire [DLQI], 36-Item Short Form Health Survey [SF-36] and EuroQol Five-Dimension Questionnaire Three-Level version [EQ-5D-3L]). Physical examination and several tests to assess desired outcomes were performed by a dermatologist and a rheumatologist during three visits. The prevalence of MetS and PsA was 50.0% and 41.8%, respectively. Dyslipidemia was the most prevalent (74.5%) secondary comorbidity, followed by hypertension (61.8%), obesity (52.5%) and T2DM (30.9%). The mean (standard deviation) DLQI score was 6.5 (6.9), and mean physical and mental SF-36 measures were 45.2 (10.4) and 45.5 (12.3), respectively, and for EQ-5D-3L, mean utility index and EQ-VAS scores were 0.68 (0.27) and 72.7 (19.7), respectively. PsA and MetS are important comorbidities; a reduced HRQoL is noted among plaque psoriasis patients with these comorbidities, emphasizing the relevance of diagnosis and treatment beyond the care of skin lesions.
C1 [Souza, Cacilda S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [de Castro, Caio C. S.] Pontificia Univ Catolica Parana, Hosp Santa Casa Curitiba, Curitiba, Parana, Brazil.
   [Carneiro, Francisca R. O.] Univ State Para, Belem, Para, Brazil.
   [Pinto, Jane M. N.] Fed Fluminense Univ, Niteroi, RJ, Brazil.
   [Fabricio, Lincoln H. Z.] Evangel Univ Hosp Curitiba, Curitiba, Parana, Brazil.
   [Azulay-Abulafia, Luna] Inst Dermatol & Aesthet Rio De Janeiro, Rio De Janeiro, Brazil.
   [Romiti, Ricardo] Univ Sao Paulo, Hosp Clin, Dept Dermatol, Sao Paulo, Brazil.
   [Cestari, Tania F.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Suzuki, Claudia E.] AbbVie, N Chicago, IL USA.
   [Oyafuso, Luiza K. M.] Fac Med ABC, Sao Paulo, Brazil.
RP Souza, CS (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM cssouza@fmrp.usp.br
RI Cestari, Tania/U-4385-2019; Silva Souza, Cacilda/F-9926-2012
OI Silva Souza, Cacilda/0000-0002-8157-7658
FU AbbVie
FX The design, study conduct and financial support for the study were
   provided by AbbVie. AbbVie participated in the interpretation of data,
   review and approval of the content. All the authors had access to all
   relevant data and participated in the writing, review and approval of
   this manuscript. Medical writing support and editorial support was
   provided by Leticia Dias, Pamela Santana and Maira Takemoto of ANOVA -
   Consultoria em Saude Ltda (Rio de Janeiro/Brazil) and was funded by
   AbbVie.
CR Al-Mutairi N, 2010, J DERMATOL, V37, P146, DOI 10.1111/j.1346-8138.2009.00777.x
   Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-s064, 10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S062]
   AssociacAo Brasileira para o Estudo da Obesidade e da Sindrome Metabolica (Abeso), 2009, DIR BRAS OB SOBR OB, P11
   Augustin M, 2010, ACTA DERM-VENEREOL, V90, P147, DOI 10.2340/00015555-0770
   Balogh O, 2014, EUR J HEALTH ECON, V15, pS101, DOI 10.1007/s10198-014-0599-z
   Carneiro JN, 2012, AN BRAS DERMATOL, V87, P539, DOI 10.1590/S0365-05962012000400003
   Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001
   Chen YJ, 2008, ARCH DERMATOL, V144, P1571, DOI 10.1001/archderm.144.12.1571
   Choi WJ, 2010, ANN DERMATOL, V22, P300, DOI 10.5021/ad.2010.22.3.300
   de Soarez PC, 2007, REV PANAM SALUD PUBL, V22, P21, DOI 10.1590/S1020-49892007000600003
   Departamento de Ciencia e Tecnologia Ministerio da Saude Brasil . Secretaria de Ciencia Tecnologia e Insumos Estrategicos, 2013, PROT CLIN DIR TER PS
   Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002
   Finlay AY, 2005, BRIT J DERMATOL, V152, P861, DOI 10.1111/j.1365-2133.2005.06502.x
   FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x
   Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x
   Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768
   Gudjonsson JE, 2007, CLIN DERMATOL, V25, P535, DOI 10.1016/j.clindermatol.2007.08.007
   Haroon M, 2013, ANN RHEUM DIS, V72, P736, DOI 10.1136/annrheumdis-2012-201706
   Laguardia Josué, 2013, Rev. bras. epidemiol., V16, P889, DOI 10.1590/S1415-790X2013000400009
   Langan SM, 2012, J INVEST DERMATOL, V132, P556, DOI 10.1038/jid.2011.365
   Lau Melisa Yi Zhi, 2011, J Allergy (Cairo), V2011, P964509, DOI 10.1155/2011/964509
   Marques F, 2010, ARQ BRAS CARDIOL, V95, P107, DOI 10.1590/S0066-782X2010005000062
   Martins Gladys Aires, 2004, An. Bras. Dermatol., V79, P521, DOI 10.1590/S0365-05962004000500002
   Meier M, 2009, CURR PROBL DERMATOL, V38, P1, DOI 10.1159/000232301
   Menegon DB, 2014, INT J DERMATOL, V53, pE518, DOI 10.1111/ijd.12186
   Meyer N, 2010, J EUR ACAD DERMATOL, V24, P1075, DOI 10.1111/j.1468-3083.2010.03600.x
   Moller AH, 2015, PATIENT-RELAT OUTCOM, V6, P167, DOI 10.2147/PROM.S81428
   Moradi M, 2015, ARCH IRAN MED, V18, P153, DOI 0151803/AIM.004
   Mrowietz U, 2006, ARCH DERMATOL RES, V298, P309, DOI 10.1007/s00403-006-0707-8
   Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339
   Parodi A, 2014, AM J CLIN DERMATOL, V15, P371, DOI 10.1007/s40257-014-0074-8
   Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x
   Phan C, 2016, ANN DERMATOL VENER, V143, P264, DOI 10.1016/j.annder.2015.06.024
   Pinto EB, 2011, ARQ NEURO-PSIQUIAT, V69, P320, DOI 10.1590/S0004-282X2011000300010
   Praveenkumar U, 2016, J CLIN DIAGN RES, V10, pWC1, DOI 10.7860/JCDR/2016/17791.7218
   Prey S, 2010, J EUR ACAD DERMATOL, V24, P31, DOI 10.1111/j.1468-3083.2009.03565.x
   Ranza R, 2015, J RHEUMATOL, V42, P829, DOI 10.3899/jrheum.140474
   Reich K, 2009, BRIT J DERMATOL, V160, P1040, DOI 10.1111/j.1365-2133.2008.09023.x
   Baeta IGR, 2014, AN BRAS DERMATOL, V89, P735, DOI 10.1590/abd1806-4841.20142874
   Romiti R, 2017, INT J DERMATOL, V56, pE167, DOI 10.1111/ijd.13604
   de Oliveira MDSP, 2015, AN BRAS DERMATOL, V90, P9, DOI 10.1590/abd1806-4841.20153038
   Saris-Baglama R.N., 2010, QUALITYMETRIC HLTH O, P138
   Sociedade Brasileira de Dermatologia, 2012, CONS BRAS PSOR 2012
   Sojevic Timotijevic Z, 2013, J DERMATOL, V40, P797, DOI 10.1111/1346-8138.12201
   Spelman L, 2015, J EUR ACAD DERMATOL, V29, P2184, DOI 10.1111/jdv.13210
   Sposito AC, 2007, ARQ BRAS CARDIOL, V88, P2, DOI 10.1590/S0066-782X2007000700002
   Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972
   Tejada CD, 2011, AN BRAS DERMATOL, V86, P1113, DOI 10.1590/S0365-05962011000600008
   The EuroQol Group, 2015, EQ D US GUID
   Vidigal FD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1198
NR 50
TC 11
Z9 11
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0385-2407
EI 1346-8138
J9 J DERMATOL
JI J. Dermatol.
PD JAN
PY 2019
VL 46
IS 1
BP 3
EP 10
DI 10.1111/1346-8138.14706
PG 8
WC Dermatology
SC Dermatology
GA HF9ZH
UT WOS:000454600900002
PM 30474868
OA Other Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bechara, V
   Chan, IT
   Vieira, E
   Azulay-Abulafia, L
AF Bechara, Victor
   Chan, I. Thien
   Vieira, Eduardo
   Azulay-Abulafia, Luna
TI Sturge Weber syndrome: A rare clinical presentation with bilateral port
   wine stain and leptomenigeal angiomatosis
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Academy-of-Dermatology (AAD)
CY FEB 16-20, 2018
CL San Diego, CA
SP Amer Acad Dermatol
C1 [Bechara, Victor; Chan, I. Thien; Vieira, Eduardo; Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, HUPE, Rio De Janeiro, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD SEP
PY 2018
VL 79
IS 3
SU 1
MA 7261
BP AB270
EP AB270
PG 1
WC Dermatology
SC Dermatology
GA GP1HM
UT WOS:000440565902086
DA 2020-12-01
ER

PT J
AU Bressan, AL
   Picciani, BLS
   Azulay-Abulafia, L
   Fausto-Silva, AK
   Almeida, PN
   Cunha, KSG
   Dias, EP
   Carneiro, S
AF Bressan, Aline L.
   Picciani, Bruna L. S.
   Azulay-Abulafia, Luna
   Fausto-Silva, Anna K.
   Almeida, Paula N.
   Cunha, Karin S. G.
   Dias, Eliane P.
   Carneiro, Sueli
TI Evaluation of ICAM-1 expression and vascular changes in the skin of
   patients with plaque, pustular, and erythrodermic psoriasis
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
ID CAPILLARY LEAK SYNDROME; VCAM-1; CELLS
AB Background Psoriasis is a chronic inflammatory disease. Pustular, erythrodermic, and extensive plaque psoriasis are responsible for systemic complications. Systemic capillary leak syndrome is the complication with greater progression to death and occurs due to vascular changes. Purpose The aim of this study was to evaluate vascular changes through the expression of CD34 and ICAM-1 in plaque, pustular, and erythrodermic psoriasis.
   Methods The sample consisted of seven patients with erythrodermic psoriasis, 24 with moderate-severe plaque psoriasis, 14 with mild plaque psoriasis and 13 with pustular psoriasis. Patients were submitted to physical examination and skin biopsy for histopathological examination and immunohistochemical analysis with anti-CD34 and anti-ICAM-1 antibodies. Subsequently, tissue fragments were organized by groups using the Tissue Macroarray (TMA) technique to perform immunohistochemistry.
   Results In 58 patients, analysis of vessels using anti-CD34 demonstrated vascular immunostaining in superficial dermis and between dermal papillae. There were more blood vessels in erythrodermic psoriasis, followed by plaque psoriasis. In erythrodermic psoriasis, there were small and few tortuous blood vessels with great dilatation, while plaque psoriasis presented larger vessels that were less dilated and more tortuous. There was an intense and localized expression of ICAM-1 in endothelial and lymphocytic cells in all groups, with significant differences.
   Conclusions Vascular alterations are important in psoriasis, with an increase in the number of blood vessels and ICAM-1 overexpression, especially in erythrodermic form. Therefore, vascular changes and the expression of intercellular adhesion molecules could help to diagnose the erythrodermic form of psoriasis.
C1 [Bressan, Aline L.; Azulay-Abulafia, Luna; Carneiro, Sueli] Univ Estado Rio De Janeiro, Sect Dermatol, Rio De Janeiro, Brazil.
   [Picciani, Bruna L. S.; Fausto-Silva, Anna K.; Almeida, Paula N.; Cunha, Karin S. G.; Dias, Eliane P.] Fluminense Fed Univ, Sch Med, Grad Program Pathol, Rio De Janeiro, Brazil.
   [Carneiro, Sueli] Rio de Janeiro Fed Univ, Dept Clin Med, Sect Dermatol, Rio De Janeiro, Brazil.
RP Picciani, BLS (corresponding author), Fed Fluminense Univ, Univ Hosp, Sch Med, Dept Pathol, Marques Parana 303,4 Floor, BR-24033900 Rio De Janeiro, Brazil.
EM brunapicciani@gmail.com
RI Cunha, Karin SG/D-4519-2015; Karol, Anna/N-1992-2019; Cunha, K.
   S./J-9636-2012; Picciani, Bruna/B-8227-2013
OI Cunha, Karin SG/0000-0002-5647-282X; Picciani, Bruna/0000-0001-7592-1785
FU CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [APQ1 2010/2, E-26/110.322/2011]
FX The authors acknowledge the Brazilian agencies CAPES and FAPERJ for
   financial support (APQ1 2010/2, E-26/110.322/2011).
CR Archid R, 2016, SKIN PHARMACOL PHYS, V29, P47, DOI 10.1159/000443211
   Batycka-Baran A, 2014, J EUR ACAD DERMATOL, V28, P116, DOI 10.1111/j.1468-3083.2012.04671.x
   Bressan AL, 2011, AN BRAS DERMATOL, V86, P593, DOI 10.1590/S0365-05962011000300031
   Cabrijan L, 2009, MED HYPOTHESES, V72, P327, DOI 10.1016/j.mehy.2008.06.049
   Cai JP, 1996, BRIT J DERMATOL, V134, P7, DOI 10.1046/j.1365-2133.1996.d01-750.x
   Creamer D, 2002, ARCH DERMATOL, V138, P791, DOI 10.1001/archderm.138.6.791
   Danno K, 1996, J DERMATOL SCI, V13, P49, DOI 10.1016/0923-1811(95)00495-5
   ELIAS AN, 1993, CLIN EXP DERMATOL, V18, P526, DOI 10.1111/j.1365-2230.1993.tb01022.x
   Enamandram M, 2013, J INVEST DERMATOL, V133, P287, DOI 10.1038/jid.2012.434
   Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008
   Guffroy A, 2016, SEMIN ARTHRITIS RHEU, V12, P593
   Gupta Shilpa, 2011, Indian J Dermatol, V56, P647, DOI 10.4103/0019-5154.91820
   Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008
   Hern S, 2001, BRIT J DERMATOL, V145, P45, DOI 10.1046/j.1365-2133.2001.04280.x
   Kim BY, 2015, ANN DERMATOL, V27, P26, DOI 10.5021/ad.2015.27.1.26
   Kimura Y, 2016, BRIT J DERMATOL, V175, P979, DOI 10.1111/bjd.14717
   Mrowietz U, 2009, DTSCH ARZTEBL INT, V106, P11, DOI 10.3238/arztebl.2009.0011
   Nishikawa R, 2016, J DERMATOL, V43, P1273, DOI 10.1111/1346-8138.13412
   ODONNELL PG, 1995, BRIT J DERMATOL, V132, P160
   Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339
   Raut AS, 2013, CRIT REV THER DRUG, V30, P183, DOI 10.1615/CritRevTherDrugCarrierSyst.2013005268
   Sadeh JS, 1997, ARCH DERMATOL, V133, P747, DOI 10.1001/archderm.133.6.747
   Vos LE, 2007, J AM ACAD DERMATOL, V56, P339, DOI 10.1016/j.jaad.2006.08.006
NR 23
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD FEB
PY 2018
VL 57
IS 2
BP 209
EP 216
DI 10.1111/ijd.13883
PG 8
WC Dermatology
SC Dermatology
GA FZ0XF
UT WOS:000427297500022
PM 29318579
DA 2020-12-01
ER

PT J
AU Bressan, AL
   Pereira, D
   Medeiros, PM
   Carneiro, S
   Azulay-Abulafia, L
AF Bressan, Aline Lopes
   Pereira, Daniele
   Medeiros, Paula Mota
   Carneiro, Sueli
   Azulay-Abulafia, Luna
TI How relevant are vascular endothelial growth factor and intercellular
   adhesion molecule in the systemic capillary leak syndrome of psoriasis?
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Review
DE Capillary permeability; Endothelial growth factors; Endothelium,
   vascular; Psoriasis; Vascular endothelial growth factor,
   endocrine-gland-derived
ID HYPERPERMEABILITY; DISEASE; PERMEABILITY; INFLAMMATION; ICAM-1
AB Psoriasis is a chronic disease, characterized by erythematous scaly lesions, presented in eight different forms: plaques, guttate, pustular, erythrodermic, inverse, nail and scalp psoriasis, and psoriatic arthritis. Its development depends on genetic factors, external stimulus and immune response alteration. (1) Proinflammatory cytokines such as TNF-alpha, IL-12 and 23 may also be involved. In the worst cases, systemic complications linked to endothelial alterations may occur. A literature review was conducted for a better understanding of what roles VEGF (vascular endothelial growth factor) and ICAM-1 (intercellular adhesion molecule) have, among other cytokines, in systemic capillary leak syndrome, involved in erythrodermic and pustular psoriasis, the most unstable forms of the disease.
C1 [Bressan, Aline Lopes; Pereira, Daniele; Medeiros, Paula Mota; Carneiro, Sueli; Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, HUPE, Dept Dermatol, Rio De Janeiro, RJ, Brazil.
   [Pereira, Daniele] Private Clin, Salvador, BA, Brazil.
   [Medeiros, Paula Mota] Ctr Univ Cesmac, Dept Dermatol, Maceio, AL, Brazil.
   [Medeiros, Paula Mota] Ctr Univ Tiradentes Unit, Dept Dermatol, Maceio, AL, Brazil.
RP Bressan, AL (corresponding author), Blvd 28 Setembro 77, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM alinebressan@ig.com.br
CR Alves Cláudia Maria Pereira, 2010, J. Bras. Patol. Med. Lab., V46, P207, DOI 10.1590/S1676-24442010000300007
   Amoura Z, 1997, AM J MED, V103, P514, DOI 10.1016/S0002-9343(97)00272-6
   BARNADAS MA, 1995, J AM ACAD DERMATOL, V32, P364, DOI 10.1016/0190-9622(95)90405-0
   Bonadies N, 2006, EUR J INTERN MED, V17, P363, DOI 10.1016/j.ejim.2005.12.011
   Bressan AL, 2011, AN BRAS DERMATOL, V86, P593, DOI 10.1590/S0365-05962011000300031
   Bressan AL, 2010, AN BRAS DERMATOL, V85, P9, DOI 10.1590/S0365-05962010000100002
   Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023
   Creamer D, 2002, ARCH DERMATOL, V138, P791, DOI 10.1001/archderm.138.6.791
   Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129
   DIAS P.F., 2002, BIOTECNOLOGIA CIENC, V25, P28
   Dowlatshahi EA, 2013, BRIT J DERMATOL, V169, P266, DOI 10.1111/bjd.12355
   DVORAK HF, 1995, AM J PATHOL, V146, P1029
   Fabricio L., 2013, COMPENDIO PSORIASE, P75
   Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008
   Gripp A, 2012, CONSENSO BRASILEIRO, P159
   Gripp AC, 2008, 63 C BRAS DERM SOC B, V63
   HOLGATE MC, 1975, BRIT J DERMATOL, V92, P443, DOI 10.1111/j.1365-2133.1975.tb03106.x
   Jain A, 2013, MOL VIS, V19, P1760
   Magalhaes RF., 2013, COMPENDIO PSORIASE, P23
   Meki ARMA, 2014, J CLIN LAB ANAL, V28, P496, DOI 10.1002/jcla.21717
   Ortigosa LCM, 2013, COMPENDIO PSORIASE, P41
   Psoriasis.org [Internet], PEOPLE ALL RACES OVE
   Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x
   Tahirkheli NK, 1999, ANN INTERN MED, V130, P905, DOI 10.7326/0003-4819-130-11-199906010-00015
   Tonel G, 2009, INT J BIOCHEM CELL B, V41, P963, DOI 10.1016/j.biocel.2008.10.022
   Van de Kerkhof PCM, 2008, DERMATOLOGY, V1, P115
   Vigneau U, 2002, NEPHROL DIAL TRANSPL, V17, P492
   Vos LE, 2007, J AM ACAD DERMATOL, V56, P339, DOI 10.1016/j.jaad.2006.08.006
   Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816
NR 29
TC 2
Z9 3
U1 0
U2 1
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2017
VL 92
IS 6
BP 826
EP 829
DI 10.1590/abd1806-4841.20175994
PG 4
WC Dermatology
SC Dermatology
GA FT1AD
UT WOS:000422863200012
PM 29364440
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lopes, N
   Antonio, JR
   Fabricio, L
   Azulay-Abulafia, L
   Dias, LL
   Pertel, P
AF Lopes, N.
   Antonio, J. R.
   Fabricio, L.
   Azulay-Abulafia, L.
   Dias, L. L.
   Pertel, P.
TI WORK PRODUCTIVITY IN BRAZILIAN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE
   PSORIASIS
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Lopes, N.; Pertel, P.] Novartis Biociencias SA, Sao Paulo, Brazil.
   [Antonio, J. R.] Fundacao Fac Reg Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Fabricio, L.] Hosp Univ Evangel Curitiba, Curitiba, Parana, Brazil.
   [Azulay-Abulafia, L.] Inst Dermatol & Estet Rio de Janeiro JDERJ, Rio De Janeiro, Brazil.
   [Dias, L. L.] ANOVA, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD OCT-NOV
PY 2017
VL 20
IS 9
MA PSY34
BP A902
EP A902
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA FK6FX
UT WOS:000413599903544
DA 2020-12-01
ER

PT J
AU Correa, MC
   Nardelli, R
   Azulay-Abulafia, L
   Delia, M
   Pereira, C
   Steffen, M
AF Correa, Mariana Cesar
   Nardelli, Raquel
   Azulay-Abulafia, Luna
   Delia, Marcella
   Pereira, Cibele
   Steffen, Mairam
TI Topical sirolimus with satisfactory response in facial angiofibromas of
   tuberous sclerosis-Two case reports
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Academy-of-Dermatology
CY MAR 03-07, 2017
CL Orlando, FL
SP Amer Acad Dermatol
C1 [Correa, Mariana Cesar] Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil.
   [Nardelli, Raquel; Azulay-Abulafia, Luna; Delia, Marcella; Pereira, Cibele; Steffen, Mairam] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JUN
PY 2017
VL 76
IS 6
SU 1
MA 5642
BP AB262
EP AB262
PG 1
WC Dermatology
SC Dermatology
GA EX6RH
UT WOS:000403369302251
DA 2020-12-01
ER

PT J
AU Andersen, LK
   Azulay-Abulafia, L
   Davis, MDP
AF Andersen, Louise K.
   Azulay-Abulafia, Luna
   Davis, Mark D. P.
TI Zika virus: skin is commonly involved
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Letter
ID TRANSMISSION; INFECTION; TRAVELERS; STATES
C1 [Andersen, Louise K.] Aarhus Univ Hosp, Dept Dermatovenereol, Aarhus C, Denmark.
   [Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, Inst Dermatol Prof RD Azulay, Dept Dermatol, Rio De Janeiro, Brazil.
   [Davis, Mark D. P.] Mayo Clin, Div Clin Dermatol, Rochester, MN USA.
RP Andersen, LK (corresponding author), Aarhus Univ Hosp, Dept Dermatovenereol, Aarhus C, Denmark.
EM loand02@privat.dk
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD APR
PY 2017
VL 56
IS 4
BP e84
EP e86
DI 10.1111/ijd.13509
PG 3
WC Dermatology
SC Dermatology
GA EP7TQ
UT WOS:000397580500010
PM 28102537
DA 2020-12-01
ER

PT J
AU Balbi, GGM
   Montes, RA
   Vilela, VS
   Andrade, MAB
   Nobrega, MM
   Azulay-Abulafia, L
   da Silva, RS
   Klumb, EM
   Levy, RA
AF Moreira Balbi, Gustavo Guimaraes
   Montes, Ricardo Azedo
   Vilela, Veronica Silva
   Borges Andrade, Marcella Azevedo
   Nobrega, Monisa Martins
   Azulay-Abulafia, Luna
   da Silva, Roberto Souto
   Klumb, Evandro Mendes
   Levy, Roger Abramino
TI Rapidly progressive diffuse systemic sclerosis after local vitamins A, D
   and E complex injections: literature review and report of two cases
SO IMMUNOLOGIC RESEARCH
LA English
DT Review
DE Systemic sclerosis; Autoimmune/autoinflammatory syndrome induced by
   adjuvants (ASIA); Shoenfeld's syndrome; ADE
ID SILICONE BREAST IMPLANTS; ADJUVANTS ASIA; AUTOIMMUNITY; VACCINE;
   DISEASE; RISK
AB The term autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) or Shoenfeld's syndrome refers to a wide group of immune-mediated diseases triggered by external agents. Several substances, such as vaccine adjuvants, squalene and silicone implants, are implied in the pathogenesis of ASIA syndrome. Treatment and prognosis of this complex condition are not completely known due to lack of good quality evidence. After a brief introductory literature review on ASIA, we report here two cases of patients that developed rapidly progressive systemic sclerosis clinical features after multiple intramuscular local injections of a substance recommended by a non-medical professional called ADE. ADE is an oily vitamin complex for veterinary use, and it was used in these cases for cosmetic muscular definition and enhancement purpose. To our knowledge, this is the first paper to describe the relation between injections of ADE and the development of ASIA with severe systemic sclerosis phenotype. Further investigation is needed to better understand the pathophysiology and to provide the basis for the treatment of this condition.
C1 [Moreira Balbi, Gustavo Guimaraes; Montes, Ricardo Azedo; Vilela, Veronica Silva; Borges Andrade, Marcella Azevedo; Klumb, Evandro Mendes; Levy, Roger Abramino] Univ Estado Rio de Janeiro, Dept Rheumatol, Hosp Univ Pedro Ernesto, Blvd 28 Setembro,77 Vila Isabel, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Nobrega, Monisa Martins; Azulay-Abulafia, Luna; da Silva, Roberto Souto] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, Dept Dermatol, Rio De Janeiro, Brazil.
RP Balbi, GGM (corresponding author), Univ Estado Rio de Janeiro, Dept Rheumatol, Hosp Univ Pedro Ernesto, Blvd 28 Setembro,77 Vila Isabel, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM ggmbalbi@gmail.com
RI Balbi, Gustavo Guimaraes Moreira/AAD-5794-2020
OI Balbi, Gustavo Guimaraes Moreira/0000-0003-0235-8834
CR Asa PB, 2000, EXP MOL PATHOL, V68, P55, DOI 10.1006/exmp.1999.2295
   Bar-Meir E, 2003, AUTOIMMUNITY, V36, P193, DOI 10.1080/08916931000148818
   Boin F, 2008, RHEUM DIS CLIN N AM, V34, P199, DOI 10.1016/j.rdc.2007.11.001
   Carvalho JF, 2010, REV BRAS REUMATOL, V50, P489
   Cervera R, 2011, LUPUS, V20, P665, DOI 10.1177/0961203311402247
   Conti F, 2008, AUTOIMMUN REV, V8, P124, DOI 10.1016/j.autrev.2008.07.007
   Diot E, 2002, OCCUP ENVIRON MED, V59, P545, DOI 10.1136/oem.59.8.545
   Fernandez-Flores A, 2014, AM J DERMATOPATH, V36, P449, DOI 10.1097/DAD.0000000000000049
   Gatto M, 2013, CLIN RHEUMATOL, V32, P1301, DOI 10.1007/s10067-013-2266-7
   Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821
   HAUSTEIN UF, 1985, INT J DERMATOL, V24, P147, DOI 10.1111/j.1365-4362.1985.tb05406.x
   Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105
   Kappel RM, 2014, CLIN EXP RHEUMATOL, V32, P256
   Kivity S, 2012, LUPUS, V21, P136, DOI 10.1177/0961203311429551
   Lidar M, 2012, LUPUS, V21, P121, DOI 10.1177/0961203311430703
   Loyo E, 2013, AUTOIMMUN HIGHLIGHTS, V4, P33, DOI 10.1007/s13317-012-0044-1
   Maijers MC, 2013, NETH J MED, V71, P534
   Perricone C, 2013, J AUTOIMMUN, V47, P1, DOI 10.1016/j.jaut.2013.10.004
   Shoenfeld Y, 2009, LUPUS, V18, P1127, DOI 10.1177/0961203309351081
   Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003
   Vera-Lastra O, 2012, LUPUS, V21, P128, DOI 10.1177/0961203311429317
   Whitehouse M, 2012, LUPUS, V21, P217, DOI 10.1177/0961203311429818
   Yel L, 2004, ANN ALLERG ASTHMA IM, V92, P88, DOI 10.1016/S1081-1206(10)61716-4
   Zafrir Y, 2012, LUPUS, V21, P146, DOI 10.1177/0961203311429318
NR 24
TC 2
Z9 2
U1 0
U2 3
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0257-277X
EI 1559-0755
J9 IMMUNOL RES
JI Immunol. Res.
PD FEB
PY 2017
VL 65
IS 1
SI SI
BP 285
EP 292
DI 10.1007/s12026-016-8851-5
PG 8
WC Immunology
SC Immunology
GA ET3JX
UT WOS:000400175600034
PM 27515982
DA 2020-12-01
ER

PT J
AU Lisboa, AP
   Silvestre, KJ
   Pedreira, RL
   Alves, NRD
   Obadia, DL
   Azulay-Abulafia, L
AF Lisboa, Alice Paixao
   Silvestre, Keline Jacome
   Pedreira, Renata Leite
   de Magalhaes Alves, Natalia Ribeiro
   Obadia, Daniel Lago
   Azulay-Abulafia, Luna
TI Agminated blue nevus - Case report
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Melanocytes; Nevus, Blue; Nevi and Melanomas
AB Blue nevi are benign melanocytic lesions located in the deeper reticular dermis, consequence of failure of melanocytic migration into the dermal-epidermal junction from the neural crest. Lesions are usually asymptomatic and solitary, but may present in a multiple or agminated (grouped) pattern. The agminated subtype is formed when bluish-pigmented lesions cluster together in a well-defined area. Lesions can be flat or raised. We report the case of a patient who presented multiple bluish macules (1-3 mm in diameter) grouped on the left upper back. Dermoscopy and anatomic pathological examination were consistent with blue nevus.
C1 [Lisboa, Alice Paixao; Silvestre, Keline Jacome; Pedreira, Renata Leite; de Magalhaes Alves, Natalia Ribeiro; Obadia, Daniel Lago; Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro HUPE UERJ, Hosp Univ Pedro Ernesto, Rio De Janeiro, RJ, Brazil.
   [Lisboa, Alice Paixao; Silvestre, Keline Jacome; Pedreira, Renata Leite; de Magalhaes Alves, Natalia Ribeiro; Obadia, Daniel Lago; Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro UERJ, Rio De Janeiro, RJ, Brazil.
   [Obadia, Daniel Lago] Univ Grande Rio Unigranrio, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Univ Estacio Sa, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Santa Casa Misericordia Rio de Janeiro IDPRDA SCM, Inst Dermatol Prof Rubem David Azulay, Rio De Janeiro, RJ, Brazil.
RP Lisboa, AP (corresponding author), Blvd 28 Setembro 77, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM alicepaixaolisboa@yahoo.com
CR Barcaui C, 2011, ATLAS DERMATOSCOPIA, P79
   Barnhill RL, 2011, DERMATOLOGICA, P1713
   Chen T, 2013, J AM ACAD DERMATOL, V68, pE52, DOI 10.1016/j.jaad.2012.08.007
   HSIAO GH, 1994, J AM ACAD DERMATOL, V30, P849, DOI 10.1016/S0190-9622(94)70095-8
   Jovani SG, 2002, ACTA DERMOSIFILIOGR, V93, P594
   Lapresta A, 2011, ACTAS DERMO-SIFILOGR, V102, P219, DOI [10.1016/j.ad.2010.09.006, 10.1016/S1578-2190(11)70789-2]
   UPSHAW BY, 1947, SURGERY, V22, P761
   Wen SY, 1997, ACTA DERM-VENEREOL, V77, P458
NR 8
TC 6
Z9 6
U1 0
U2 0
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD SEP-OCT
PY 2016
VL 91
IS 5
BP 658
EP 660
DI 10.1590/abd1806-4841.20164448
PG 3
WC Dermatology
SC Dermatology
GA EC9LC
UT WOS:000388465100019
PM 27828645
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Carneiro, F
   Cestari, T
   Souza, C
   Oyafuso, L
   Azulay-Abulafia, L
   Neffa, J
   Fabricio, L
   de Castro, CS
   Romiti, R
   Furlan, F
AF Carneiro, Francisca
   Cestari, Tania
   Souza, Cacilda
   Oyafuso, Luiza
   Azulay-Abulafia, Luna
   Neffa, Jane
   Fabricio, Lincoln
   de Castro, Caio Silva
   Romiti, Ricardo
   Furlan, Fabricio
TI Metabolic syndrome and psoriatic arthritis among Brazilian patients with
   plaque psoriasis-Preliminary results of the BEYOND study
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 74th Annual Meeting of the American-Academy-of-Dermatology
CY MAR 04-08, 2016
CL Washington, DC
SP Amer Acad Dermatol
C1 [Carneiro, Francisca] Univ Estado Para, Belem, Para, Brazil.
   [Cestari, Tania] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Souza, Cacilda] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Oyafuso, Luiza] ABC, Fac Med, Santo Andre, Brazil.
   [Azulay-Abulafia, Luna] Inst Dermatol Estet Brasil, Rio De Janeiro, Brazil.
   [Neffa, Jane] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Fabricio, Lincoln] Hosp Univ Evangel Curitiba, Curitiba, Parana, Brazil.
   [de Castro, Caio Silva] Irmandade Santa Casa Miserordia Curitiba, Curitiba, Parana, Brazil.
   [Romiti, Ricardo] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Furlan, Fabricio] AbbVie Pharmaceut Brazil, Sao Paulo, Brazil.
RI Cestari, Tania/U-4385-2019
FU AbbVie Brazil
FX The design, study conduct, and financial support for the BEYOND study
   were provided by AbbVie Brazil. AbbVie Brazil participated in the
   interpretation of data, review, and approval of the publication.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAY
PY 2016
VL 74
IS 5
SU 1
MA 3402
BP AB260
EP AB260
PG 1
WC Dermatology
SC Dermatology
GA FJ5BR
UT WOS:000412760201874
DA 2020-12-01
ER

PT J
AU Brandao, ED
   dos Santos, I
   Lanzillotti, RS
   Ferreira, AM
   Gamba, MA
   Azulay-Abulafia, L
AF Brandao, Euzeli da Silva
   dos Santos, Iraci
   Lanzillotti, Regina Serrao
   Ferreira, Adriano Menis
   Gamba, Monica Antar
   Azulay-Abulafia, Luna
TI Nursing diagnoses in patients with immune-bullous dermatosis
SO REVISTA LATINO-AMERICANA DE ENFERMAGEM
LA English
DT Article
DE Nursing; Nursing Care; Nursing Diagnosis; Dermatology
ID CARE
AB Objective: identify nursing diagnoses in patients with immune-bullous dermatosis. Method: a quantitative and descriptive research, carried out in three institutions located in Rio de Janeiro and Mato Grosso do Sul, Brazil, using the Client Assessment Protocol in Dermatology during a nursing consultation. Simple descriptive statistics was used for data analysis. Results: 14 subjects participated in the study, nine with a diagnosis of pemphigus vulgaris, pemphigus two and three of bullous pemphigoid. The age ranged between 27 and 82 years, predominantly females (11). 14 nursing diagnoses were discussed and identified from a clinical rationale in all study participants, representing the most common human responses in this sample. The application of the Assessment Protocol in Dermatology facilitated the comprehensive assessment, in addition to providing the identification of diagnostics according to the North American Nursing Diagnosis Association International. Conclusion: the nursing diagnoses presented confirm the necessity of interdisciplinary work during the care for this clientele. For better description of the phenomena related to the client in question, it is suggested the inclusion of two risk factors related in three diagnoses of this taxonomy. It is worth noting the contribution of the findings for the care, education and research in nursing in dermatology.
C1 [Brandao, Euzeli da Silva] Univ Fed Fluminense, Escola Enfermagem Aurora Afonso Costa, Niteroi, RJ, Brazil.
   [dos Santos, Iraci] Univ Estado Rio de Janeiro, Fac Enfermagem, Rio De Janeiro, RJ, Brazil.
   [Lanzillotti, Regina Serrao] Univ Estado Rio de Janeiro, Inst Matemat & Estat, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Adriano Menis] Univ Fed Mato Grosso, Tres Lagoas, MS, Brazil.
   [Gamba, Monica Antar] Univ Fed Sao Paulo, Escola Paulista Enfermagem, Sao Paulo, SP, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil.
RP Brandao, ED (corresponding author), Univ Fed Fluminense, Escola Enfermagem Aurora Afonso Costa, Niteroi, RJ, Brazil.
EM euzelibrandao@gmail.com
RI Gamba, Monica Antar/K-8903-2013; Ferreira, Adriano Menis/L-5054-2019; da
   Silva Brandao, Euzeli/Y-6851-2019; Ferreira, Adriano Menis/AAO-3396-2020
OI Gamba, Monica Antar/0000-0003-1470-4474; Ferreira, Adriano
   Menis/0000-0002-4054-768X; da Silva Brandao, Euzeli/0000-0001-8988-8103;
   
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [477063/2011-0]
FX Supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, CNPq, process no 477063/2011-0.
CR Brandao ES, 2011, REV ENFERM UERJ, V19, P479
   Brandao ES, 2013, ONLINE BRAZ J NURS, V12, P162
   Brandao ED, 2013, ACTA PAUL ENFERM, V26, P460, DOI 10.1590/S0103-21002013000500009
   Coelho MO, 2009, CIENC SAUDE COLETIVA, V14, P1523, DOI 10.1590/S1413-81232009000800026
   Cunha PR, 2009, AN BRAS DERMATOL, V84, P111, DOI 10.1590/S0365-05962009000200003
   Santos APD, 2014, REV LAT-AM ENFERM, V22, P255, DOI 10.1590/0104-1169.3101.2410
   de Souza SR, 2011, AN BRAS DERMATOL, V86, P284, DOI 10.1590/S0365-05962011000200012
   Teixeira CRD, 2009, ACTA PAUL ENFERM, V22, P385, DOI 10.1590/S0103-21002009000400006
   Garcia TR, 2009, ESC ANNA NERY, V13, P816
   Kletemberg DF, 2010, REV BRAS ENFERM, V63, P26, DOI 10.1590/S0034-71672010000100005
   Merhy EE, 2003, SAUDE DEBATE, V27, P316
   NANDA International, 2013, DIAGN ENF NAND DEF C
   Pokomy ME, 2010, NURSING THEORISTS TH, P54
   Cavalcante AMRZ, 2015, REV BRAS ENFERM, V68, P155, DOI 10.1590/0034-7167.2015680121i
   Saldanha ED, 2014, REV BRAS ENFERM, V67, P430, DOI 10.5935/0034-7167.20140057
   Santos I, 2009, REV ENFERM UERJ, V17, P124
   Santos I, 2012, REV ENFERM UERJ, V20, P4
NR 17
TC 0
Z9 0
U1 0
U2 1
PU UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO
PI RIBEIRAO PRETO
PA AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL
SN 1518-8345
J9 REV LAT-AM ENFERM
JI Rev. Latino-Am. Enfermagem
PY 2016
VL 24
AR e2766
DI 10.1590/1518-8345.0424.2766
PG 7
WC Nursing
SC Nursing
GA EN8VI
UT WOS:000396277500027
PM 27533274
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Vieira, CD
   Bernardes, F
   Azulay-Abulafia, L
AF Vieira, Camille de Oliveira
   Bernardes Filho, Fred
   Azulay-Abulafia, Luna
TI CAPYBARA BITES: REPORT OF HUMAN INJURY CAUSED BY A HYDROCHOERUS
   HYDROCHAERIS
SO JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
DE rodents; bites and stings; capybara; wild animal attack; wild animal
   trauma
ID WOUNDS
AB Background: Health care demand due to animal bites is frequent, especially in the emergency department (ED). In addition to the physical trauma caused by bites, one should be concerned with infectious diseases that can be transmitted. The range of the lesions depends on the animal species. Bites of Hydrochoerus hydrochaeris (capybaras) in humans are relatively uncommon. Capybaras are docile animals; however, their large rodent incisive teeth could cause serious injury. Localized care, antibiotic therapy when necessary, careful examination of the structures, tetanus and rabies immunization as indicated, and follow-up are recommended for wild animal bites. The authors hereby describe and discuss the medical management of a case of multiple lesions from capybara bites on the right thigh of a man. Case Report: A 54-year-old male patient was admitted to the ED with a compression bandage soaked with blood after being bitten by a capybara. At the clinical examination, the patient had two lacerating wounds and multiple abrasions on the anterior face of the right thigh. Rabies prophylaxis was administered and the wounds were irrigated and closed with sterile dressings. Oral amoxicillin/clavulanate potassium for 7 days was administered to the patient. The patient was followed up; 3 months after the attack he returned to his previous level of activity without any complication. Why Should an Emergency Physician Be Aware of This?: We recommend that practitioners and physicians should provide prompt attention due to potentially significant morbidities, particularly rabies. The adequate care of the wound will allow better aesthetic and functional results to victims of wild animal bites. (C) 2015 Elsevier Inc.
C1 [Vieira, Camille de Oliveira; Bernardes Filho, Fred] Policlin Reg Largo da Batalha, Emergency Dept, Niteroi, RJ, Brazil.
   [Bernardes Filho, Fred; Azulay-Abulafia, Luna] Santa Casa Misericordia Rio de Janeiro, Inst Dermatologia Prof Rubem David Azulay, Rio De Janeiro, Brazil.
RP Bernardes, F (corresponding author), Arnaldo Victaliano,971-152 Jd Palma Travassos, Ribeirao Preto, SP, Brazil.
CR Abrahamian FM, 2011, CLIN MICROBIOL REV, V24, P231, DOI 10.1128/CMR.00041-10
   Brasil. Ministe A rio da Sau A de. Secretaria de Vigila A ncia em Sau A de. Departamento de Vigila A ncia Epidemiologica, 2011, NORM TECN PROF RAIV
   Brook Itzhak, 2009, Curr Infect Dis Rep, V11, P389, DOI 10.1007/s11908-009-0055-x
   Goldstein EJC, 1998, J MED MICROBIOL, V47, P95, DOI 10.1099/00222615-47-2-95
   Langley R, 2014, WILD ENVIRON MED, V25, P14, DOI 10.1016/j.wem.2013.08.007
   Levin AS, 2011, GUIA UTILIZACAO ANTI
   Moreira J.R., 2013, CAPYBARA BIOL USE CO
   Porto GG, 2013, REV CIR TRAUMATOL BU, V13, P39
   Stefanopoulos PK, 2005, INT J ORAL MAX SURG, V34, P464, DOI 10.1016/j.ijom.2005.04.001
   Universidade Federal de Vicosa. Centro de Ciencias Agrarias. Departamento de Engenharia Florestal, CAP AMPL REV EST AN
   VANRELL J. P., 2009, ODONTOLOGIA LEGAL AN
NR 11
TC 1
Z9 2
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0736-4679
EI 1090-1280
J9 J EMERG MED
JI J. Emerg. Med.
PD DEC
PY 2015
VL 49
IS 6
BP E179
EP E182
DI 10.1016/j.jemermed.2015.08.007
PG 4
WC Emergency Medicine
SC Emergency Medicine
GA CX0TC
UT WOS:000365408800004
PM 26432078
DA 2020-12-01
ER

PT J
AU Sittart, JAD
   da Costa, A
   Mulinari-Brenner, F
   Follador, I
   Azulay-Abulafia, L
   de Castro, LCM
AF de Souza Sittart, Jose Alexandre
   da Costa, Adilson
   Mulinari-Brenner, Fabiane
   Follador, Ivonise
   Azulay-Abulafia, Luna
   Miranda de Castro, Lia Candida
TI Multicenter study for efficacy and safety evaluation of a fixed-dose
   combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo
   (R)) for the treatment of acne vulgaris in Brazilian population
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Acne vulgaris; Benzoyl peroxide; Combined modality therapy; Dermatology;
   Drug therapy, combination; Multicenter Study; Propionibacterium acnes;
   Skin diseases; Treatment outcome
ID DOUBLE-BLIND; THERAPY
AB BACKGROUND: The current options for the treatment of acne vulgaris present many mechanisms of action. For several times, dermatologists try topical agents combinations, looking for better results.
   OBJECTIVES: To evaluate the efficacy, tolerability and safety of a topical, fixed-dose combination of adapalene 0.1% and benzoyl peroxide 2.5% gel for the treatment of acne vulgaris in the Brazilian population.
   METHODS: This is a multicenter, open-label and interventionist study. Patients applied 1.0 g of the fixed-dose combination of adapalene 0.1% and benzoyl peroxide 2.5% gel on the face, once daily at bedtime, during 12 weeks. Lesions were counted in all of the appointments, and the degree of acne severity, overall improvement, tolerability and safety were evaluated in each visit.
   RESULTS: From 79 recruited patients, 73 concluded the study. There was significant, fast and progressive reduction of non-inflammatory, inflammatory and total number of lesions. At the end of the study, 75.3% of patients had a reduction of > 50% in non-inflammatory lesions, 69.9% in inflammatory lesions and 78.1% in total number of lesions. Of the 73 patients, 71.2% had good to excellent response and 87.6% had satisfactory to good response. In the first week of treatment, erythema, burning, scaling and dryness of the skin were frequent complaints, but, from second week on, these signals and symptoms have reduced.
   CONCLUSION: The fixed-dose combination of adapalene 0.1% and benzoyl peroxide 2.5% gel is effective, safe, well tolerated and apparently improves patient compliance with the treatment.
C1 [de Souza Sittart, Jose Alexandre] Hosp Servidor Publ Estadual Sao Paulo HSPE, Sao Paulo, SP, Brazil.
   [da Costa, Adilson] Pontificia Univ Catolica Campinas, BR-13020100 Campinas, SP, Brazil.
   [Mulinari-Brenner, Fabiane] Univ Fed Parana UFPR, Curitiba, Parana, Brazil.
   [Follador, Ivonise] Univ Fed Bahia, Salvador, BA, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Santa Casa de Misericordia Rio de Janeiro, Inst Dermatol Prof Rubem David Azulay, Rio De Janeiro, RJ, Brazil.
   [Miranda de Castro, Lia Candida] Univ Fed Goias, Goiania, Go, Brazil.
RP da Costa, A (corresponding author), Pontificia Univ Catolica Campinas, KOLderma Inst Pesquisa Clin Ltda, 350 Dr Delfino Cintra St, BR-13020100 Campinas, SP, Brazil.
EM adilson_costa@hotmail.com
FU Galderma do Brasil
FX Galderma do Brasil was the financial sponsor of the study.
CR Bikowski Joseph B, 2005, J Drugs Dermatol, V4, P41
   Brogden RN, 1997, DRUGS, V53, P511, DOI 10.2165/00003495-199753030-00010
   CUNLIFFE WJ, 1979, BRIT MED J, V1, P1109, DOI 10.1136/bmj.1.6171.1109
   Dreno B, 2010, INT J DERMATOL, V49, P448, DOI 10.1111/j.1365-4632.2010.04416.x
   Gold LS, 2009, CUTIS, V84, P110
   Gollnick HPM, 2009, BRIT J DERMATOL, V161, P1180, DOI 10.1111/j.1365-2133.2009.09209.x
   Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x
   Kircik Leon H, 2011, J Clin Aesthet Dermatol, V4, P30
   KRANING KK, 1979, J INVEST DERMATOL, V73, P395
   Leyden JJ, 2003, J AM ACAD DERMATOL, V49, pS200, DOI 10.1067/S0190-9622(03)01154-X
   Leyden JJ, 2001, J EUR ACAD DERMATOL, V15, P51, DOI 10.1046/j.0926-9959.2001.00013.x
   Loesche C, 2008, EUR J DERMATOL, V18, P524, DOI 10.1684/ejd.2008.0488
   Michel S, 1998, BRIT J DERMATOL, V139, P3
   Pariser David M, 2007, J Drugs Dermatol, V6, P899
   Pawin H, 2004, EUR J DERMATOL, V14, P4
   Tan J, 2011, J DERMATOL TREAT, V22, P197, DOI 10.3109/09546631003681094
   Tanghetti E, 2008, CUTIS, V82, P5
   Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x
   Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x
   Thiboutot DM, 2007, J AM ACAD DERMATOL, V57, P791, DOI 10.1016/j.jaad.2007.06.006
   Waugh J, 2004, DRUGS, V64, P1465, DOI 10.2165/00003495-200464130-00005
   Zaghloul SS, 2005, BRIT J DERMATOL, V152, P1015, DOI 10.1111/j.1365-2133.2005.06357.x
NR 22
TC 9
Z9 9
U1 0
U2 1
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2015
VL 90
IS 6
SU 1
BP 6
EP 15
DI 10.1590/abd1806-4841.20153969
PG 10
WC Dermatology
SC Dermatology
GA DM5MD
UT WOS:000376392200001
PM 27168522
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Trujillo, JM
   Alves, NRD
   Medeiros, PM
   Azulay-Abulafia, L
   Alves, MDGS
   Gripp, AC
AF Trujillo, Jeniffer Munoz
   de Magalhaes Alves, Natalia Ribeiro
   Medeiros, Paula Mota
   Azulay-Abulafia, Luna
   Guimaraes Scotelaro Alves, Maria de Ftima
   Gripp, Alexandre Carlos
TI Clinical exuberance of classic Kaposi's sarcoma and response to
   radiotherapy
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Aged; Herpesvirus 8, human; Radiotherapy; Sarcoma, Kaposi
ID AIDS
AB Kaposi's sarcoma (KS) is a multicentric vascular neoplasm, with cutaneous and extracutaneous involvement. Different clinical and epidemiological variants have been identified. The classic form is manifested mainly in elderly men with indolent and long-term evolution, with lesions localized primarily in the lower extremities. We present two cases of classic Kaposi's sarcoma (CKS) in two female patients with extensive, exuberant skin involvement and rapid evolution, with good response to radiotherapy.
C1 [Trujillo, Jeniffer Munoz; de Magalhaes Alves, Natalia Ribeiro; Medeiros, Paula Mota; Azulay-Abulafia, Luna; Guimaraes Scotelaro Alves, Maria de Ftima; Gripp, Alexandre Carlos] Univ Estado Rio de Janeiro UERJ, Rio De Janeiro, RJ, Brazil.
RP Trujillo, JM (corresponding author), Rua Estocolmo 101,Apto 101 F, BR-21931480 Rio De Janeiro, RJ, Brazil.
EM jeniffer848@gmail.com
CR Altunay I, 2012, J DERMATOL CASE REP, V6, P8, DOI 10.3315/jdcr.2012.1088
   Brambilla L, 2003, EUR J DERMATOL, V13, P83
   Fatahzadeh M, 2012, OR SURG OR MED OR PA, V113, P2, DOI 10.1016/j.tripleo.2011.05.011
   Jakob L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018397
   KOLIOS G, 1995, GASTROINTEST ENDOSC, V42, P336, DOI 10.1016/S0016-5107(95)70133-8
   Mohanna S, 2005, INT J INFECT DIS, V9, P239, DOI 10.1016/j.ijid.2005.02.004
   Mohanna Salim, 2007, Med Oral Patol Oral Cir Bucal, V12, pE365
   Radu O, 2013, ARCH PATHOL LAB MED, V137, P289, DOI 10.5858/arpa.2012-0101-RS
   Regnier-Rosencher E, 2013, J AM ACAD DERMATOL, V68, P313, DOI 10.1016/j.jaad.2012.04.018
   Vanni T, 2006, CANCER TREAT REV, V32, P445, DOI 10.1016/j.ctrv.2006.06.001
NR 10
TC 3
Z9 4
U1 0
U2 3
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2015
VL 90
IS 6
BP 883
EP 886
DI 10.1590/abd1806-4841.20153877
PG 4
WC Dermatology
SC Dermatology
GA DA3XG
UT WOS:000367733900016
PM 26734872
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Quaresma, MV
   Bernardes, F
   Hezel, J
   Peretti, MC
   Kac, BK
   Azulay-Abulafia, L
AF Quaresma, Maria Victoria
   Bernardes Filho, Fred
   Hezel, Janaina
   Peretti, Murilo Calvo
   Kac, Bernard Kawa
   Azulay-Abulafia, Luna
TI Dapsone in the treatment of pemphigus vulgaris: adverse effects and its
   importance as a corticosteroid sparing agent
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Dapsone; Hepatitis; Pemphigus; Prednisone
ID MANAGEMENT
AB Pemphigus vulgaris is an autoimmune disease characterized by suprabasal blisters with acantholysis, which has a fatal course in a large number of untreated patients. Systemic corticosteroid therapy is considered first-line therapy. Adjuvant treatment with the goal of sparing corticosteroids include, among others, dapsone. This drug is not without side effects and its use requires clinical and laboratory control. We present a patient with PV initially managed with suboptimal dose of prednisone, evolving into drug-induced hepatitis after introduction of dapsone.
C1 [Quaresma, Maria Victoria; Bernardes Filho, Fred; Hezel, Janaina; Peretti, Murilo Calvo; Kac, Bernard Kawa; Azulay-Abulafia, Luna] IDPRDA SCMRJ, Rio De Janeiro, RJ, Brazil.
RP Quaresma, MV (corresponding author), Alameda Itu 1030-9B, BR-01421001 Sao Paulo, SP, Brazil.
EM mavi@mavictoria.com.br
CR Agrawal S, 2005, J DERMATOL, V32, P883, DOI 10.1111/j.1346-8138.2005.tb00865.x
   Ash-Bernal R, 2004, MEDICINE, V83, P265, DOI 10.1097/01.md.0000141096.00377.3f
   Bernabe D. G., 2005, REV ODONTOL UNESP, V34, P49
   Ciarrocca KN, 1999, ORAL SURG ORAL MED O, V88, P159, DOI 10.1016/S1079-2104(99)70110-1
   Cunha PR, 2009, AN BRAS DERMATOL, V84, P111, DOI 10.1590/S0365-05962009000200003
   Enk AH, 1999, ARCH DERMATOL, V135, P54, DOI 10.1001/archderm.135.1.54
   Han Anne, 2009, J Clin Aesthet Dermatol, V2, P19
   Heaphy MR, 2005, ARCH DERMATOL, V141, P699, DOI 10.1001/archderm.141.6.699
   Scully C, 2002, CRIT REV ORAL BIOL M, V13, P397, DOI 10.1177/154411130201300504
   Werth VP, 2008, ARCH DERMATOL, V144, P25, DOI 10.1001/archderm.144.1.25
NR 10
TC 3
Z9 3
U1 0
U2 0
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAY-JUN
PY 2015
VL 90
IS 3
SU 1
BP 51
EP 54
DI 10.1590/abd1806-4841.20153408
PG 4
WC Dermatology
SC Dermatology
GA DB7DZ
UT WOS:000368676100013
PM 26312673
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bonatto, DC
   Slaibi, EB
   Silveira, BRL
   Teixeira Marquezini, MA
   Kac, BK
   Hertz, A
   Azulay-Abulafia, L
AF Bonatto, Danielle Cristine
   Slaibi, Erica Bertolace
   Lages Silveira, Bruno Rebelo
   Teixeira Marquezini, Mirna Ayusso
   Kac, Bernard Kawa
   Hertz, Amanda
   Azulay-Abulafia, Luna
TI Milia-like idiopathic calcinosis cutis and syringomas in patient with
   Down syndrome
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
C1 [Bonatto, Danielle Cristine; Slaibi, Erica Bertolace; Lages Silveira, Bruno Rebelo; Teixeira Marquezini, Mirna Ayusso; Kac, Bernard Kawa; Hertz, Amanda; Azulay-Abulafia, Luna] Inst Dermatol Prof Rubem David Azulay Santa Casa, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAY
PY 2015
VL 72
IS 5
SU 1
MA 2062
BP AB201
EP AB201
PG 1
WC Dermatology
SC Dermatology
GA CQ9NW
UT WOS:000360942901519
DA 2020-12-01
ER

PT J
AU Marquezini, MAT
   Slaibi, EB
   Gusman, LMP
   Medeiros, ABG
   Kac, BK
   Hertz, A
   Azulay-Abulafia, L
AF Teixeira Marquezini, Mirna Ayusso
   Slaibi, Erica Bertolace
   Paz Gusman, Lina Maria
   Goncalves Medeiros, Andressa Blumer
   Kac, Bernard Kawa
   Hertz, Amanda
   Azulay-Abulafia, Luna
TI Cutaneous mastocytosis in an infant: A case report
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
C1 [Teixeira Marquezini, Mirna Ayusso; Slaibi, Erica Bertolace; Paz Gusman, Lina Maria; Goncalves Medeiros, Andressa Blumer; Kac, Bernard Kawa; Hertz, Amanda; Azulay-Abulafia, Luna] Inst Dermatol Prof Rubem David Azulay Santa Casa, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAY
PY 2015
VL 72
IS 5
SU 1
MA 2070
BP AB199
EP AB199
PG 1
WC Dermatology
SC Dermatology
GA CQ9NW
UT WOS:000360942901511
DA 2020-12-01
ER

PT J
AU Bernardes, F
   Avelleira, JCR
   Azulay-Abulafia, L
   Goncalves, TCM
   Quaresma, MV
   Azulay, DR
   Bastos, AQ
AF Bernardes Filho, Fred
   Regazzi Avelleira, Joao Carlos
   Azulay-Abulafia, Luna
   Monte Goncalves, Teresa Cristina
   Quaresma, Maria Victoria
   Azulay, David Rubem
   Bastos, Amanda Queiroz
TI Bed bug dermatitis, description of two cases in Rio de Janeiro, Brazil
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Arthropods; Bed bugs; Cimicidae; Prurigo
AB Bed bugs are hematophagous insects which due to their morphological and biological characteristics are able to easily adapt themselves to human households. The authors describe two cases of dermatitis caused by bed bug bites in the city of Rio de Janeiro, Brazil. Patients presented linear lesions in the usual "breakfast, lunch and dinner" arrangement, suggesting this diagnosis. A visit to their dwellings showed infestation of insects identified as Cimex hemipterus. The knowledge of these insects by the dermatological community will contribute to an accurate diagnosis as well as subsidize the dissemination of information aiming for prevention.
C1 [Bernardes Filho, Fred; Regazzi Avelleira, Joao Carlos; Azulay-Abulafia, Luna; Quaresma, Maria Victoria; Azulay, David Rubem] IDPRDA, SCMRJ, Rio De Janeiro, RJ, Brazil.
   [Bernardes Filho, Fred; Quaresma, Maria Victoria; Azulay, David Rubem] PUC RJ, Rio De Janeiro, RJ, Brazil.
   [Azulay, David Rubem] Fundacao Tecn Educ Souza Marques, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Bastos, Amanda Queiroz] Univ Fed Rural Rio de Janeiro, Inst Oswaldo Cruz, Lab Transmissores Leishmanioses, Setor Entomol Med & Forense Fiocruz, Rio de Janeiro, RJ, Brazil.
   [Monte Goncalves, Teresa Cristina] Inst Oswaldo Cruz, Lab Transmissores Leishmanioses, Setor Entomol Med & Forense Fiocruz, BR-20001 Rio De Janeiro, RJ, Brazil.
RP Bernardes, F (corresponding author), Marques de Caxias,9 Sobrado Ctr, BR-24030050 Niteroi, RJ, Brazil.
EM f9filho@gmail.com
RI Goncalves, Teresa/AAT-3566-2020
CR Araujo RN, 2009, J INSECT PHYSIOL, V55, P1151, DOI 10.1016/j.jinsphys.2009.08.011
   Coto H, 2011, REV PLAGAS AMBIENTE, V48, P34
   Criado PR, 2011, AN BRAS DERMATOL, V86, P157
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P1
   Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405
   Nascimento LGG, 2010, THESIS U SAO PAULO S
   NEGROMONTE M R S, 1991, Revista Brasileira de Entomologia, V35, P715
   Potter Michael F., 2011, American Entomologist, V57, P14
   Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913
   Usinger RL, 1966, MONOGRAPH CIMICIDAE, V7
NR 10
TC 6
Z9 6
U1 0
U2 3
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAR-APR
PY 2015
VL 90
IS 2
BP 240
EP 243
DI 10.1590/abd1806-4841.20153214
PG 4
WC Dermatology
SC Dermatology
GA CF0DB
UT WOS:000352211800013
PM 25830996
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bernardes, F
   Martins, G
   Alves, AO
   da Costa, JRV
   Azulay, DR
   Azulay-Abulafia, L
AF Bernardes Filho, Fred
   Martins, Gustavo
   Alves, Andreia Oliveira
   Vieira da Costa, Jose Ronaldo
   Azulay, David Rubem
   Azulay-Abulafia, Luna
TI Rigid swelling of sublingual caruncle area due to the salivary gland
   duct obstruction by a sialolith
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Oral medicine; Salivary duct calculi; Salivary gland calculi
AB Sialolithiasis is the presence of calculus within the ductal system of a salivary gland. Among the diagnostic methods are inspection, palpation, checking the amount of saliva secreted and the identification of a sialolith. The authors present the case of a 37-year-old female patient with edema of the submandibular area and a bulging sublingual caruncle due to a calculus that obstructed the salivary gland ostium.
C1 [Bernardes Filho, Fred; Azulay, David Rubem; Azulay-Abulafia, Luna] IDPRDA SCMRJ, Rio De Janeiro, RJ, Brazil.
   [Bernardes Filho, Fred; Azulay, David Rubem] PUC RJ, Rio De Janeiro, RJ, Brazil.
   [Martins, Gustavo] Private Clin, Ituiutaba, MG, Brazil.
   [Alves, Andreia Oliveira] Ctr Univ Barao de Maua, Ribeirao Preto, SP, Brazil.
   [Vieira da Costa, Jose Ronaldo] UNIFAL, Alfenas, MG, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
RP Bernardes, F (corresponding author), Rua Marques Caxias 9, BR-24030050 Niteroi, RJ, Brazil.
EM f9filho@gmail.com
CR Armstrong MA, 2013, EMERG MED CLIN N AM, V31, P481, DOI 10.1016/j.emc.2013.01.004
   Gabrielli MAC, 2008, ROBRAC, V17, P110
   Grases F, 2003, CLIN CHIM ACTA, V334, P131, DOI 10.1016/S0009-8981(03)00227-4
   Harrison John D, 2009, Otolaryngol Clin North Am, V42, P927, DOI 10.1016/j.otc.2009.08.012
   Koch Michael, 2009, Otolaryngol Clin North Am, V42, P1173, DOI 10.1016/j.otc.2009.08.002
   Neville B. W., 2009, PATOLOGIA ORAL MAXIL
   Sampaio SAP, 2008, DERMATOLOGICA, P1339
   Thomas BL, 2010, FRONT ORAL BIOL, V14, P129, DOI 10.1159/000313711
   Uluc ME, 2006, OTOLARYNG HEAD NECK, V134, P533, DOI 10.1016/j.otohns.2005.03.073
NR 9
TC 1
Z9 1
U1 0
U2 0
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2014
VL 89
IS 6
BP 977
EP 979
DI 10.1590/abd1806-4841.20143179
PG 3
WC Dermatology
SC Dermatology
GA AT7YJ
UT WOS:000345150200017
PM 25387506
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bernardes, F
   Maier, LD
   Bonatto, DC
   Nery, JAD
   Martins, G
   Azulay-Abulafia, L
AF Bernardes Filho, Fred
   Maier, Leonardo de Medeiros
   Bonatto, Danielle Cristine
   da Costa Nery, Jose Augusto
   Martins, Gustavo
   Azulay-Abulafia, Luna
TI Occurrence of two autochthonous cases of American cutaneous
   leishmaniasis in the neighborhood of Caju, city of Rio de Janeiro,
   Brazil
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Leishmaniasis, cutaneous; Leishmaniasis, visceral; Psychodidae
AB American cutaneous leishmaniasis is in full geographic expansion in Brazil and it is considered among the infectious and parasitic diseases of utmost importance worldwide, not only by its frequency, but mainly by therapeutic difficulties, deformities and sequelae that may result. In the state of Rio de Janeiro, the first autochthonous case of American cutaneous leishmaniasis was registered by Rabello in 1913. The authors report two cases of the disease in the region around the Cemetery Sao Francisco Xavier, in the Caju neighborhood, Rio de Janeiro city, and emphasize the need for actions that aim to early diagnosis and treatment of American cutaneous leishmaniasis cases.
C1 [Bernardes Filho, Fred; Bonatto, Danielle Cristine; da Costa Nery, Jose Augusto; Azulay-Abulafia, Luna] IDPRDA SCMRJ, Rio De Janeiro, RJ, Brazil.
   [Bernardes Filho, Fred; Bonatto, Danielle Cristine] Pontificia Univ Catolica Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Maier, Leonardo de Medeiros] Hosp Municipal Rocha Maia, City Hosp Rocha Maia, Botafogo, RJ, Brazil.
   [Martins, Gustavo] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
RP Bernardes, F (corresponding author), Rua Marques Caxias,9 Sobrado Ctr, BR-24030050 Niteroi, RJ, Brazil.
EM f9filho@gmail.com
CR Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2007, MAN VIG LEISHM TEG A
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento Vigilancia Epidemiologica, 2006, ATL LEISHM TEG AM A
   Brito AC, 2013, DERMATOLOGICA, P533
   [Crmvrj.org Secretaria Municipal de Saude e Defesa Civil do Rio Janeiro], 22013 SSUBPAVSVS CRM
   Fernandes Nurimar C., 2004, An. Bras. Dermatol., V79, P431, DOI 10.1590/S0365-05962004000400005
   Magalhaes RRSG, 2001, THESIS FUNDACAO I O
   WHO, LEISHM WORLDW EP DRU
NR 7
TC 5
Z9 5
U1 0
U2 1
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD SEP-OCT
PY 2014
VL 89
IS 5
BP 848
EP 850
DI 10.1590/abd1806-4841.20143539
PG 3
WC Dermatology
SC Dermatology
GA AP0SE
UT WOS:000341773300031
PM 25184938
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Sousa, MAJ
   Pussanti, A
   Coimbra, DD
   Vega, H
   Bernardes, F
AF Azulay-Abulafia, Luna
   Jeunon Sousa, Maria Auxiliadora
   Pussanti, Andrea
   Coimbra, Daniel Dal'Asta
   Vega, Hernando
   Bernardes Filho, Fred
TI Invasive aspergillosis in a user of inhaled cocaine: rhinosinusitis with
   bone and cartilage destruction
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Aspergillosis; Aspergillus flavus; Rhinosinusitis; Cocaine addiction
ID IMMUNOCOMPETENT PATIENT; SINUS ASPERGILLOSIS
AB Aspergillosis is an infection caused by saprophytic fungi of the genus Aspergillus, which typically occurs in immunosuppressed individuals, but has also been reported in immunocompetent patients. The main routes of entry are the respiratory tract, skin, cornea, and ear, and the infection may be localized or disseminated by contiguity or vascular invasion. We report a severe case of rhinosinusitis with cutaneous involvement, caused by invasive aspergillosis, in an immunocompetent user of inhaled cocaine. Invasive aspergillosis related to cocaine abuse has not yet been reported in the literature. After itraconazole treatment and surgical debridement, complete clinical remission was achieved. Nasal reconstruction with a skin graft over a silicone prosthesis resulted in a satisfactory esthetic outcome.
C1 [Azulay-Abulafia, Luna; Bernardes Filho, Fred] Santa Casa Misericordia Rio Janeiro, Inst Dermatol Prof Rubem Davi Azulay, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna; Jeunon Sousa, Maria Auxiliadora] Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Vega, Hernando] Corp Univ Rafael Nunez Cartagena, Cartagena, Colombia.
RP Azulay-Abulafia, L (corresponding author), Av Alexandre Ferreira 206, BR-22470220 Rio De Janeiro, RJ, Brazil.
EM lunaazulay@gmail.com
FU Hospital Universitario Pedro Ernesto da Universidade do Estado do Rio de
   Janeiro (HUPE/UERJ), Rio de Janeiro, Brazil
FX Research performed in Hospital Universitario Pedro Ernesto da
   Universidade do Estado do Rio de Janeiro (HUPE/UERJ), Rio de Janeiro,
   Brazil.
CR Agarwal S, 2005, Indian J Med Microbiol, V23, P195
   Chakrabarti A, 2011, MED MYCOL, V49, pS35, DOI 10.3109/13693786.2010.505206
   Kaya S, 2011, MIKROBIYOL BUL, V45, P546
   Khatri ML, 2000, INT J DERMATOL, V39, P853, DOI 10.1046/j.1365-4362.2000.00095-3.x
   Knipping S, 2007, EUR ARCH OTO-RHINO-L, V264, P1163, DOI 10.1007/s00405-007-0336-7
   Pushker N, 2011, OPHTHALMOLOGY, V118, P1886, DOI 10.1016/j.ophtha.2011.01.059
   Simsek S, 2006, NETH J MED, V64, P248
   Subramanian S, 2007, AUSTRALAS RADIOL, V51, pB189, DOI 10.1111/j.1440-1673.2007.01838.x
   Trimarchi M, 2003, AM J RHINOL, V17, P33, DOI 10.1177/194589240301700107
   Webb BJ, 2010, MYCOPATHOLOGIA, V170, P403, DOI 10.1007/s11046-010-9338-x
   Woodruff CA, 2002, PEDIATR DERMATOL, V19, P439, DOI 10.1046/j.1525-1470.2002.00203.x
   Yagi HI, 1999, J OTOLARYNGOL, V28, P90
NR 12
TC 3
Z9 3
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2014
VL 47
IS 4
BP 533
EP 536
DI 10.1590/0037-8682-0086-2014
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AP8WV
UT WOS:000342361000024
PM 25229300
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Bernardes, F
   Quaresma, MV
   Rezende, FC
   Kac, BK
   Nery, JAD
   Azulay-Abulafia, L
AF Bernardes Filho, Fred
   Quaresma, Maria Victoria
   Rezende, Fernanda Coelho
   Kac, Bernard Kawa
   da Costa Nery, Jose Augusto
   Azulay-Abulafia, Luna
TI Confluent and reticulate papillomatosis of Gougerot-Carteaud and
   obesity: dermoscopic findings
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Hyperpigmentation; Obesity; Papilloma
AB Confluent and reticulated papillomatosis of Gougerot and Carteaud is a dermatosis that despite showing characteristic clinical signs is often poorly recognized and diagnosed. The authors present a case with extensive skin involvement, discuss its association with obesity and describe dermoscopic findings making the histopathological correlation.
C1 [Bernardes Filho, Fred; Quaresma, Maria Victoria; Rezende, Fernanda Coelho; Kac, Bernard Kawa; da Costa Nery, Jose Augusto; Azulay-Abulafia, Luna] Santa Casa Misericordia Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Rezende, Fernanda Coelho] Univ Gama Filho, Rio De Janeiro, RJ, Brazil.
   [Azulay-Abulafia, Luna] Rio de Janeiro State Univ UERJ, Rio De Janeiro, RJ, Brazil.
RP Bernardes, F (corresponding author), Rua Marques de Caxias,9 Sobrado Ctr, BR-24030050 Niteroi, RJ, Brazil.
EM f9filho@gmail.com
CR Bowman PH, 2003, J AM ACAD DERMATOL, V48, pS80, DOI 10.1067/mjd.2003.155
   Cockerell CJ, 2008, DERMATOLOGY, P1677
   Davis MDP, 2006, BRIT J DERMATOL, V154, P287, DOI 10.1111/j.1365-2133.2005.06955.x
   Duarte GV, 2010, AN BRAS DERMATOL, V85, P355, DOI 10.1590/S0365-05962010000300009
   Ferreira LM, 2009, AN BRAS DERMATOL, V84, P78, DOI 10.1590/S0365-05962009000100012
   Halpern A, 2006, TRATADO CLIN MED, P3555
   Rezze Gisele Gargantini, 2006, An. Bras. Dermatol., V81, P261, DOI 10.1590/S0365-05962006000300009
   Schmitt JV, 2012, AN BRAS DERMATOL, V87, P936, DOI 10.1590/S0365-05962012000600024
   Schmitt JV, 2002, AN BRAS DERMATOL, V77, P537
   Tamega AD, 2010, AN BRAS DERMATOL, V85, P25, DOI 10.1590/S0365-05962010000100003
NR 10
TC 8
Z9 8
U1 0
U2 5
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAY-JUN
PY 2014
VL 89
IS 3
BP 507
EP 509
DI 10.1590/abd1806-4841.20142705
PG 3
WC Dermatology
SC Dermatology
GA AJ7WL
UT WOS:000337911100021
PM 24937831
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Hexsel, D
   Lacerda, DA
   Cavalcante, AS
   Machado, CAS
   Kalil, CLPV
   Ayres, EL
   Azulay-Abulafia, L
   Weber, MB
   Serra, MS
   Lopes, NFP
   Cestari, TF
AF Hexsel, Doris
   Lacerda, Davi A.
   Cavalcante, Andrea S.
   Machado Filho, Carlos A. S.
   Kalil, Celia Luiza P. V.
   Ayres, Eloisa L.
   Azulay-Abulafia, Luna
   Weber, Magda B.
   Serra, Marcio S.
   Lopes, Nadya F. P.
   Cestari, Tania F.
TI Epidemiology of melasma in Brazilian patients: a multicenter study
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
ID CUTANEOUS DISEASES; HYPERPIGMENTATION; VALIDATION; MEN
AB Background Melasma is an acquired, irregularly patterned, light to dark-brown hypermelanosis, with symmetric distribution mostly over the face. The aim of this study was to evaluate clinical characteristics and factors related to melasma in Brazilian patients. Methods This was a cross-sectional, multicenter study performed in Brazil. Investigators examined and questioned 953 patients over 18years of age on clinical characteristics and other factors related to their melasma. Results Melasma was more prevalent in women (97.5%) and in Fitzpatrick skin phototypes II (12.8%), III (36.3%), and IV (39.7%). Skin phototypes II and III and family history of melasma had early onset of the disorder when compared with skin phototypes IV, V, and VI (P<0.0001). Similar results were also observed when these same groups were compared with the absence of family history (P<0.0001). Extra-facial melasma was more frequent in postmenopausal women compared with those who were not experiencing menopause (14.2% vs. 3.5%, P<0.0001). Conclusions Data suggested that the age of melasma onset are related to skin phototypes and family history. Additionally, extra-facial melasma was more common in menopausal women. This is the first study on the epidemiology of melasma in Brazil involving a large sample of the population. These data can be a source of new relevant research on the cause and development of melasma.
C1 [Hexsel, Doris] Pontificia Univ Catolica Rio Grande do Sul, Dept Dermatol, Porto Alegre, RS, Brazil.
   [Hexsel, Doris] Brazilian Ctr Studies Dermatol, Porto Alegre, RS, Brazil.
   [Lacerda, Davi A.] Univ Sao Paulo, Hosp Local Sapopemba, Sao Paulo, Brazil.
   [Lacerda, Davi A.] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil.
   [Cavalcante, Andrea S.] Fundacao Med Trop Amazonas, Dermatol Serv, Manaus, Amazonas, Brazil.
   [Machado Filho, Carlos A. S.] Fac Med ABC, Dermatol Serv, Santo Andre, SP, Brazil.
   [Kalil, Celia Luiza P. V.] Santa Casa Misericordia Porto Alegre, Dermatol Serv, Porto Alegre, RS, Brazil.
   [Ayres, Eloisa L.] Fundacao Municipal Saude Niteroi, Niteroi, RJ, Brazil.
   [Azulay-Abulafia, Luna] Santa Casa Misericordia Rio de Janeiro, Dermatol Serv, Rio De Janeiro, RJ, Brazil.
   [Weber, Magda B.] Univ Fed Ciencias Saude Porto Alegre, Dept Dermatol, Porto Alegre, RS, Brazil.
   [Serra, Marcio S.] Univ Fed Estado Rio de Janeiro, Dept Dermatol, Gaffree & Guinle Univ Hosp, Rio De Janeiro, RJ, Brazil.
   [Lopes, Nadya F. P.] Fundacao Alfredo da Matta, Dermatol Serv, Manaus, Amazonas, Brazil.
   [Cestari, Tania F.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Dermatol, Porto Alegre, RS, Brazil.
RP Hexsel, D (corresponding author), 782 Dr Timoteo St, BR-90570040 Porto Alegre, RS, Brazil.
EM doris@hexsel.com.br
RI Hexsel, Doris/AAD-3295-2020; Cestari, Tania/U-4385-2019
CR Balkrishnan R, 2003, BRIT J DERMATOL, V149, P572, DOI 10.1046/j.1365-2133.2003.05419.x
   Bleehen SS, 2004, TXB DERMATOLOGY, V2, P39
   Cestari TF, 2006, BRIT J DERMATOL, V156, P13, DOI 10.1111/j.1365-2133.2006.07591.x
   Choi HJ, 2001, WOMENS DERMATOLOGY I, P174
   Goh C. L., 1999, SMJ, V40, P455
   GRIMES PE, 1995, ARCH DERMATOL, V131, P1453, DOI 10.1001/archderm.131.12.1453
   Guinot C, 2010, J EUR ACAD DERMATOL, V24, P1060, DOI 10.1111/j.1468-3083.2010.03592.x
   Hexsel D, 2006, BRIT J DERMATOL, V156, P7, DOI 10.1111/j.1365-2133.2006.07589.x
   Ho SGY, 2009, AM J CLIN DERMATOL, V10, P153, DOI 10.2165/00128071-200910030-00002
   Kang WH, 2002, BRIT J DERMATOL, V146, P228, DOI 10.1046/j.0007-0963.2001.04556.x
   Katsambas A, 1995, J EUR ACAD DERMATOL, V4, P217
   Kauh YC, 1999, ADV EXP MED BIOL, V455, P491
   Kircik LH, 2011, J DRUGS DERMATOL, V10, P586
   Moin A, 2006, INT J DERMATOL, V45, P285, DOI 10.1111/j.1365-4632.2004.02470.x
   Ortonne JP, 2009, J EUR ACAD DERMATOL, V23, P1254, DOI 10.1111/j.1468-3083.2009.03295.x
   Sanchez MR, 2003, DERMATOL CLIN, V21, P689, DOI 10.1016/S0733-8635(03)00087-1
   Sanchez N P, 1986, P R Health Sci J, V5, P123
   Sarkar R, 2010, J EUR ACAD DERMATOL, V24, P768, DOI 10.1111/j.1468-3083.2009.03524.x
   VAZQUEZ M, 1988, INT J DERMATOL, V27, P25, DOI 10.1111/j.1365-4362.1988.tb02329.x
   Victor FC, 2004, J CUTAN MED SURG, V8, P97, DOI 10.1177/120347540400800204
NR 20
TC 23
Z9 25
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD APR
PY 2014
VL 53
IS 4
BP 440
EP 444
DI 10.1111/j.1365-4632.2012.05748.x
PG 5
WC Dermatology
SC Dermatology
GA AE9MQ
UT WOS:000334332300050
PM 23967822
DA 2020-12-01
ER

PT J
AU Bernardes, F
   Martins, G
   Luchi, GS
   Kac, BK
   Nery, JAD
   Azulay-Abulafia, L
   Azulay, DR
AF Bernardes Filho, Fred
   Martins, Gustavo
   Luchi, Gustavo Sabaini
   Kac, Bernard Kawa
   da Costa Nery, Jose Augusto
   Azulay-Abulafia, Luna
   Azulay, David Rubem
TI Multiple lesions by vampire bat bites in a patient in Niteroi, Brazil -
   Case report
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Bites and stings; Chiroptera; Rabies
AB Over the last few centuries, the expansion of urbanization brought bats closer to urbanized areas, increasing the risk of accidents by bat bites. The morphology of bat bites can be varied, usually having an elliptical shape, about 0.5 cm along its greatest length, and the characteristic corkscrew bite pattern. The authors present the case of a patient who was repeatedly bitten by vampire bats for two months. A polymerase chain reaction was performed in the cutaneous nerves at the base of the hair follicles which showed negativity towards the rabies virus. The authors highlight the public health importance of this case, and discuss the morphological characteristics of these hematophagous bat bites.
C1 [Bernardes Filho, Fred; da Costa Nery, Jose Augusto; Azulay-Abulafia, Luna; Azulay, David Rubem] SCMRJ, IDPRDA, Rio De Janeiro, Brazil.
   [Martins, Gustavo] Private Clin, Ituiutaba, MG, Brazil.
   [Luchi, Gustavo Sabaini] IPP, Rio De Janeiro, Brazil.
   [Bernardes Filho, Fred; Kac, Bernard Kawa; Azulay, David Rubem] PUC RJ, Rio De Janeiro, Brazil.
   [da Costa Nery, Jose Augusto] Fundacao Oswaldo Cruz LaHan Fiocruz, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Azulay, David Rubem] Fundacao Tecn Educ Souza Marques, Rio De Janeiro, Brazil.
   [Azulay, David Rubem] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
RP Bernardes, F (corresponding author), Rua Marques Caxias 9, BR-24030050 Niteroi, RJ, Brazil.
EM f9filho@gmail.com
CR Brasil. Ministerio da Saude, 2011, MIN SAUD NORM MAN A
   Brasil. Ministerio da Saude, 1998, MORC AR URB RUR MAN
   Cabral CC, 2012, REV SOC BRAS MED TRO, V45, P180, DOI 10.1590/S0037-86822012000200008
   CDC.gov, RAB ANT MORT TEST
   Ciprandi Alessandra, 2003, Rev. Bras. Hematol. Hemoter., V25, P250, DOI 10.1590/S1516-84842003000400012
   Esberard C. E. L., 2001, REV BRAS MED VET, V23, P219
   Kimura LMS, 2006, THESIS FUNDACAO O CR
   Macedo Carla Isabel, 2006, Braz J Infect Dis, V10, P341, DOI 10.1590/S1413-86702006000500008
   Martins Felipe de Mello, 2008, THESIS U SAO PAULO S
   Moutinho F. F. B., 2013, Revista Brasileira de Ciencia Veterinaria, V20, P26
NR 10
TC 2
Z9 2
U1 0
U2 2
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAR-APR
PY 2014
VL 89
IS 2
BP 340
EP 343
DI 10.1590/abd1806-4841.20142996
PG 4
WC Dermatology
SC Dermatology
GA AG1JP
UT WOS:000335171600024
PM 24770518
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lavorato, FG
   Alves, MDGS
   Maceira, JMP
   Unterstell, N
   Serpa, LA
   Azulay-Abulafia, L
AF Lavorato, Fernanda Guedes
   Guimaraes Scotelaro Alves, Maria de Fatima
   Pineiro Maceira, Juan Manuel
   Unterstell, Natasha
   Serpa, Laura Araujo
   Azulay-Abulafia, Luna
TI Primary systemic amyloidosis, acquired cutis laxa and cutaneous
   mucinosis in a patient with multiple myeloma
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Amyloidosis; Cutis laxa; Mucinoses; Multiple myeloma
AB A 57-year-old woman presented with periorbital ecchymoses, laxity in skin folds, polyneuropathy and bilateral carpal tunnel syndrome. A skin biopsy of the axillary lesion demonstrated fragmentation of elastic fibers, but with a negative von Kossa stain, consistent with cutis laxa. The diagnosis of primary systemic amyloidosis was made by the presence of amyloid material in the eyelid using histopathological techniques, besides this, the patient was also diagnosed with purpura, polyneuropathy, bilateral carpal tunnel syndrome and monoclonal gammopathy. She was diagnosed as suffering from multiple myeloma based on the finding of 40% plasma cells in the bone marrow, component M in the urine and anemia. The patient developed blisters with a clear content, confirmed as mucinosis by the histopathological exam. The final diagnoses were: primary systemic amyloidosis, acquired cutis laxa and mucinosis, all related to multiple myeloma.
C1 [Lavorato, Fernanda Guedes; Guimaraes Scotelaro Alves, Maria de Fatima; Pineiro Maceira, Juan Manuel; Unterstell, Natasha; Serpa, Laura Araujo; Azulay-Abulafia, Luna] Rio de Janeiro State Univ HUPE UERJ, Pedro Ernesto Univ Hosp, Rio De Janeiro, RJ, Brazil.
RP Lavorato, FG (corresponding author), Secretaria Dermatol, Av 28 Setembro,77 Vila Isabel, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM fglavorato@yahoo.com.br
CR Alvarez-Ruiz SB, 2005, ACTAS DERMO-SIFILOGR, V96, P69, DOI 10.1016/S0001-7310(05)73042-8
   Gupta A, 2002, CUTIS, V69, P114
   ISHIBASHI A, 1989, Journal of Dermatology (Tokyo), V16, P64
   McCarthy MJ, 1996, CUTIS, V57, P267
   Oliveira Ederson Valei Lopes de, 2012, An. Bras. Dermatol., V87, P119, DOI 10.1590/S0365-05962012000100015
   Shah-Desai Sabrina D., 1999, Orbit, V18, P53, DOI 10.1076/orbi.18.1.53.2722
NR 6
TC 7
Z9 7
U1 0
U2 3
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2013
VL 88
IS 6
SU 1
BP 32
EP 35
DI 10.1590/abd1806-4841.20132531
PG 4
WC Dermatology
SC Dermatology
GA 279DR
UT WOS:000328941000007
PM 24346874
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   da Silva, JOL
AF Azulay-Abulafia, L.
   Lyra da Silva, J. O.
TI Quality of life in psoriasis: ambulatorial usage of PDI- psoriasis
   disability index - validated for Portuguese language
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Meeting Abstract
C1 [Azulay-Abulafia, L.; Lyra da Silva, J. O.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD JUL
PY 2013
VL 27
SU 4
SI SI
MA P148
BP 59
EP 59
PG 1
WC Dermatology
SC Dermatology
GA 238BU
UT WOS:000325916200149
DA 2020-12-01
ER

PT J
AU Lavorato, FG
   Azulay-Abulafia, L
   Ramos, V
   Obadia, DL
   Rocha, DS
   de Souza, VFM
AF Lavorato, Fernanda Guedes
   Azulay-Abulafia, Luna
   Ramos, Vanessa
   Obadia, Daniel Lago
   Rocha, Diego Santos
   Monteiro de Souza, Vivian Fichman
TI Case for diagnosis
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Editorial Material
DE Darier disease; Mosaicism; Skin diseases; genetic
ID SEGMENTAL DARIERS-DISEASE; MOSAICISM; ATP2A2; MUTATIONS
AB Linear Darier is a rare variant of Darier's Disease. The keratotic papules follow Blaschko's lines, characterizing the cutaneous mosaicism. We report the case of a 42-year-old woman who presented with small, linearly distributed, reddish-brown papules on the left mammary region, from the left flank to the hypogastrium and on the pretibial area of the left leg. Histologically, suprabasal acantholysis and dyskeratotic cells were seen, confirming the diagnosis.
C1 [Azulay-Abulafia, Luna] Rio de Janeiro State Univ HUPE UERJ, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, Luna] Gama Filho Univ UGF, Rio De Janeiro, Brazil.
   [Obadia, Daniel Lago] Rio de Janeiro State Univ HUPE UERJ, Pedro Ernesto Univ Hosp, Dept Dermatol, Rio De Janeiro, Brazil.
   [Obadia, Daniel Lago] Cent Army Hosp, Trop Dermatol Serv HCE, Rio De Janeiro, Brazil.
   [Rocha, Diego Santos] Rio de Janeiro Gen Hosp HGeRJ, Rio De Janeiro, Brazil.
RP Lavorato, FG (corresponding author), Ave 28 Setembro,77 Vila Isabel, BR-20551080 Rio De Janeiro, Brazil.
EM fglavorato@yahoo.com.br
CR Sakuntabhai A, 2000, J INVEST DERMATOL, V115, P1144, DOI 10.1046/j.1523-1747.2000.00182.x
   Sakuntabhai A, 1999, NAT GENET, V21, P271
   Sanderson EA, 2007, J DERMATOL, V34, P761, DOI 10.1111/j.1346-8138.2007.00379.x
   Tarle RG, 1997, AN BRAS DERMATOL, V72, P37
   Wada T, 2003, BRIT J DERMATOL, V149, P185, DOI 10.1046/j.1365-2133.2003.05412.x
NR 5
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD JUL-AUG
PY 2013
VL 88
IS 4
BP 656
EP 658
DI 10.1590/abd1806-4841.20132251
PG 3
WC Dermatology
SC Dermatology
GA 224YM
UT WOS:000324929100030
PM 24068148
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Abreu, L
   Adriano, AR
   Bravo, BF
   Azulay-Abulafia, L
   Rezende, PM
   Schechtman, RC
AF Abreu, Luciana
   Adriano, Andre Ricardo
   Bravo, Bruna Felix
   Azulay-Abulafia, Luna
   Rezende, Patricia Makino
   Schechtman, Regina Casz
TI Treatment of pityriasis versicolor with photodynamic therapy
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Academy-of-Dermatology (AAD)
CY MAR 01-05, 2013
CL Miami Beach, FL
SP Amer Acad Dermatol (AAD)
C1 [Abreu, Luciana; Adriano, Andre Ricardo; Bravo, Bruna Felix; Azulay-Abulafia, Luna; Rezende, Patricia Makino; Schechtman, Regina Casz] Santa Casa de Misercordia Rio de Janeiro, Prof Rubem David Azulay Inst Dermatol, Rio De Janeiro, Brazil.
NR 0
TC 2
Z9 2
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD APR
PY 2013
VL 68
IS 4
SU 1
BP AB131
EP AB131
PG 1
WC Dermatology
SC Dermatology
GA 096NZ
UT WOS:000315412600519
DA 2020-12-01
ER

PT J
AU de Oliveira, FL
   Vasconcellos, BO
   de Morais, TS
   Nascimento, MB
   Teles, R
   Nery, JAD
   Miranda, MJS
   Azulay-Abulafia, L
AF de Oliveira, Felipe Ladeira
   Vasconcellos, Bruna Obeica
   de Morais, Thais Schiavo
   Nascimento, Mayara Brito
   Teles, Renata
   da Costa Nery, Jose Augusto
   Sumrell Miranda, Marcos Jose
   Azulay-Abulafia, Luna
TI Netherton's syndrome and lepromatous leprosy: a mere coincidence?
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
ID SUSCEPTIBILITY
AB Objectives Nethertons syndrome (NS) is a rare autosomal recessive condition, first described in 1958, which involves a complex immunological dysfunction, ichthyosiform dermatitis, and erythroderma, characteristic defects of the hair shaft and atopy. Recurrent bacterial infection in the skin of patients with NS is frequent. Methods This paper represents the first case report of leprosy and concurrent NS. Discussion This case merits discussion among doctors in endemic and non-endemic areas to evaluate the chronic use of systemic corticosteroids as a risk factor for leprosy. The present patient came from an endemic area of leprosy and was treated chronically with systemic corticosteroids for erythroderma. This treatment, along with the immunodeficiency related to the syndrome and caused by a genetic mutation in SPINK5, may be a facilitating factor for the infection.
C1 [de Oliveira, Felipe Ladeira; Vasconcellos, Bruna Obeica; de Morais, Thais Schiavo; Nascimento, Mayara Brito; Teles, Renata; da Costa Nery, Jose Augusto; Sumrell Miranda, Marcos Jose; Azulay-Abulafia, Luna] Hosp Santa Casa Misericordia, Prof RD Azulay Inst Dermatol, Sect Sexually Transmitted Dis & Leprosy, Rio De Janeiro, RJ, Brazil.
RP Azulay-Abulafia, L (corresponding author), Ave Epitacio Pessoa 2664,Apto 902,Bloco 1, BR-22471003 Lagoa, RJ, Brazil.
EM lunaazulay@gmail.com
CR Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006
   Allen A, 2001, ARCH DERMATOL, V137, P747
   Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284
   Goulart Isabela Maria Bernardes, 2002, Rev Soc Bras Med Trop, V35, P365, DOI 10.1590/S0037-86822002000400014
   GREENE SL, 1985, J AM ACAD DERMATOL, V13, P329, DOI 10.1016/S0190-9622(85)70170-3
   HARTSCHUH W, 1989, HAUTARZT, V40, P430
   JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x
   Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x
   Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096
   Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326
   Muller FB, 2002, BRIT J DERMATOL, V146, P495, DOI 10.1046/j.1365-2133.2002.04625.x
   NETHERTON EW, 1958, ARCH DERMATOL, V78, P483, DOI 10.1001/archderm.1958.01560100059009
   NylanderLundqvist E, 1997, ACTA DERM-VENEREOL, V77, P203
   Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625
   Piris A, 2010, J CUTAN PATHOL, V37, P125, DOI 10.1111/j.1600-0560.2010.01522.x
   Prigent H, 2004, CRIT CARE, V8, P122, DOI [10.1186/cc2374), 10.1186/cc2374]
   Pruszkowski A, 2000, ARCH DERMATOL, V136, P875, DOI 10.1001/archderm.136.7.875
   SERALY MP, 1994, PEDIATR DERMATOL, V11, P61, DOI 10.1111/j.1525-1470.1994.tb00077.x
   SMITH DL, 1995, J ALLERGY CLIN IMMUN, V95, P116, DOI 10.1016/S0091-6749(95)70159-1
NR 19
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD FEB
PY 2013
VL 52
IS 2
BP 186
EP 190
DI 10.1111/j.1365-4632.2012.05620.x
PG 5
WC Dermatology
SC Dermatology
GA 077ZW
UT WOS:000314068900010
PM 23347305
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Eljaiek, HV
   Francesconi, F
   de Figueiredo, JWV
AF Azulay-Abulafia, Luna
   Eljaiek, Hernando Vega
   Francesconi, Fabio
   Vieira de Figueiredo, Jose Walter
TI Learning to love dermatology by caring for the underserved: a field trip
   into the heart of Amazonia
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
C1 [Azulay-Abulafia, Luna; Eljaiek, Hernando Vega] Inst Dermatol Prof Rubem David Azulay Santa Casa, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio Brazil, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, Luna] Univ Gama Filho, Rio De Janeiro, Brazil.
   [Eljaiek, Hernando Vega] Inst Anat Patol Prof Joao Lobato, Rio De Janeiro, Brazil.
   [Francesconi, Fabio] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Francesconi, Fabio] Fundacao Med Trop, Manaus, Amazonas, Brazil.
   [Vieira de Figueiredo, Jose Walter] Dept Infect Dis, Sao Paulo, Brazil.
   [Vieira de Figueiredo, Jose Walter] Mil Hosp, Sao Paulo, Brazil.
   [Vieira de Figueiredo, Jose Walter] Ctr Hosp Sistema Penitenciario, Sao Paulo, Brazil.
RP Azulay-Abulafia, L (corresponding author), Inst Dermatol Prof Rubem David Azulay Santa Casa, Rio De Janeiro, Brazil.
EM lunaazulay@gmail.com
RI Francesconi, Fabio/AAF-2150-2019
OI Francesconi, Fabio/0000-0001-6381-3584
CR Boyd AS, 1998, J AM ACAD DERMATOL, V39, P658, DOI 10.1016/S0190-9622(98)70024-6
   Feldmeier H, 2009, J AM ACAD DERMATOL, V60, P436, DOI 10.1016/j.jaad.2008.11.005
   Mitka M, 2005, JAMA-J AM MED ASSOC, V294, P671, DOI 10.1001/jama.294.6.671
   Morrone A, 2008, DERMATOL CLIN, V26, P245, DOI 10.1016/j.det.2007.11.004
   Ryan AS, 1996, CLIN DERMATOL, V14, P389, DOI 10.1016/0738-081X(96)00068-5
   Saxton-Daniels S, 2007, J AM ACAD DERMATOL, V56, P672, DOI 10.1016/j.jaad.2006.08.008
   World Health Organization (WHO), 2007, WORLD HLTH REP 2006
NR 7
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD OCT
PY 2012
VL 51
IS 10
BP 1259
EP 1262
DI 10.1111/j.1365-4632.2012.05640.x
PG 4
WC Dermatology
SC Dermatology
GA 009YY
UT WOS:000309062700022
PM 22994673
DA 2020-12-01
ER

PT J
AU Costa, MC
   Eljaiek, HV
   Abraham, LS
   Azulay-Abulafia, L
   Ardigo, M
AF Costa, Mariana Carvalho
   Eljaiek, Hernando Vega
   Abraham, Leonardo Spagnol
   Azulay-Abulafia, Luna
   Ardigo, Marco
TI In vivo reflectance confocal microscopy in a typical case of melasma
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Editorial Material
DE Hyperpigmentation; Microscopy, confocal; Pigmentation disorders
AB Melasma is a common disorder of hypermelanosis that affects mainly young and middle-aged women of Fitzpatrick's phototypes III-V. The disease significantly impacts their lives. In vivo reflectance confocal microscopy, a spreading technology for the noninvasive evaluation of the skin up to the papillary dermis, provides real-time en face images with cellular resolution. We present a case of melasma with in vivo reflectance confocal microscopy findings closely correlated to the histopathological features described in the literature.
C1 [Costa, Mariana Carvalho; Eljaiek, Hernando Vega; Abraham, Leonardo Spagnol; Azulay-Abulafia, Luna; Ardigo, Marco] IDERJ, Rio De Janeiro, Brazil.
RP Costa, MC (corresponding author), Ave Alexandre Ferreira,206 Lagoa, BR-22470220 Rio De Janeiro, RJ, Brazil.
EM maricosta133@gmail.com
RI Abraham, Leonardo S/I-8721-2016; Costa, Mariana C/K-5895-2012; Ardigo,
   Marco/E-5741-2018
OI Abraham, Leonardo S/0000-0002-9165-6026; Ardigo,
   Marco/0000-0002-5772-4937; Costa, Mariana Carvalho/0000-0003-0502-2826
CR Ardigo M, 2010, J EUR ACAD DERMATOL, V24, P1296, DOI 10.1111/j.1468-3083.2010.03633.x
   Berardesca E., 2008, EXPERT REV DERMATOL, V3, P187
   Kang HY, 2010, EXP DERMATOL, V19, pE228, DOI 10.1111/j.1600-0625.2009.01057.x
   Kang HY, 2010, EXP DERMATOL, V19, P233, DOI 10.1111/j.1600-0625.2009.00983.x
   Liu HX, 2011, SKIN RES TECHNOL, V17, P398, DOI 10.1111/j.1600-0846.2011.00517.x
   Rito C, 2010, AN BRAS DERMATOL, V84, P636
   SANCHEZ NP, 1981, J AM ACAD DERMATOL, V4, P698, DOI 10.1016/S0190-9622(81)70071-9
   Sheth VM, 2011, J AM ACAD DERMATOL, V65, P689, DOI 10.1016/j.jaad.2010.12.046
NR 8
TC 2
Z9 3
U1 0
U2 3
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD SEP-OCT
PY 2012
VL 87
IS 5
BP 782
EP 784
DI 10.1590/S0365-05962012000500021
PG 3
WC Dermatology
SC Dermatology
GA 019EG
UT WOS:000309719300021
PM 23044577
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Arellano, I
   Cestari, T
   Ocampo-Candiani, J
   Azulay-Abulafia, L
   Neto, PBT
   Hexsel, D
   Machado-Pinto, J
   Munoz, H
   Rivitti-Machado, MC
   Sittart, A
   de Almeida, ART
   Rego, V
   Paliargues, F
   Marques-Hassun, K
AF Arellano, I.
   Cestari, T.
   Ocampo-Candiani, J.
   Azulay-Abulafia, L.
   Bezerra Trindade Neto, P.
   Hexsel, D.
   Machado-Pinto, J.
   Munoz, H.
   Rivitti-Machado, M. C.
   Sittart, A.
   Trindade de Almeida, A. R.
   Rego, V.
   Paliargues, F.
   Marques-Hassun, K.
TI Preventing melasma recurrence: prescribing a maintenance regimen with an
   effective triple combination cream based on long-standing clinical
   severity
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Article
ID OF-LIFE QUESTIONNAIRE; RETINOIC ACID; VALIDATION; TRETINOIN;
   HYDROQUINONE; EFFICACY; THERAPY; SAFETY; WOMEN; SKIN
AB Background The relapsing nature of melasma emphasizes the need to maintain efficacy achieved after acute treatment.
   Objective To compare clinical efficacy and safety of two 6-month Triple Combination (TC; containing fluocinolone acetonide, hydroquinone and tretinoin) maintenance regimens in subjects with moderate to severe melasma, after daily treatment up to 8 weeks.
   Methods This randomized, investigator-blinded, controlled study had a maintenance phase of 6 months. Sixteen centres in Brazil and Mexico enrolled 242 subjects 18 years or older attaining no or mild melasma after 8 weeks of daily TC applications. Subjects were randomized to receive TC in a twice weekly or tapering regimen [3/week (1st month), 2/week (2nd month), 1/week (4th month)].
   Efficacy and safety measurements included median time to relapse and relapse-free rate, Global Severity Score, Melasma Area and Severity Index score (MASI), subject's assessment, quality of life questionnaire (MelasQol), and adverse events.
   Results The majority (78.8%) had no or mild melasma (GSS <= 1) at week 8 and entered maintenance phase. After 6 months, 53% of patients remained relapse-free with improved quality of life, and time to relapse was similar between groups (about 190 days). Melasma severity at study entry, not maintenance baseline, influenced relapse rate. The twice weekly regimen tended to show better effectiveness in postponing relapse in severe melasma. Both regimens were safe.
   Conclusions After resolution of melasma with TC, maintenance therapy over 6 months was successful in preventing relapse in over half of the patients who entered maintenance phase. Prescribing medicines should be adapted to patients based on melasma severity.
C1 [Arellano, I.] Hosp Gen Mexico OPD, Mexico City, DF, Mexico.
   [Cestari, T.] Univ Rio Grande Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Ocampo-Candiani, J.] Hosp Univ Jose E Gonzalez, Monterrey, Mexico.
   [Azulay-Abulafia, L.] Inst Dermatol & Estet Rio de Janeiro, Rio De Janeiro, Brazil.
   [Bezerra Trindade Neto, P.] Hosp Univ Onofre Lopes, Petropolis, Brazil.
   [Rivitti-Machado, M. C.] Hosp Clin FMUSP, Sao Paulo, Brazil.
   [Sittart, A.] Hosp Servidor Publ Estado Sao Paulo, Sao Paulo, Brazil.
   [Trindade de Almeida, A. R.] Hosp Servidor Publ Municipal Sao Paulo, Sao Paulo, Brazil.
   [Rego, V.] Univ Fed Bahia, BR-41170290 Salvador, BA, Brazil.
   [Marques-Hassun, K.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Arellano, I (corresponding author), Hosp Gen Mexico OPD, Mexico City, DF, Mexico.
EM mariare1@yahoo.com
RI Cestari, Tania/U-4385-2019; Hexsel, Doris/AAD-3295-2020;
   Ocampo-Candiani, Jorge/B-6853-2015
OI Ocampo-Candiani, Jorge/0000-0002-0213-0031
CR Balkrishnan R, 2003, BRIT J DERMATOL, V149, P572, DOI 10.1046/j.1365-2133.2003.05419.x
   Barankin B, 2002, J CUTAN MED SURG, V6, P236, DOI 10.1007/s10227-001-0045-240
   Bhawan J, 2009, AM J DERMATOPATH, V31, P794, DOI 10.1097/DAD.0b013e3181a9070d
   Cestari T, 2009, J EUR ACAD DERMATOL, V23, P760, DOI 10.1111/j.1468-3083.2009.03251.x
   Cestari TF, 2006, BRIT J DERMATOL, V156, P13, DOI 10.1111/j.1365-2133.2006.07591.x
   Dominguez AR, 2006, J AM ACAD DERMATOL, V55, P59, DOI 10.1016/j.jaad.2006.01.049
   GANO SE, 1979, CUTIS, V23, P239
   Giannotti B, 1995, CLIN DRUG INVEST S2, V10, P57
   Grimes PE, 2010, J AM ACAD DERMATOL, V62, P962, DOI 10.1016/j.jaad.2009.06.067
   Javaheri SN, 2001, INT J DERMATOL, V40, P354, DOI 10.1046/j.1365-4362.2001.01149.x
   Kang WH, 1998, J DERMATOL, V25, P87
   Katsambas A, 1995, J EUR ACAD DERMATOL, V4, P217
   KIMBROUGHGREEN CK, 1994, ARCH DERMATOL, V130, P727, DOI 10.1001/archderm.130.6.727
   KLIGMAN AM, 1975, ARCH DERMATOL, V111, P40
   Mosher D. B., 1999, DERMATOLOGY GEN MED, P945
   Ortonne JP, 2009, J EUR ACAD DERMATOL, V23, P1254, DOI 10.1111/j.1468-3083.2009.03295.x
   Pandya AG, 2000, DERMATOL CLIN, V18, P91, DOI 10.1016/S0733-8635(05)70150-9
   Pandya AG, 2011, J AM ACAD DERMATOL, V64, P78, DOI 10.1016/j.jaad.2009.10.051
   PATHAK MA, 1986, J AM ACAD DERMATOL, V15, P894, DOI 10.1016/S0190-9622(86)70247-8
   Taylor SC, 2003, CUTIS, V72, P67
   Torok Helen, 2005, J Drugs Dermatol, V4, P592
   VAZQUEZ M, 1983, CUTIS, V32, P92
NR 22
TC 14
Z9 17
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD MAY
PY 2012
VL 26
IS 5
BP 611
EP 618
DI 10.1111/j.1468-3083.2011.04135.x
PG 8
WC Dermatology
SC Dermatology
GA 929HG
UT WOS:000303051300011
PM 21623930
DA 2020-12-01
ER

PT J
AU Schechtman, RC
   de Crignis, GSN
   Pockstaller, MP
   Azulay-Abulafia, L
   Quintella, LP
   Belo, M
AF Schechtman, Regina Casz
   Neto de Crignis, Giselly Silva
   Pockstaller, Mercedes Prates
   Azulay-Abulafia, Luna
   Quintella, Leonardo Pereira
   Belo, Marcia
TI Molluscum-like lesions in a patient with sporotrichosis
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA Portuguese
DT Article
DE Itraconazole; Mycoses; Molluscum contagiosum; Sporotrichosis
AB Sporotrichosis is a subcutaneous fungal infection caused by Sporothrix schenckii and acquired by direct inoculation. Although the majority of cases consist of the classic lymphocutaneous presentation, the frequency of atypical and severe clinical forms of the disease has increased progressively. Systemic and disseminated cutaneous sporotrichosis constitute rare variants and such cases are generally associated with cellular immunodeficiency or debilitated states. The present paper describes the first published case of molluscum-like lesions in disseminated mucocutaneous sporotrichosis. Direct mycological examination and histopathology revealed numerous yeast cells.
C1 [Schechtman, Regina Casz; Neto de Crignis, Giselly Silva; Pockstaller, Mercedes Prates; Azulay-Abulafia, Luna; Quintella, Leonardo Pereira; Belo, Marcia] Inst Dermatol Prof Rubem David Azulay Santa Casa, Rio De Janeiro, RJ, Brazil.
RP Schechtman, RC (corresponding author), Rua Vonluntarios Patria 435,5 Andar, BR-22270000 Rio De Janeiro, RJ, Brazil.
EM regina.schechtman@gmail.com
CR Pereira JCB, 2008, REV PORT PNEUMOL, V14, P443, DOI 10.1016/S0873-2159(15)30252-X
   Edwards C, 2000, SOUTH MED J, V93, P803, DOI 10.1097/00007611-200093080-00013
   Kauffman CA, 2007, CLIN INFECT DIS, V45, P1255, DOI 10.1086/522765
   Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009
   Neto RJP, 1999, REV SOC BRAS MED TRO, V32, P57
   Ramos-e-Silva M, 2007, CLIN DERMATOL, V25, P181, DOI 10.1016/j.clindermatol.2006.05.006
   SCHAMROTH JM, 1988, INT J DERMATOL, V27, P28, DOI 10.1111/j.1365-4362.1988.tb02330.x
   Schechtman Regina Casz, 2010, Skinmed, V8, P275
   Schechtman Regina Casz, 2010, Skinmed, V8, P216
NR 9
TC 7
Z9 8
U1 0
U2 2
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2011
VL 86
IS 6
BP 1217
EP 1219
DI 10.1590/S0365-05962011000600028
PG 3
WC Dermatology
SC Dermatology
GA 881TR
UT WOS:000299512700028
PM 22281918
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Benez, MDV
   Abreu, CD
   Miranda, CVD
   Alves, MDGS
AF Azulay-Abulafia, Luna
   Villela Benez, Marcela Duarte
   de Souza Abreu, Clarissa
   da Rocha Miranda, Carolina Villela
   Guimaraes Scotelaro Alves, Maria de Fatima
TI Case for diagnosis
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA Portuguese
DT Editorial Material
DE Elastic tissue; Foot dermatoses; Hand dermatoses; Keratoderma;
   palmoplantar
ID BENIGN CEPHALIC HISTIOCYTOSIS
AB Acrokeratoelastoidosis is a type of palmoplantar keratoderma first described by Oswaldo Goncalves Costa, a Brazilian Dermatologist from the state of Minas Gerais. It is a rare autosomal-dominant genodermatosis; however it may occur sporadically. The disease is not congenital; rather, its onset occurs in childhood or adolescence. Clinically, the condition is characterized by multiple yellowish papules, sometimes glossy and keratotic, measuring approximately 2-4 mm in diameter, sometimes umbilicated, and located symmetrically on the sides of the hands and feet, symmetry being the most typical sign. The most common histopathological findings are hyperkeratosis, mild acanthosis and elastorrhexis, as revealed by orcein staining.
C1 [Azulay-Abulafia, Luna; Villela Benez, Marcela Duarte; de Souza Abreu, Clarissa; da Rocha Miranda, Carolina Villela; Guimaraes Scotelaro Alves, Maria de Fatima] Univ Estado Rio de Janeiro, HUPE, BR-20550011 Rio De Janeiro, RJ, Brazil.
RP Azulay-Abulafia, L (corresponding author), Blvd 28 Setembro,51 Vila Isabel, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM lunaazulay@gmail.com
CR Bolognia J. L., 2008, DERMATOLOGY, V1
   Dadzie O, 2005, PEDIATR DERMATOL, V22, P444, DOI 10.1111/j.1525-1470.2005.113.x
   Hasegawa S, 2009, J DERMATOL, V36, P69, DOI 10.1111/j.1346-8138.2008.00590.x
   Jih DM, 2002, J AM ACAD DERMATOL, V47, P908, DOI 10.1067/mjd.2002.124602
   Luz Flávio Barbosa, 2003, An. Bras. Dermatol., V78, P99, DOI 10.1590/S0365-05962003000100011
   Miranda PAC, 2007, ARQ BRAS ENDOCRINOL, V51, P1018, DOI 10.1590/S0004-27302007000600019
   Saez-De-Ocariz M, 2006, PEDIATR DERMATOL, V23, P101, DOI 10.1111/j.1525-1470.2006.00187.x
   Weston WL, 2000, PEDIATR DERMATOL, V17, P296, DOI 10.1046/j.1525-1470.2000.01779.x
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD NOV-DEC
PY 2011
VL 86
IS 6
BP 1224
EP 1225
PG 2
WC Dermatology
SC Dermatology
GA 881TR
UT WOS:000299512700031
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Zimmermann, CC
   Sforza, D
   de Macedo, PM
   Azulay-Abulafia, L
   Alves, MDGS
   Carneiro, SCD
AF Zimmermann, Carolina Cotta
   Sforza, Deborah
   de Macedo, Priscila Marques
   Azulay-Abulafia, Luna
   Alves, Maria de Fatima G. S.
   Carneiro, Sueli Coelho da S.
TI Dowling-Degos disease: classic clinical and histopathological
   presentation
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA Portuguese
DT Article
DE Hyperpigmentation; Keratin-5; Skin diseases, genetic
ID GALLI-GALLI-DISEASE; ENTITY
AB Dowling-Degos disease (DDD) is a rare genetic disease of the skin (reticulate pigmented anomaly), clinically characterized by flexural brown pigmented reticulate macules, comedo-like papules on the back, neck and pitted perioral or facial scars. We present the case of a 51 year-old man with macro-comedo-like lesions, pitted scars, cysts, hyperpigmented macules in his back, chest, axillae, neck, groin and face. The patient reported having two children, three brothers and a father with a similar condition. The histopathology of the skin biopsies was very characteristic of Dowling-Degos disease, showing dilated follicular, fingerlike projections called rete ridges (dermal pegs), with thinning of the suprapapillary plates, resulting in an "antler-like" pattern and increased pigmentation of the basal layer.
C1 [Zimmermann, Carolina Cotta; Sforza, Deborah; de Macedo, Priscila Marques; Azulay-Abulafia, Luna; Alves, Maria de Fatima G. S.; Carneiro, Sueli Coelho da S.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
RP Zimmermann, CC (corresponding author), Rua Sambaiba 304, BR-22450190 Rio De Janeiro, Brazil.
EM carolczim@gmail.com
OI de Macedo, Priscila Marques/0000-0002-6900-9703
CR AZULAYABULAFIA L, 1992, AN BRAS DERMATOL, V67, P275
   Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850
   Bhagwat PV, 2009, INDIAN J DERMATOL VE, V75, P398, DOI 10.4103/0378-6323.53139
   Braun-Falco M, 2001, J AM ACAD DERMATOL, V45, P760, DOI 10.1067/mjd.2001.116340
   CHANG MW, 2008, DERMATOLOGY, P1820
   FENSKE NA, 1991, J AM ACAD DERMATOL, V24, P888, DOI 10.1016/0190-9622(91)70141-N
   Gilchrist H, 2008, J AM ACAD DERMATOL, V58, P299, DOI 10.1016/j.jaad.2007.05.041
   Kim YC, 1999, J AM ACAD DERMATOL, V40, P462, DOI 10.1016/S0190-9622(99)70498-6
   McCormack C J, 1997, Australas J Dermatol, V38, P82, DOI 10.1111/j.1440-0960.1997.tb01113.x
   Nishizawa A, 2009, BRIT J DERMATOL, V160, P215, DOI 10.1111/j.1365-2133.2008.08938.x
   OPPOLZER G, 1987, HAUTARZT, V38, P615
   Schnur RE, 1997, SEMIN CUTAN MED SURG, V16, P72, DOI 10.1016/S1085-5629(97)80038-7
   Wenzel J, 2003, DERMATOL SURG, V29, P1161, DOI 10.1046/j.1524-4725.2003.29361.x
NR 13
TC 5
Z9 5
U1 0
U2 1
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD SEP-OCT
PY 2011
VL 86
IS 5
BP 979
EP 982
DI 10.1590/S0365-05962011000500016
PG 4
WC Dermatology
SC Dermatology
GA 857WY
UT WOS:000297756500016
PM 22147038
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Costa, RO
   Bernardes-Engemann, AR
   Azulay-Abulafia, L
   Benvenuto, F
   Neves, MDP
   Lopes-Bezerra, LM
AF Costa, Rosane Orofino
   Bernardes-Engemann, Andrea Reis
   Azulay-Abulafia, Luna
   Benvenuto, Fabiana
   Palermo Neves, Maria de Lourdes
   Lopes-Bezerra, Leila Maria
TI Sporotrichosis in pregnancy: case reports of 5 patients in a zoonotic
   epidemic in Rio de Janeiro, Brazil
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA Portuguese
DT Article
DE Amphotericin B; Pregnant women; Sporotrichosis; Therapeutics; Treatment
   outcome
ID THERAPY
AB Five cases of sporotrichosis occurring in pregnant women in a zoonotic epidemic in Rio de Janeiro, Brazil, are described. The main clinical features, as well as the challenging therapeutic choices for this specific group of patients, are discussed.
C1 Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, Serv Dermatol, BR-20550011 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Dept Biol Celular & Genet, Lab Micol Celular & Prote, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil.
RP Costa, RO (corresponding author), Av 28 Setembro 87,2 Andar, BR-20551030 Rio De Janeiro, Brazil.
EM micologia@uerj.br
RI Lopes Bezerra, Leila/K-8405-2015; Orofino-Costa, Rosane/AAF-6844-2020
OI Lopes Bezerra, Leila/0000-0003-2397-7597; Orofino-Costa,
   Rosane/0000-0002-1603-418X
CR Agarwal S, 2008, INT J DERMATOL, V47, P367, DOI 10.1111/j.1365-4632.2008.03538.x
   Barros MBD, 2004, CLIN INFECT DIS, V38, P529
   BENNETT JE, 2006, GOODMAN GILMANS PHAR, P1240
   Bernardes-Engemann AR, 2005, MED MYCOL, V43, P487, DOI 10.1080/13693780400019909
   Costa RO, 2008, REV IBEROAM MICOL, V25, P54, DOI 10.1016/S1130-1406(08)70014-7
   Kauffman CA, 2007, CLIN INFECT DIS, V45, P1255, DOI 10.1086/522765
   King CT, 1998, CLIN INFECT DIS, V27, P1151, DOI 10.1086/514977
   Marques S. A., 1998, Anais Brasileiros de Dermatologia, V73, P559
   PLAUCHE WC, 1968, AM J OBSTET GYNECOL, V100, P1150, DOI 10.1016/S0002-9378(15)33419-0
   ROMIG DA, 1972, ARCH INTERN MED, V130, P910, DOI 10.1001/archinte.130.6.910
   TAGAMI H, 1979, ARCH DERMATOL, V115, P740, DOI 10.1001/archderm.115.6.740
   VANDERVEEN EE, 1982, CUTIS, V30, P761
NR 12
TC 8
Z9 9
U1 0
U2 2
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD SEP-OCT
PY 2011
VL 86
IS 5
BP 995
EP 998
DI 10.1590/S0365-05962011000500020
PG 4
WC Dermatology
SC Dermatology
GA 857WY
UT WOS:000297756500020
PM 22147042
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Costa, MC
   Abraham, LS
   Ardigo, M
   Picardo, M
   Araujo, PL
   Azulay-Abulafia, L
   Pineiro-Maceira, JM
AF Costa, M. C.
   Abraham, L. S.
   Ardigo, M.
   Picardo, M.
   Araujo, P. L.
   Azulay-Abulafia, L.
   Pineiro-Maceira, J. M.
TI Hairs presence and pigmentation in vitiligo lesions: the usefulness of
   dermatoscopy in prognosis and treatment response evaluation
SO PIGMENT CELL & MELANOMA RESEARCH
LA English
DT Meeting Abstract
C1 Inst Dermatol Prof Azulay, Rio De Janeiro, Brazil.
   Inst Dermatol Prof Azulay, Brasilia, DF, Brazil.
RI Costa, Mariana C/K-5895-2012; Ardigo, Marco/E-5741-2018
OI Ardigo, Marco/0000-0002-5772-4937
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1755-1471
J9 PIGM CELL MELANOMA R
JI Pigment Cell Melanoma Res.
PD AUG
PY 2011
VL 24
IS 4
BP 788
EP 788
PG 1
WC Oncology; Cell Biology; Dermatology
SC Oncology; Cell Biology; Dermatology
GA 808YZ
UT WOS:000294019200120
DA 2020-12-01
ER

PT J
AU de Souza, SR
   Azulay-Abulafia, L
   do Nascimento, LV
AF de Souza, Savio Reder
   Azulay-Abulafia, Luna
   do Nascimento, Leninha Valerio
TI Validation of the Commitment Index of Skin and Mucous Membranes in
   Pemphigus Vulgaris for the clinical evaluation of patients with
   pemphigus vulgaris
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Pemphigus; Severity of Illness Index; Therapeutics
AB BACKGROUND: Pemphigus vulgaris is a severe bullous disease, produced by the autoimmune destruction of desmosomes, resulting in the formation of intraepidermal blisters, affecting skin and mucous membranes, with a mortality of 5 to 10%. Side effects of therapy contributed to increased morbidity, accounting for considerable part of the immediate causes of death due to PV today. There is no reproducible score for clinical evaluation of patients with Pemphigus vulgaris, making the therapeutic decision subjective, and its results, uncertain.
   OBJECTIVES: Create and evaluate the reproducibility of a scoring system for clinical evaluation of patients with pemphigus vulgaris.
   METHODS: The Commitment Index of Skin and Mucous in Pemphigus Vulgaris was created, scoring easily observed findings on clinical examination. During 3 years, 7 patients with active PV were submitted to pairings of Commitment Index of Skin and Mucous in Pemphigus Vulgaris conduced by independent examiners for determinate its reproducibility.
   RESULTS: The Commitment Index of Skin and Mucous in Pemphigus Vulgaris proved that it is reproducible in all the statistical methods used to assess agreement between the independent examiners. In adition, it permited us to separate the patients into classes of severity.
   CONCLUSION: The Commitment Index of Skin and Mucous in Pemphigus Vulgaris can classify the severity of Pemphigus Vulgaris, contributing to medical research, and to the standardization of the therapy in the near future.
C1 [de Souza, Savio Reder; Azulay-Abulafia, Luna; do Nascimento, Leninha Valerio] Univ Estado Rio De Janeiro, Pedro Ernesto Teaching Hosp, Rio De Janeiro, Brazil.
RP de Souza, SR (corresponding author), Rua Miguel de Frias 41,Ap 801,Bloco 3, BR-24220008 Niteroi, RJ, Brazil.
EM physician-d@uol.com.br
CR Aoki V, 2008, AN BRAS DERMATOL, V83, P157, DOI 10.1590/S0365-05962008000200010
   Camacho-Alonso Fabio, 2005, Med Oral Patol Oral Cir Bucal, V10, P282
   Fellner MJ, 2001, MT SINAI J MED, V68, P268
   HABIF TP, 2005, DERMATOLOGIA CLIN GU, P561
   Lenz P, 1999, ARCH DERMATOL, V135, P143, DOI 10.1001/archderm.135.2.143
   Mimouni D, 2002, DERMATOL THER, V15, P362
   ODOM RB, 2000, ANDREWS DIS SKIN CLI, P574
   Pfutze M, 2007, EUR J DERMATOL, V17, P4
   Sanchez-Perez J, 2005, ACTAS DERMO-SIFILOGR, V96, P329, DOI 10.1016/S0001-7310(05)73090-8
   Scully C, 2002, CRIT REV ORAL BIOL M, V13, P397, DOI 10.1177/154411130201300504
   Sitaru C, 2007, ARCH DERMATOL RES, V299, P1, DOI 10.1007/s00403-007-0734-0
NR 11
TC 2
Z9 3
U1 0
U2 1
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD MAR-APR
PY 2011
VL 86
IS 2
BP 284
EP 291
DI 10.1590/S0365-05962011000200012
PG 8
WC Dermatology
SC Dermatology
GA 767OT
UT WOS:000290866600012
PM 21603812
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU da Silva, RS
   Bressan, AL
   Nascimento, LB
   Kac, BK
   Azulay-Abulafia, L
AF da Silva, Roberto Souto
   Bressan, Aline Lopes
   Nascimento, Livia Barbosa
   Kac, Bernard Kawa
   Azulay-Abulafia, Luna
TI Tufted angioma and myofascial pain syndrome
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA Portuguese
DT Article
DE Local anesthesia; Hemangioma; Myofascial pain syndrome
ID SPONTANEOUS REGRESSION
AB Tufted angioma is a rare acquired vascular tumor. It is characterized by painful purplish macules that may progress to plaques containing angiomatous papules. The condition is benign; however, it often affects extensive areas of the skin, leading to functional disability of the affected limb if painful. The present report describes a case of a tufted angioma associated with myofascial pain syndrome in which the predisposing element was the presence of this tumor since childhood. Pain at the site of the lesion affected muscle use and led to the onset of the associated syndrome. Complete relief from symptoms was achieved by blocking the trigger points of the affected limb with anesthesia.
C1 [da Silva, Roberto Souto; Bressan, Aline Lopes; Nascimento, Livia Barbosa; Kac, Bernard Kawa; Azulay-Abulafia, Luna] Univ Estado Rio de Janeiro, Serv Dermatol, HUPE, BR-20550011 Rio De Janeiro, Brazil.
RP da Silva, RS (corresponding author), Praia Joao Caetano 81,Apt 602, BR-24210405 Niteroi, RJ, Brazil.
EM rs_souto@yahoo.com.br
CR BERNSTEIN EF, 1994, J AM ACAD DERMATOL, V31, P307, DOI 10.1016/S0190-9622(94)70160-1
   Cardoso Alberto Oiticica, 2006, An. Bras. Dermatol., V81, pS273, DOI 10.1590/S0365-05962006000900003
   HEAGERTY AHM, 1992, CLIN EXP DERMATOL, V17, P344, DOI 10.1111/j.1365-2230.1992.tb00227.x
   Herron MD, 2002, PEDIATR DERMATOL, V19, P394, DOI 10.1046/j.1525-1470.2002.00113.x
   Jang KA, 1998, BRIT J DERMATOL, V138, P912
   LAM WY, 1994, J CUTAN PATHOL, V21, P461, DOI 10.1111/j.1600-0560.1994.tb00290.x
   McKenna KE, 2000, CLIN EXP DERMATOL, V25, P656, DOI 10.1046/j.1365-2230.2000.00730-3.x
   SANDE LP, 1999, REV BRAS FISIOTER, V4, P1
   Satter EK, 2002, PEDIATR DERMATOL, V19, P445, DOI 10.1046/j.1525-1470.2002.00204.x
   Simons D. G., 2002, J BODYW MOV THER, V6, P81, DOI DOI 10.1054/jbmt.2002.0271
   Wong SN, 2002, PEDIATR DERMATOL, V19, P388, DOI 10.1046/j.1525-1470.2002.00112.x
   Yeng LT, 2001, REV MED, V80, P94
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD JAN-FEB
PY 2011
VL 86
IS 1
BP 119
EP 121
PG 3
WC Dermatology
SC Dermatology
GA 739LB
UT WOS:000288717400017
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Abraham, LS
   Azulay-Abulafia, L
   Aguiar, DD
   Torres, F
   Argenziano, G
AF Abraham, Leonardo Spagnol
   Azulay-Abulafia, Luna
   Aguiar, Danielle de Paula
   Torres, Fernanda
   Argenziano, Giuseppe
TI Dermoscopy features for the diagnosis of furuncular myiasis
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Dermoscopy; Diagnosis; Myiasis; Parasitic diseases
ID DERMATOBIA-HOMINIS
AB We describe a 56-year-old Brazilian woman presenting three nodular lesions on the scalp. Dermoscopy of all lesions showed a creamy-white body with central bird's feet-like structures surrounded by a thorn crown, corresponding to the posterior segment of the Dermatobia hominis larvae. These novel dermoscopic features allowed us to easily diagnose furuncular myiasis.
C1 [Abraham, Leonardo Spagnol; Azulay-Abulafia, Luna; Aguiar, Danielle de Paula; Torres, Fernanda; Argenziano, Giuseppe] Inst Dermatol Prof Rubem David Azulay, Dept Dermatol, Rio De Janeiro, Brazil.
RP Abraham, LS (corresponding author), 32-201 B Laranjeiras, BR-22231110 Rio De Janeiro, Brazil.
EM leosabraham@gmail.com
RI Abraham, Leonardo S/I-8721-2016; Argenziano, Giuseppe/E-5926-2010
OI Abraham, Leonardo S/0000-0002-9165-6026; Argenziano,
   Giuseppe/0000-0003-1413-8214
CR Abraham LS, 2010, AN BRAS DERMATOL, V85, P723, DOI 10.1590/S0365-05962010000500022
   Abraham LS, 2010, J AM ACAD DERMATOL, V63, P721, DOI 10.1016/j.jaad.2009.12.011
   Bakos RM, 2007, ARCH DERMATOL, V143, P123, DOI 10.1001/archderm.143.1.123
   Clyti E, 2008, Med Trop (Mars), V68, P7
   Llamas-Velasco M, 2010, ACTAS DERMO-SIFILOGR, V101, P893, DOI 10.1016/j.ad.2010.03.026
   Maier H, 2004, J AM ACAD DERMATOL, V50, pS26, DOI 10.1016/S0190-9622(03)01488-9
   Micali G, 2010, SER DERMATOL TREAT, P1
   Mohrenschlager M, 2007, J AM ACAD DERMATOL, V57, P716, DOI 10.1016/j.jaad.2007.05.019
   Zalaudek I, 2008, DERMATOLOGY, V216, P14, DOI 10.1159/000109353
NR 9
TC 10
Z9 10
U1 0
U2 1
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD JAN-FEB
PY 2011
VL 86
IS 1
BP 154
EP 156
PG 3
WC Dermatology
SC Dermatology
GA 739LB
UT WOS:000288717400027
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Vilar, AN
   Ferreira, ACF
   Paula, MD
   Lopes, MRA
   Aguiar, LS
   Schechtman, R
   Azulay-Abulafia, L
   Azulay, DR
AF Vilar, A. N.
   Ferreira, A. C. F.
   Paula, M. D.
   Lopes, M. R. A.
   Aguiar, L. S.
   Schechtman, R.
   Azulay-Abulafia, L.
   Azulay, D. R.
TI Subcutaneous pre- patellar Phaeohyphomycosis in an immunocompetent
   patient: a case in the state of Santa Catarina, Brazil
SO HISTOPATHOLOGY
LA English
DT Meeting Abstract
CT 28th International Congress of the International-Academy-of-Pathology
CY OCT 10-15, 2010
CL Sao Paulo, BRAZIL
SP Int Acad Pathol
C1 [Vilar, A. N.; Lopes, M. R. A.; Aguiar, L. S.; Schechtman, R.; Azulay-Abulafia, L.; Azulay, D. R.] Dermatol Inst Prof Rubem David Azulay, Rio De Janeiro, Brazil.
   [Vilar, A. N.; Ferreira, A. C. F.] Neo Diagnost, Concordia, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0309-0167
J9 HISTOPATHOLOGY
JI Histopathology
PD OCT
PY 2010
VL 57
SU 1
MA 494
BP 177
EP 177
PG 1
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 656GW
UT WOS:000282317400492
DA 2020-12-01
ER

PT J
AU Abraham, LS
   Torres, FN
   Azulay-Abulafia, L
AF Abraham, Leonardo Spagnol
   Torres, Fernanda Nogueira
   Azulay-Abulafia, Luna
TI Dermoscopic clues to distinguish trichotillomania from patchy alopecia
   areata
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Editorial Material
DE Alopecia; Anxiety disorders; Dermoscopy; Differential Diagnosis; Nail
   biting
ID INCOGNITA; DIAGNOSIS
AB BACKGROUND: Trichotillomania and patchy alopecia areata have similar clinical and dermoscopic features.
   OBSERVATIONS: In trichotillomania, dermoscopy shows decreased hair density, short vellus hair, broken hairs with different shaft lengths, coiled hairs, short vellus hair, trichoptilosis, sparse yellow dots, which may or may not contain black dots and no exclamation mark hairs.
   CONCLUSIONS: In the case of patchy alopecia and broken hairs, the absence of exclamation mark hairs suggests a diagnosis of trichotillomania. On the other hand, the finding of yellow dots without black dots does not exclude it.
C1 [Abraham, Leonardo Spagnol] IDERJ, BR-22470220 Rio De Janeiro, Brazil.
RP Abraham, LS (corresponding author), IDERJ, R Alexandre Ferreira 206, BR-22470220 Rio De Janeiro, Brazil.
EM leosabraham@gmail.com
RI Abraham, Leonardo S/I-8721-2016
OI Abraham, Leonardo S/0000-0002-9165-6026
CR Bartels NGB-PU, 2008, HAIR GROWTH DISORDER, P293
   Inui S, 2008, INT J DERMATOL, V47, P688, DOI 10.1111/j.1365-4632.2008.03692.x
   Inui S, 2007, J DERMATOL, V34, P635, DOI 10.1111/j.1346-8138.2007.00345.x
   Lee DY, 2009, J EUR ACAD DERMATOL, V23, P731, DOI 10.1111/j.1468-3083.2009.03193.x
   Pereira José Marcos, 2004, An. Bras. Dermatol., V79, P609, DOI 10.1590/S0365-05962004000500012
   Rakowska A, 2009, J AM ACAD DERMATOL, V60, P162, DOI 10.1016/j.jaad.2008.07.062
   Rivitti Evandro A., 2005, An. Bras. Dermatol., V80, P57, DOI 10.1590/S0365-05962005000100009
   Ross EK, 2006, J AM ACAD DERMATOL, V55, P799, DOI 10.1016/j.jaad.2006.04.058
   Tosti A, 2008, J AM ACAD DERMATOL, V59, P64, DOI 10.1016/j.jaad.2008.03.031
NR 9
TC 36
Z9 42
U1 0
U2 6
PU SOC BRASILEIRA DERMATOLOGIA
PI RIO DE JANEIRO RJ
PA AV RIO BRANCO, 39-18 ANDAR, RIO DE JANEIRO RJ, 20090-003, BRAZIL
SN 0365-0596
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD SEP-OCT
PY 2010
VL 85
IS 5
BP 723
EP 726
DI 10.1590/S0365-05962010000500022
PG 4
WC Dermatology
SC Dermatology
GA 693TM
UT WOS:000285248300021
PM 21152803
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Sakuma, TH
   Kac, BK
   Azulay-Abulafia, L
   Rajagopal, R
AF Sakuma, Thais Harumi
   Kac, Bernard Kawa
   Azulay-Abulafia, Luna
   Rajagopal, Ram
TI Digital measurement of melasma: Towards eliminating subjectivity from
   treatment evaluation
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the American-Academy-of-Dermatology
CY MAR 05-09, 2010
CL Miami, FL
SP Amer Acad Dermatol
C1 [Sakuma, Thais Harumi] Univ Fed Rio de Janeiro, HUGG Unirio, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, Santa Casa Misericordia Rio de Janeiro, Rio De Janeiro, Brazil.
   [Rajagopal, Ram] Univ Calif Berkeley, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAR
PY 2010
VL 62
IS 3
SU S
BP AB64
EP AB64
PG 1
WC Dermatology
SC Dermatology
GA 573AL
UT WOS:000275880700245
DA 2020-12-01
ER

PT J
AU Felix, PAO
   Azulay-Abulafia, L
AF Felix, P. A. O.
   Azulay-Abulafia, L.
TI FIRST BRAZILIAN REGISTRY OF BIOLOGICAL TREATMENT IN PSORIASIS PATIENTS:
   PRELIMINARY CONCEPT AND RESULTS
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Felix, P. A. O.] Hosp Servidor Estadual, Rio De Janeiro, Brazil.
   [Azulay-Abulafia, L.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1098-3015
J9 VALUE HEALTH
JI Value Health
PD OCT
PY 2009
VL 12
IS 7
BP A527
EP A527
DI 10.1016/S1098-3015(10)75501-7
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA 495GH
UT WOS:000269878101425
DA 2020-12-01
ER

PT J
AU Charlin, R
   Barcaui, CB
   Kac, BK
   Soares, DB
   Rabello-Fonseca, R
   Azulay-Abulafia, L
AF Charlin, Raul
   Barcaui, Carlos B.
   Kac, Bernard Kawa
   Soares, Deborah Brazuna
   Rabello-Fonseca, Rosa
   Azulay-Abulafia, Luna
TI Hydroquinone-induced exogenous ochronosis: a report of four cases and
   usefulness of dermoscopy
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
ID SWITCHED RUBY-LASER; BLEACHING CREAMS; PIGMENTATION; MELASMA; SKIN;
   DERMABRASION; CARBOLURIA; LESIONS; BLACKS
AB Hydroquinone is the first choice of topical bleaching agents used in treatment of melasma. In Brazil, hydroquinone is widely prescribed by physicians and often used by patients without a prescription. The principal adverse effects of its chronic use are confetti-like depigmentation and exogenous ochronosis. The latter manifests clinically with gray-brown or blue-black hyperpigmentation, as well as pinpoint hyperchromic papules that look like caviar, and therefore called caviar-like. On histopathology, curved ochre-colored structures, 'banana-shaped' fibers, appear in the papillary dermis. No description of dermoscopy in ochronosis is found in the literature. We report four cases of hydroquinone-induced exogenous ochronosis. Dermoscopy was performed in two patients on the areas with ochronosis, and in addition to the melasma findings, amorphous densely pigmented structures obliterating some follicular openings were observed. Exogenous ochronosis is an avoidable dermatosis that is difficult to treat. Dermatologists should be able to differentiate it from melasma and immediately discontinue hydroquinone. Dermoscopy might become a valuable resource in approaching exogenous ochronosis.
C1 [Charlin, Raul; Barcaui, Carlos B.; Kac, Bernard Kawa; Soares, Deborah Brazuna; Rabello-Fonseca, Rosa; Azulay-Abulafia, Luna] Hosp Santa Casa Misericordia Rio de Janeiro, Inst Dermatol Prof RD Azulay, Rio De Janeiro, Brazil.
RP Charlin, R (corresponding author), Los Navegantes 2179 Depto B, Santiago, Chile.
EM rauliano@hotmail.com
CR Beddard AP, 1912, Q J MED, V5, P505
   Bellew SG, 2004, DERMATOL SURG, V30, P555, DOI 10.1111/j.1524-4725.2004.30177.x
   Berry JL, 1931, LANCET, V2, P124
   BROGREN N, 1952, Acta Derm Venereol, V32, P258
   CONNOR T, 1987, ARCH DERMATOL, V123, P105, DOI 10.1001/archderm.123.1.105
   CONNOR T, 1987, ARCH DERMATOL, V123, P108
   CULLISON D, 1983, J AM ACAD DERMATOL, V8, P882, DOI 10.1016/S0190-9622(83)80022-X
   DIVEN DG, 1990, J DERMATOL SURG ONC, V16, P1018, DOI 10.1111/j.1524-4725.1990.tb00326.x
   DOGLIOTTI M, 1979, S AFR MED J, V56, P757
   EGORIN MJ, 1976, JAMA-J AM MED ASSOC, V236, P385, DOI 10.1001/jama.236.4.385
   FINDLAY GH, 1975, BRIT J DERMATOL, V93, P613, DOI 10.1111/j.1365-2133.1975.tb05110.x
   Fisher AA, 1998, CUTIS, V62, P11
   Fitzpatrick T., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345
   GOLDSMITH LA, 1993, DERMATOLOGY GEN MED, P1841
   Grimes PE, 2005, AM J DERMATOPATH, V27, P96, DOI 10.1097/01.dad.0000154419.18653.2e
   HOSHAW RA, 1985, ARCH DERMATOL, V121, P105, DOI 10.1001/archderm.121.1.105
   HOWARD KL, 1990, CUTIS, V45, P180
   HRUZA GJ, 1991, ARCH DERMATOL, V127, P1799, DOI 10.1001/archderm.127.12.1799
   JACYK WK, 1995, AM J DERMATOPATH, V17, P18, DOI 10.1097/00000372-199502000-00004
   Jeghers H, 1944, NEW ENGL J MED, V231, P88, DOI 10.1056/NEJM194407202310304
   JORDAAN HF, 1991, AM J DERMATOPATH, V13, P418, DOI 10.1097/00000372-199108000-00015
   Kang WH, 2002, BRIT J DERMATOL, V146, P228, DOI 10.1046/j.0007-0963.2001.04556.x
   Kramer KE, 2000, J AM ACAD DERMATOL, V42, P869, DOI 10.1016/S0190-9622(00)90257-3
   LADU BN, 2001, METABOLIC MOL BASES, P1371
   LANG PG, 1988, J AM ACAD DERMATOL, V19, P942, DOI 10.1016/S0190-9622(88)70255-8
   LUDWIG GD, 1963, ANN INTERN MED, V59, P378, DOI 10.7326/0003-4819-59-3-378
   ODONOGHUE MN, 1983, J AM ACAD DERMATOL, V8, P123, DOI 10.1016/S0190-9622(83)80287-4
   PENNEYS NS, 1985, ARCH DERMATOL, V121, P1239, DOI 10.1001/archderm.1985.01660100019003
   SANCHEZ NP, 1981, J AM ACAD DERMATOL, V4, P698, DOI 10.1016/S0190-9622(81)70071-9
   SCHULZ EJ, 1988, S AFR MED J, V73, P59
   SNIDER RL, 1993, J AM ACAD DERMATOL, V28, P662, DOI 10.1016/S0190-9622(08)81794-X
   STOLZ W, 2002, COLOR ATLAS DERMOSCO, P121
   SUGAR H S, 1946, Ill Med J, V89, P234
   TAYLOR CR, 1990, ARCH DERMATOL, V126, P893, DOI 10.1001/archderm.126.7.893
   TUFFANELLI D, 1963, ARCH DERMATOL, V88, P419, DOI 10.1001/archderm.1963.01590220051006
   VanOffel JF, 1995, ACTA CLIN BELG, V50, P358, DOI 10.1080/17843286.1995.11718475
   Victor FC, 2004, J CUTAN MED SURG, V8, P97, DOI 10.1177/120347540400800204
   VIRCHOW R, 1866, VIRCHOWS ARCH PATHOL, V37
NR 38
TC 47
Z9 47
U1 0
U2 6
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0011-9059
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD JAN
PY 2008
VL 47
IS 1
BP 19
EP 23
DI 10.1111/j.1365-4632.2007.03351.x
PG 5
WC Dermatology
SC Dermatology
GA 242QB
UT WOS:000251739400005
PM 18173595
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Spinelli, LP
   Hardmann, D
   Kac, BK
   Levy, RA
   Talhari, C
   Ruzicka, T
AF Azulay-Abulafia, L.
   Spinelli, L. Pereira
   Hardmann, D.
   Kac, B. Kawa
   Levy, R. A.
   Talhari, C.
   Ruzicka, T.
TI Lucio phenomenon. Vasculitis or occlusive vasculopathy?
SO HAUTARZT
LA German
DT Article
DE lucio phenomenon; lucio leprosy; antiphospholipid syndrome; thrombosis;
   lepromatous leprosy
ID ANTIPHOSPHOLIPID SYNDROME
AB Lucio's phenomenon (LP) occurs in patients with Lucio leprosy (LuL). Some interpret the cutaneous lesions and their histopathology as a thrombotic/occlusive condition, while others consider it leukocytoclastic vasculitis. The clinical similarities between the cutane-, ous manifestations of LP and antiphospholipid syndrome (APS) led us to investigate the relationship between these two,pathological conditions. We studied the clinical; laboratory and histopathologic aspects of LUL and LP in one patient and compare these results to APS. The examination,of antiphospholipid id antibodies showed positive anticardiolipin (aCL) and lupus anticoagulant (LAC). The-histopathological slides of cutaneous biopsies were stained by hematoxylin-eosin and Fite-Faraco. They showed the typical features of LuL, as well as thrombi, endothelial proliferation, vessel wall thickening and obliteration of the lumen. Leukocytoclastic vasculitis was not found. The clinical pattern of LuL in our case is identical to that described by Lucio and Latapi. The necrotic lesions of LP in our patient resembled APS. This suggests that LP could be considered APS secondary to LuL. Multidrug treatment for multibacillary patients (MDT-MP) was successful, with no need for thalidomide or systemic corticosteroids.
C1 Univ Dusseldorf, Hautklin, D-40225 Dusseldorf, Germany.
   Inst Dermatol Prof RD Azulay, Rio De Janeiro, Brazil.
   UERJ, Inst Rheumatol, Rio De Janeiro, Brazil.
   Univ Dusseldorf, Hautklin, D-4000 Dusseldorf, Germany.
RP Azulay-Abulafia, L (corresponding author), Univ Dusseldorf, Hautklin, Moorenstr 5, D-40225 Dusseldorf, Germany.
RI Levy, Roger A/K-3087-2014
OI Levy, Roger A/0000-0001-6393-6031
CR ACKERMAN AB, 1997, HISTOLOGIC DIAGNOSIS, P33
   Azulay R D, 1975, Z Hautkr, V50, P5
   DONNER RS, 1967, ANN INTERN MED, V67, P831, DOI 10.7326/0003-4819-67-4-831
   FURTADO T A, 1959, Int J Lepr, V27, P110
   Gibert E, 1982, Med Cutan Ibero Lat Am, V10, P41
   Gibson GE, 1997, J AM ACAD DERMATOL, V36, P970, DOI 10.1016/S0190-9622(97)80283-6
   Hughes GRV, 1996, LUPUS, V5, P345, DOI 10.1177/096120339600500502
   LATAPI F., 1948, International Journal of Leprosy, V16, P421
   LATAPI F, 1978, DERMATOL REV MEX, V22, P108
   LATAPI F, 1975, SEM MICR DERM INT SO
   LATAPI F, 1978, DERMATOL REV MEX, V22, P102
   LATAPI F, 1950, R PRENSA MED MEXICAN, V25, P416
   LATAPI F, 1948, MEM 5 C INT LEPR HAB, P102
   Lie JT, 1996, LUPUS, V5, P368, DOI 10.1177/096120339600500506
   Lucio R, 1978, DERMATOL REV MEX, V22, P93
   MERCAU AR, 1966, LEPROLOGIA, V11, P30
   Piette JC, 1996, LUPUS, V5, P354, DOI 10.1177/096120339600500504
NR 17
TC 10
Z9 11
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0017-8470
J9 HAUTARZT
JI Hautarzt
PD DEC
PY 2006
VL 57
IS 12
BP 1101
EP 1104
DI 10.1007/s00105-005-1086-3
PG 4
WC Dermatology
SC Dermatology
GA 119SQ
UT WOS:000243034000007
PM 16470373
DA 2020-12-01
ER

PT J
AU Issa, MC
   Azulay-Abulafia, L
   Vega, J
   Ferreira, T
   Azulay, RD
AF Issa, MC
   Azulay-Abulafia, L
   Vega, J
   Ferreira, T
   Azulay, RD
TI Confluent and reticulated papillomatosis (Gougerot-Carteaud Syndrome)
   treated with azithromycin pulse therapy
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 64th Annual Meeting of the American-Academy-of-Dermatology
CY MAR 03-07, 2006
CL San Francisco, CA
SP Amer Acad Dermatol
C1 Inst Dermatol Prof RD Azulay, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAR
PY 2006
VL 54
IS 3
SU S
BP AB54
EP AB54
PG 1
WC Dermatology
SC Dermatology
GA 017VI
UT WOS:000235721000207
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Spinelli, L
   Kac, B
AF Azulay-Abulafia, L
   Spinelli, L
   Kac, B
TI Lucio' phenomenon: A favorable outcome with multidrug therapy
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the American-Academy-of-Dermatology
CY FEB 06-11, 2004
CL WASHINGTON, DC
SP Amer Acad Dermatol
C1 Inst Dermatol Prof RD Azulay, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAR
PY 2004
VL 50
IS 3
SU S
MA P376
BP P98
EP P98
DI 10.1016/j.jaad.2003.10.318
PG 1
WC Dermatology
SC Dermatology
GA 802CC
UT WOS:000220140600374
DA 2020-12-01
ER

PT J
AU Azulay-Abulafia, L
   Bomfim, S
   Quintanilha, F
   Azulay, R
AF Azulay-Abulafia, L
   Bomfim, S
   Quintanilha, F
   Azulay, R
TI Darie's disease treated with acitretin
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the American-Academy-of-Dermatology
CY FEB 06-11, 2004
CL WASHINGTON, DC
SP Amer Acad Dermatol
C1 Ctr Dermatol Prof Azulay, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAR
PY 2004
VL 50
IS 3
SU S
MA P340
BP P89
EP P89
DI 10.1016/j.jaad.2003.10.282
PG 1
WC Dermatology
SC Dermatology
GA 802CC
UT WOS:000220140600338
DA 2020-12-01
ER

PT J
AU Levy, RA
   Pierangeli, SA
   Espinola, RG
   Azulay-Abulafia, L
   Harris, NE
   Gharavi, AE
AF Levy, RA
   Pierangeli, SA
   Espinola, RG
   Azulay-Abulafia, L
   Harris, NE
   Gharavi, AE
TI Antiphospholipid beta 2-glycoprotein I dependency assay to determine
   antibody pathogenicity.
SO ARTHRITIS AND RHEUMATISM
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0004-3591
J9 ARTHRITIS RHEUM
JI Arthritis Rheum.
PD SEP
PY 2000
VL 43
IS 9
SU S
MA 1476
BP S312
EP S312
PG 1
WC Rheumatology
SC Rheumatology
GA 357JU
UT WOS:000089495801528
DA 2020-12-01
ER

PT J
AU AZULAY, RD
   AZULAYABULAFIA, L
   SODRE, CT
   AZULAY, DR
   AZULAY, MM
AF AZULAY, RD
   AZULAYABULAFIA, L
   SODRE, CT
   AZULAY, DR
   AZULAY, MM
TI LYME-DISEASE IN RIO-DE-JANEIRO, BRAZIL
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
AB Five patients living in Rio de Janeiro, Brazil, were found to have Lyme disease.  These are among the first known cases in South America.
C1 DERMATOL CTR,RIO DE JANEIRO,BRAZIL.
CR ABELE DC, 1990, J AM ACAD DERMATOL, V23, P167, DOI 10.1016/0190-9622(90)70196-O
   Afzelius A, 1921, ACTA DERM-VENEREOL, V2, P120
   Afzelius A., 1910, ARCH DERMATOLOGIE SY, V101, P404, DOI 10.1007/BF01832773
   BAFVERSTEDT B, 1943, ACTA DERM-VENEREOL, V11, P1
   BURGDORFER W, 1984, YALE J BIOL MED, V57, P515
   BURKE WA, 1986, J AM ACAD DERMATOL, V14, P137, DOI 10.1016/S0190-9622(86)80395-4
   DATTWYLER RJ, 1988, NEW ENGL J MED, V319, P1441, DOI 10.1056/NEJM198812013192203
   Duray P H, 1989, Adv Dermatol, V4, P255
   FILGUEIRA AL, 1989, RIODERMATOL, V2, P4
   HERXHEIMER K, 1902, ARCH DERMATOL SYPHIL, P255
   HERXHEIMER K, 1902, ARCH DERMATOL SYPHIL, P57
   STEERE AC, 1979, ANN INTERN MED, V91, P730, DOI 10.7326/0003-4819-91-5-730
   STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102
   WILKINSON HW, 1984, YALE J BIOL MED, V57, P567
NR 14
TC 23
Z9 25
U1 1
U2 1
PU DECKER PERIODICALS INC
PI HAMILTON
PA 4 HUGHSON STREET SOUTH PO BOX 620, LCD 1, HAMILTON ON L8N 3K7, CANADA
SN 0011-9059
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD AUG
PY 1991
VL 30
IS 8
BP 569
EP 571
PG 3
WC Dermatology
SC Dermatology
GA GA334
UT WOS:A1991GA33400008
PM 1938055
DA 2020-12-01
ER

PT J
AU AZULAY, DR
   AZULAYABULAFIA, L
AF AZULAY, DR
   AZULAYABULAFIA, L
TI ISOTRETINOIN-ASSOCIATED GRANULATION-TISSUE TREATED WITH OCCLUSIVE
   CORTICOSTEROID TAPE
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Letter
RP AZULAY, DR (corresponding author), CTR DERMATOL PROF AZULAY,AVE COPACABAMA 978-1402,BR-22070 RIO DE JANEIRO,BRAZIL.
CR CAMPBELL JP, 1983, J AM ACAD DERMATOL, V9, P708, DOI 10.1016/S0190-9622(83)70184-2
   ECNER JH, 1983, ARCH DERMATOL, V119, P808
NR 2
TC 1
Z9 1
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PY 1985
VL 13
IS 4
BP 670
EP 670
DI 10.1016/S0190-9622(85)80451-5
PG 1
WC Dermatology
SC Dermatology
GA ARP10
UT WOS:A1985ARP1000026
PM 2934440
DA 2020-12-01
ER

PT J
AU AZULAY, DR
   AZULAYABULAFIA, L
AF AZULAY, DR
   AZULAYABULAFIA, L
TI ISOTRETINOIN-ASSOCIATED GRANULATION-TISSUE TREATED WITH OCCLUSIVE
   CORTICOSTEROID TAPE
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Letter
CR GREKIN, 1985, J AM ACAD D, V13
NR 1
TC 3
Z9 3
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PY 1985
VL 13
IS 5
BP 837
EP 837
DI 10.1016/S0190-9622(85)80413-8
PG 1
WC Dermatology
SC Dermatology
GA ATK45
UT WOS:A1985ATK4500034
PM 3865941
DA 2020-12-01
ER

EF